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ABSTRACT 
 
 Metabolic perturbations including hyperinsulinemia that are induced during 
obesity and heat stress in humans and production animals are allied with several health 
hallmarks and impaired fertility. This dissertation research focused on charactering the 
impact of changes to central metabolism on ovarian function. We hypothesized that 
hyperinsulinemia induced during central metabolic perturbations, alters ovarian insulin-
mediated PI3K signaling, negatively impacting ovarian folliculogenesis, steroidogenesis 
and xenobiotic biotransformation. To test this hypothesis, mRNA and protein expression 
profiles of insulin, PI3K, steroidogenic, inflammatory and chemical metabolism 
members were quantified using qRT-PCR, Western blotting or immunohistochemistry 
techniques using three models of hyperinsulinemia: 1) high fat diet (HFD)-induced 
obesity, 2) a transgenic mouse model of progressive obesity and 3) a porcine model of 
hyperinsulinemia.  Overall, our data demonstrates that the ovarian insulin-KITLG-KIT-
AKT signaling pathway is active and upregulated during central metabolic alterations. 
Perturbations to ovarian insulin-KITLG-KIT-AKT signaling pathway are likely to 
impact 1) follicle activation, oocyte viability and recruitment, 2) steroid hormone 
biosynthesis, and 3) xenobiotic biotransformation, potentially accelerating susceptibility 
to chemical exposure. All of these scenarios could lead to impairment of ovarian 
function, and may at least partially explain why female fecundity is compromised during 
altered metabolic states. 
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ORGANIZATION OF THE DISSERTATION 
 
This dissertation is organized into eight chapters and an appendix. Chapter 1 is 
the general introduction to the research. Chapter 2 focusses on the impact of high fat diet 
induced obesity on ovarian phosphatidylinositol-3 kinase (PI3K) signaling gene 
expression. We hypothesized that obesity induced by high fat diet feeding would alter 
ovarian PI3 kinase signaling factors involved in regulating both primordial follicular 
activation and xenobiotic biotransformation in female mice. These experiments showed 
that diet-induced obesity induces increased PI3K signaling pathway potentially altering 
the rate of primordial follicle activation and oocyte viability.  Additionally, the 
expression of major xenobiotic biotransformation enzymes, that are important in ovarian 
response to ovotoxicant exposure, were also changed. In chapter 3, the impact of diet-
induced obesity on immune cell infiltration and expression of inflammatory cytokine 
genes in mouse ovarian and peri-ovarian adipose depot tissues was determined. These 
data demonstrated that diet-induced obesity elevates expression of inflammatory 
mediator genes in both the ovary and surrounding adipose depot, potentially negatively 
affecting ovarian function. Chapter 4 focuses on the impact of progressive obesity on the 
expression of ovarian pro-inflammatory and steroidogenic pathway members in mice. 
This study demonstrates that progressive obesity alters the expression of inflammatory 
and steroidogenesis signaling pathway members in ways which could alter optimal 
ovarian function. In chapter 5 we examined the impact of progressive obesity on 
expression profiles of genes involved in ovarian insulin-PI3K/AKT dependent pathway 
and ovarian xenobiotic biotransformation in mice. These results suggest that, during 
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progressive obesity insulin and KITLG-KIT signaling members are upregulated, 
potentially leading to hyperactivation of the PI3K-AKT pathway and consequently 
resulting in derangements in follicular growth, activation, and oocyte viability, leading 
to impaired fecundity. In chapter 6, the impact of obesity on ovotoxicity induced by 
7,12-dimethylbenz[a]anthracene in mice was examined. These experiments further 
established that obesity induces increased follicular activation in conjunction with 
increased basal PI3K signaling. Additionally, ovaries from obese mice were more 
sensitive to DMBA-induced ovotoxicity, potentially due to increased bioactivation by 
higher basal and DMBA-induced EPHX1 levels expression and reduced detoxification 
due to lack of GSTP1 induction. In chapter 7 we investigate the effects of HS on insulin 
mediated PI3K and steroidogenic signaling in gilt ovaries. These results suggest that HS 
alters the expression of ovarian insulin mediated-PI3K signaling pathway members 
potentially impacting follicle activation and viability. Additionally, hyperthermia may 
act as an endocrine disrupting environmental exposure altering ovarian steroidogenesis 
with subsequent malproduction of critical ovarian hormones for fertility and pregnancy 
maintenance, leading to female infertility. Chapters 2-7 are presented as manuscripts 
published or submitted to respective journals. Chapter 8 presents the general conclusions 
from all these studies. In the appendix, some results which were not included in the 
manuscripts prepared for publication are summarized. 
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CHAPTER 1: GENERAL INTRODUCTION 
The Ovary 
 
The word “ovary” is derived from the Latin word “ovarium” which literally 
means “egg” or “nut”. Histologically (Figure 1 ), mammalian ovaries contain follicles at 
different stages of development and, post-ovulation, the corpus luteum (CL) (110). 
Individual follicles contain an innermost nucleated oocyte which is surrounded by 
granulosa cells (GC) and an outer layer of theca cells (TC) (110).The mammalian ovary 
plays two significant roles; 1) production of oocytes required for perpetuation of the 
species and 2) generation of hormones mainly progesterone, P4; 17β-estradiol, E2; 
inhibins and relaxin as well as peptide growth factors, which are critical for ovarian 
function and development of female secondary sex characteristics (67).  
 
Both the ovary and oocytes differentiate from the somatic lineages of the embryo 
during embryogenesis (67, 101). Briefly, during fertilization, a zygote is formed by 
fusion of the female oocyte and the male spermatozoon. The zygote goes through 
different stages of embryogenesis and once the sixteen-cell blastmeres are formed, cells 
will undergo differentiation until three lineages; trophectoderm (future placenta), 
epiblast (future embryo), and primitive endoderm (future york sac) are defined (67, 101). 
After implantation, cells within the epiblast undergo further differentiation to form the 
precursors of the primordial germ cells (PGCs), the first cells of the future ovary to be 
defined (67, 101). In due course, the ovary develops and permits the PGCs to 
differentiate into oocytes, which under coordinated signals from several proteins and 
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small RNAs, proliferate and enter meiosis 1 where they are eventually arrested in 
diplotene stage of prophase 1 (67, 101). The meiotically arrested oocytes later become 
surrounded by pre-granulosa cells and form individual primordial follicles. These 
primordial follicles comprise the resting pool of oocytes and retain the potential to be 
activated and recruited into the growing follicle pool during puberty, with the capacity to 
be ovulated and fertilized to contribute to the next generation (67, 73, 101).  
 
Ovarian folliculogenesis 
 
In mammals, ovarian folliculogenesis consist of three major stages namely, 
formation of the primordial follicles; recruitment into the growing pool to form primary, 
secondary and tertiary follicles; and lastly ovulation and subsequent formation of the CL 
(73, 74, 101, 164). Before ovarian follicles are formed, oocytes are present within germ 
cell clusters called germ cell cysts or nests (101). During primordial follicle formation, 
the germ cell cluster undergoes breakdown and the surviving oocytes are individually 
surrounded with a single layer of flattened squamous-shaped pre-granulosa cells. This 
marks the first stage of folliculogenesis taking 1-2 days in mice and the latter half of 
fetal development in humans (67, 100). These follicles are believed to be dormant, 
showing little to no biological activity, however, they retain the potential throughout 
their lifetime to be activated and recruited into the growing follicle pool from puberty to 
menopause under well-coordinated signaling cascades that continue to be discovered 
(67, 74, 100). Principally, the primordial follicles transition to the primary follicle 
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histologically characterized by a morphological change in the pre-granulosa cells from a 
squamous to cuboidal structure. During the primary stage, the oocyte genome is 
activated to allow gene transcription and follicles at this stage develop rudimentary 
receptors for the follicle stimulating hormone (FSH), but remain incapable of responding 
to gonadotropins until the antral stage (73). Also at this follicle development stage, the 
zona pellucida forms around the oocyte, separating it from the surrounding layer of GC 
(74). The primary follicles further transition to secondary follicles which contain an 
oocyte surrounded by multiple layers of stratified GC. At the secondary stage, another 
layer of somatic cells called the TC are recruited to the follicular structure (67, 72, 198). 
Thus at this stage, histologically the follicles are characterized by oocytes surrounded by 
multiple layers of GC and TC. In humans from initial recruitment to the secondary stage 
may take several months (245). The follicles continue to mature forming a fluid-filled 
cavity called the antrum. Follicles that acquire this structure are now referred to as antral 
or graafian follicles (245). The GC and TC continue to undergo mitosis in conjunction 
with increased antrum. At the tertiary follicular stage, the TC expresses luteinizing 
hormone (LH) receptors for androgen production and subsequent aromatization to 
estrogen by the GC. Also at this stage the majority of the follicles that began growth 
almost 9 – 12 months earlier have died (101), thus only a subset of activated follicles are 
eventually selected for dominance and ovulation (164).  
 
Although the ovary contains a number of follicles at different stages of 
development, in mammalian species, the number of primordial follicles is finite and 
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becomes the only oocyte reservoir available to female mammals throughout their 
reproductive lifespan (101). On average, the number of primordial follicles is about 
seven million follicles at or immediately after birth (245). However, this pool reduces 
drastically to as low as approximately <1 million follicles by the time a human female 
reaches puberty (101, 245). This number continues to decrease until menopause, a 
physiological condition where the female is incapable of experiencing the menstrual 
cycle, due to her ovary being devoid of follicles (101, 245).Therefore the rate at which 
this precious pool of primordial follicles is lost determines the rate and time at which 
females approach menopause. The process by which follicles die is believed to be 
through atresia (101, 123), which is a form of hormonal controlled programed cell death 
(apoptosis) (111). Although atresia occurs at all stages of folliculogenesis, it is believed 
that the majority of follicles become atretic at the antral stage (100), such that only a few 
of them undergo gonadotropin stimulation to reach the preovulatory stage (101). It is 
also important to note that germ cell cluster breakdown, primordial follicle formation 
and subsequent recruitment of primordial follicles to the growing follicular pool, remain 
the least understood steps of folliculogenesis. However, some key regulators of these 
initial stages of follicle development such as insulin, kit ligand (KITLG) and the 
phosphatidylinositol 3-kinase (PI3K) pathway have been identified to be involved (67, 
164, 210) and this research area continues to determine novel regulators of these 
processes. Despite the many unanswered questions during this crucial period, the 
concept of ovarian cross talk between oocytes and somatic cells is apparent from the 
formation of primordial follicles onward (67, 69, 163).  
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Steroid hormone production in the ovary 
 
Ovarian steroidogenesis is accomplished by two families of enzymes, the 
cytochrome P450-heme containing proteins and the hydroxysteroid dehydrogenases (3, 
88). LH released from the anterior pituitary will bind to LH receptors on ovarian TC to 
trigger signaling cascades that will increase the expression of genes encoding enzymes 
required to covert cholesterol to androgens (Testosterone and Androstenedione). In 
response, FSH is released from the anterior lobe of the pituitary and binds to the FSH 
receptor localized on the ovarian GC with a subsequent increase in expression of genes 
encoding enzymes necessary for aromatization of TC-derived androgens to estrogens 
(17β-estradiol and estrone). In TC, cholesterol is either synthesized de novo (159) or 
derived from lipoproteins through low density lipoprotein receptors (87). Once in the 
cytoplasm, cholesterol is then acted upon by steroidogenic acute regulatory (StAR) 
protein localized in the outer membrane of the mitochondria (140, 168, 169). This 
protein is also believed to be the rate-limiting enzyme in steroid hormone production due 
to its key role in shuttling cholesterol from the outer to the inner mitochondrial 
membrane, an event which facilitates the cleavage of cholesterol into pregnenolone (140, 
169). Cytochrome P450, Family 11, Subfamily A, Polypeptide 1 (Cyp11a1), previously 
known as cholesterol side chain cleavage, is a 56 kDa protein located in the inner 
mitochondrial matrix that is required for the conversion of cholesterol to pregnenolone 
(88, 226, 227). Pregnenolone exits the mitochondria to the endoplasmic reticulum where 
under the influence of Hydroxyl-Delta-5-Steroid Dehydrogenase, 3 Beta- and Steroid 
Delta-Isomerase 2 (HSD3B2) in humans or Hsd3b1 in mice, commonly known as 3β-
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hydroxysteroid dehydrogenase is converted to progesterone (3, 136). Cytochrome P450, 
Family 17, Subfamily A. Polypeptide 1 (Cyp17a1), also localized to the endoplasmic 
reticulum, catalyzes the conversion of progesterone to androstenedione (7, 56, 88, 120, 
170, 195, 227, 244). Androstenedione can diffuse to the GC prior to its conversion to 
testosterone or in the presence of hydroxysteroid 17-β dehydrogenase 1 (HSD17B1) in 
humans or hydroxysteroid 11-β dehydrogenase 2 in mice (Hsd11b2), androstenedione is 
first converted to testosterone which enters the GC for further processing.  In the GC, 
testosterone is aromatized to estrogens by Cytochrome P450, Family 19, Subfamily A. 
Polypeptide 1 (Cyp19a1) also known as aromatase (88, 120, 136). 
 
At puberty, the reproductive cycles of mammalian species are tightly regulated 
by a system of positive and negative feedback of reproductive hormones secreted and 
released from the hypothalamus (gonadotrophin-releasing hormone, GnRH) (64, 167), 
the pituitary (FSH, LH, oxytocin and prolactin) (64, 242), the ovaries (P4, E2, inhibins 
and relaxin) (120, 202) and the uterus (prostaglandin F2α)(9, 229). Briefly, FSH secreted 
by the pituitary promotes further granulosa cell proliferation and survival. Ovulation of 
the dominant follicle occurs in response to a rise in LH, due to a positive surge in 
ovarian E2. After ovulation, the remaining GC and TC undergo terminal differentiation 
to form the CL which produces P4. Unlike humans, rodents and pigs ovulate over eight 
oocytes in one estrus period, however, like humans, the ovulation rate and quality of the 
ovulating follicles depends on the process of folliculogenesis in the earlier period (229). 
It is therefore important to keep a balance between folliculogenesis and steroidogenesis 
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for optimal fertility since any disruption in these processes will likely compromise 
ovulation rate, subsequent conception rates and adversely impact embryonic viability, 
thus leading to impaired fecundity. 
 
Impact of ovotoxicant exposure on ovarian function 
 
Human environmental exposure is widespread and if these chemicals are not 
detoxified to lesser toxic products, various target organs/tissues suffer damage leading to 
several health complications including reproductive and developmental impairments (62, 
63, 77, 138, 233, 249). For instance, relative to non-smokers, women who are cigarette 
smokers have a greater risk of early onset of menopause and suffer infertility (92, 121, 
230). Postmenopausal females have a great risk for developing gynecological cancers, 
osteoporosis and cardiovascular disease (105-107). Although the liver is the primary site 
for xenobiotic metabolism, the ovary’s capacity to metabolize xenobiotics without the 
liver’s contribution is well documented (14, 19, 24, 28, 115, 125, 160, 173, 186, 207). 
Therefore, in addition to its fundamental functions of oocyte and steroid hormone 
production, the mammalian ovary plays another critical role of xenobiotic metabolism 
(24, 56, 105). In animal models, xenobiotic exposures have been demonstrated to target 
the ovary and destroy the primordial follicles as well as other follicle types, leading to 
premature ovarian failure, infertility and other health impairments (23, 24, 33, 105, 127).  
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Xenobiotic biotransformation enzymes  
 
The ovary responds to the environmental exposure through increased expression 
of genes encoding xenobiotic biotransformation enzymes such as cytochrome P450 
isoform 2E1 (CYP 2E1) (44, 126, 206), microsomal epoxide hydrolase (EPHX1) (45, 
115), glutathione S-transferase Pi (GSTP1) (25, 127) and glutathione S-transferase Mu 1 
(GSTM1) (27) whose expression and activity levels are altered during xenobiotic 
exposure.  These enzymes are primarily involved in the detoxification of xenobiotic 
compounds (31, 94, 96-99, 103, 130), however, their expression may also lead to 
bioactivation of some environmental compounds (23, 24, 44, 94, 106, 109, 206), leading 
to increased toxicity.  
 
GSTP1 and GSTM1 are members of the glutathione S-transferases (GST) 
superfamily of enzymes (190). The GST protein family is involved in phase II 
metabolism of xenobiotic compounds by converting a variety of electrophilic and 
hydrophobic compounds into more soluble, easily excretable compounds through 
catalysing their conjunction with glutathione (GSH) (222). These enzymes have long 
been known as part of the cell defense against several endogenous and xenobiotic toxic 
compounds (94). However, recently these enzymes are now known to be involved in a 
number of other cellular processes other than detoxification. They are mediators of 
signaling processes involved in cell proliferation and death (134) and are thought to be 
involved in intracellular transport and isomerization of steroid hormones (95, 134, 141). 
These enzymes have also been implicated in the pathophysiology of a range of human 
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diseases including cancer (78, 83), diabetes (254) and inflammatory diseases (78, 94). In 
recent years, GSTP1’s and GSTM1’s involvement in the development of 
chemotherapeutic-drug resistance as well as poor prognosis of certain types of 
malignancies is well documented (235, 239). Moreover, GSTP1 and GSTM1 are also 
known for their ability to negatively regulate pro-apoptotic pathways leading to reduced 
programmed cell death which could explain their implications in poor prognosis of 
certain types of malignancies (78, 94, 127, 134, 236, 239). For instance, GSTP1 inhibits 
the phosphorylation of C-Jun N-Terminal Kinase 1 (JNK1) and p38 pro-apoptotic 
proteins of the Mitogen-Activated Protein Kinase (MAPK) signaling (127, 134, 235, 
236, 239), modulating apoptotic pathways. Similarly, GSTM1 interacts with Apoptosis 
Signal-regulating Kinase 1 (ASK1), repressing its induction of the pro-apoptotic p38 and 
JNK activities on the MAPK signaling (26, 78, 94, 239). The above literature does not 
only highlight the multiple roles of the GST enzymes, but it also raises concerns about 
the potential pleiotropic consequences that may face the ovary if alterations in their 
expression occur. 
 
Like the GSTs, the xenobiotic biotransformation enzymes, EPHX1 and CYP2E1 
are involved in other biological processes other than their known detoxification roles. In 
rodent models, exposure to the environmental carcinogen (57, 108, 124, 139, 219) and 
ovotoxicant (24, 33, 115, 125), 7,12-dimethylbenz[a]anthracene (DMBA), has been 
demonstrated to target and destroy all follicle stages leading to accelerated premature 
ovarian senescence (23, 24, 115, 162, 246). DMBA is a polycyclic aromatic hydrocarbon 
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present in organic compounds including coal, cigarettes, and petroleum. Therefore 
human exposure is widespread and it is mainly through inhalation of smoke from 
burning of such organic substances (115, 207). This could partially explain why some 
female cigarette smokers undergo early onset of menopause and suffer infertility 
compared to female non-smokers of the same age (92, 121, 230). Both the carcinogenic 
and ovotoxic potency of DMBA are believed to mediated through its metabolite DMBA-
3,4-diol-1,2-epoxide which is synthesized by hepatic cytochrome P450 isoforms 1B1 
(CYP1B1)  and 1A1 (CYP1A1) (115, 160, 186, 207) in conjunction with microsomal 
epoxide hydrolase (EPHX1) (172, 173) enzymes. Importantly, DMBA bioactivation has 
been demonstrated to occur in the mammalian ovary even without hepatic contributions 
(14, 19, 24, 115, 173, 186, 207), underscoring the ovary’s capacity to metabolize 
environment chemicals.  
 
Another industrial chemical of reproductive importance that has been widely 
studied is the occupational chemical 4-Vinylcyclohexene (VCH). VCH exposure results 
from the manufacture of rubber tires, flame retardants, insecticides, plasticizers and 
antioxidants (72, 109). Like DMBA, VCH requires bioactivation to VCH diepoxide 
(VCD) its ovotoxic metabolite (126, 206). This processes is accomplished by 
cytochrome P450 isoform 2E1 (CYP 2E1) together with CYP450 enzymes (126, 206). 
In rodent models, VCD exposure leads to loss of ovarian primordial and primary 
follicles (109), compromising animal fertility. Interestingly, EPHX1 detoxifies VCD to a 
lesser toxic tetrol metabolite (28, 72). Thus, depending on the chemical substrate, the 
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action of EPHX1 can protect or damage ovarian follicles. This data strengthens the need 
for ovarian uninterrupted capacity to metabolize and detoxify such compounds in order 
to protect the female germ cell and ensure sound ovarian function. 
 
The phosphatidylinositol-3 kinase signaling pathway 
 
The lipid kinase, phosphatidylinositol 3 kinase (PI3K) is one of the central 
signaling pathways that integrate the major functions of the ovary (1, 67). PI3K 
activation by several growth factors and hormones including insulin and KITLG (46, 
209), results in signaling events which regulate a number of biological processes 
including cell proliferation, survival, death, metabolism and regulation of gene 
expression (1, 30, 46, 104, 156). Most of the PI3K signaling cascades are mediated 
through the serine/threonine protein kinase B (AKT). In mammals, AKT has three 
isoforms, alpha (AKT1), beta (AKT2) and gamma (AKT3), which all contain a 
pleckstrin homolog domain, a central kinase domain with a threonine 308 
phosphorylation site and a regulatory serine 473 phosphorylation site (30, 70). Once 
PI3K is activated, AKT is recruited to the cell membrane where it becomes 
phosphorylated (pAKT) at both of these sites and activated (30, 46, 70). Following AKT 
activation, pAKT translocates to the cell nucleus where it can regulate gene expression 
of many targets including the functional forkhead box transcription factors (FOXO), 
FOXO1, FOXO3 and FOXO4 (30, 60, 131, 156, 178). These FOXOs can be involved in 
unique or divergent cellular responses depending on the tissue and physiological state of 
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the tissues involved (104). For instance in mammalian oocytes, FOXO3 leads to 
transcription of molecules involved in apoptosis stress responses and cell cycle arrest 
(40, 240).  
 
As previously mentioned, the mechanisms underlying the initial primordial 
follicle activation and recruitment to the growing pool are still elusive. Available 
evidences however, suggest that, growth factors such as insulin and KITLG and their 
downstream PI3K signaling pathway are key regulators of this process (67, 142). These 
studies have demonstrated that ovarian PI3K/AKT/FOXO3 signaling pathway is 
involved in follicular activation (143, 209), recruitment, survival (2, 210), and 
development (1, 37, 50, 122, 210) as well as ovarian steroidogenesis (2, 53, 119). In 
rodent models, Akt-/- mice have reduced primordial follicle viability (37), FOXO3OE 
mice show no activation of primordial follicle pool (144), whereas FOXO3-/- mice 
display global primordial follicle activation by postnatal day 14, leading to oocyte death, 
early depletion of functional ovarian follicles and secondary infertility (50). This 
pathway has also been implicated in ovarian carcinoma (1, 34, 37, 50, 119, 125, 143, 
208, 210), underscoring the importance of PI3K/AKT/FOXO3 signaling pathway in 
female reproduction.  
 
In addition to regulation of folliculogenesis, PI3K signaling is also involved in 
regulation of xenobiotic biotransformation gene expression (25, 28). Inhibition of PI3K 
increased mRNA and protein abundance of EPHX1, GSTP1, GSTM1 as well as induced 
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elevations in the mRNA and protein encoding transcription factors known to be involved 
in regulation of xenobiotic biotransformation genes, the Arylhydrocarbon receptor (Ahr) 
and Nuclear factor erythroid-related factor 2 (Nrf2).   
 
The aryl hydrocarbon receptor (Ahr) is a member of the basic helix-loop-helix 
(bHLH) DNA binding protein family (184), located in the cytoplasm in a protein 
complex with HSP90 under non-stimulated conditions.  Upon activation, the 
AHR:HSP90 complex dissociates, and AHR can translocate to the nucleus to dimerize 
with the Ahr nuclear translocator (ARNT) and bind to the xenobiotic response element 
(XRE) in target gene promoters (90).  Using alpha-naphthoflavone (ANF; an 
arylhydrocarbon receptor antagonist), AHR’s involvement during DMBA ovotoxicity 
has been determined.  Co-treatment of ovaries with ANF prevented DMBA-induced 
follicle destruction, supporting an involvement of AHR in DMBA bioactivation (25, 
224), through activation of CYP1B1 (90).   
 
NRF2 is a cap’n’collar basic-region leucine zipper protein that can bind to the 
antioxidant response element (ARE) in target genes.  NRF2 protein action is maintained 
in an inactive state through interaction with the Kelch-like ECH-associated protein 1 
(Keap1), which results in proteasomal degradation of NRF2 (152, 165).  When exposure 
to a xenobiotic occurs, KEAP1 can be inactivated resulting in NRF2 protein release and 
nuclear translocation where gene expression of target genes is activated (152).  NRF2 
knockout mice have increased susceptibility to DMBA-induced skin (112), and 
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mammary (15) tumors.  NRF2 activates the Gstp gene promoter (116) and interestingly, 
only 3-20% of hepatic GST expression is observed in NRF2 deficient mice relative to 
their wild-type littermates (52).  Taken together, NRF2 is liely involved in DMBA 
detoxification, potentially through the action of GSTP.     
 
Insulin signaling 
 
Insulin is a pleiotropic hormone, regulating an array of biological processes 
including, but not limited to, glucose and lipid metabolism (215), xenobiotic metabolism 
(130) and reproductive function (12, 203, 204). Insulin’s actions are mediated through its 
receptors and receptor’s substrate (IRS) proteins. Insulin receptor (INSR) is a 
heterodimer comprised of two alpha (INSRα) and beta (INSRβ) subunits and there are 
four (IRS 1-4) insulin receptor substrate proteins (129, 234). Binding of insulin to the 
alpha subunits activates the INSR tyrosine kinase in the beta subunits, with subsequent 
auto phosphorylation and recruitment of different substrate adaptor (IRS 1-4) proteins. 
Tyrosine phosphorylated IRS then displays binding sites for numerous signaling partners 
including the PI3K/AKT signaling pathway (81, 84, 176, 232). Defects in IRS, more 
specifically IRS1 and IRS2, have been implicated in female infertility and rodent models 
with such defects have been found to display both ovarian and hypothalamic dysfunction 
(39, 54, 203). Insulin has been demonstrated to induce primordial follicle transition 
primary follicle stage as well as further follicle development in cultured human ovarian 
cortex (147), canine (221), fetal hamster cultured ovaries (253), bovine cortical pieces 
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(73) as well as rodents (128, 179). Taken together, these studies suggest a role for insulin 
signaling in ovarian folliculogenesis. 
The proto-tyrosine kinase receptor (KIT) and its associated ligand, KITLG, are 
respectively encoded by the Kit and Kitlg genes (66, 73). Kit is majorly expressed in 
oocytes (102, 157, 158), whereas Kitlg is predominantly expressed in the theca and 
granulosa cells (66, 73, 117). Binding of KITLG to its receptor induces signaling 
cascades that regulate a number of ovarian process, notably folliculogenesis (66, 76, 
188, 189, 191, 192, 252) and steroidogenesis (174). Although gonadotropins are critical 
for later stages of folliculogenesis, initial follicle activation is believed to be independent 
of their influence (68, 200). Studies in this area have demonstrated that KITLG is one of 
the essential molecules for initial follicular activation. In a number of studies, KITLG 
has been demonstrated to stimulate follicle activation in rodents (192, 252), human 
ovarian follicles (48) and bovine ovarian cortical pieces (76). Previous literature also 
indicates that KITLG’s actions are not limited to initial follicle activation but as well as 
regulation of multiples stages of follicle development (66, 113, 188, 191, 213). To date, 
the mechanism(s) behind KITLG’s action on follicle activation and successive follicle 
development are not fully known, nevertheless, available evidence suggest that binding 
of KITLG to its cognate receptor induces phosphorylation of the regulatory subunit of 
PI3K leading to AKT activation and subsequent FOXO3 under expression (132, 142, 
209). Despite their paucity, studies in rats (128, 179), mice (93), and bovine (73, 75, 76) 
have implicated insulin in KITLG-induced follicle activation and subsequent 
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development. Overall, these studies accentuate the relevance of insulin-KITLG-KIT-
PI3K-AKT-FOXO3 signaling pathway in ovarian folliculogenesis.  
 
Obesity 
 
Obesity and overweight are the most prevalent health burdens of the modern 
society claiming about 2.8 million lives of adults globally every year (71). Obesity is 
defined as a medical condition in which a person abnormally accumulates body fat, 
usually 20% or more over his/her ideal body weight (71). Both obesity and overweight 
are majorly classified based on body mass index (BMI) which is a measure of one’s 
body weight (kg) relative to their height (m2). Based on this criterion, an individual is 
overweight if his/her BMI is 25.0 ≤ 29.9. Similarly, an individual with a BMI ≥ 30 is 
classified as obese. In the past three decades, the world has seen a rapid rise in the 
incidence of overweight and obesity which in 2008 was estimated to be 35% and 12% 
respectively among adults of 20 years and over (231). According to this study (231), 
much of this increase is seen in the developing countries (904 million people) which 
have been long afflicted by hunger than developed countries (577 million people), 
making obesity a global epidemic that requires urgent intervention. Obesity and 
overweight is also escalating in children and young adolescents, aged 5-19 years (49, 59, 
61, 137, 153), predisposing them to diseases such as type 2 diabetes and cardiovascular 
diseases which were previously considered adult diseases.  
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Obesity is associated with a number of health problems including diabetes (51, 
71, 89, 155), cardiovascular diseases (8, 114, 149, 155), cancer (41, 42, 133, 211) and 
reproductive impairments (133, 154). Among females, the common reproductive 
complications associated with obesity are early menarche (225), irregular menstrual 
cycles and polycystic ovarian syndrome (11, 65), poor quality oocytes (35, 154), 
impaired fecundity (17, 35, 65), increased risk for gynecological cancers (133), 
intrauterine fetal death and stillbirth (16, 18, 135, 180), gestational diabetes (16, 133, 
135) as well as increased risk for birth defects in offspring (16, 49, 135, 150, 180).  
 
Although the mechanism(s) underlying these complications are still less well 
understood, available evidence indicate that obesity is associated with metabolic 
perturbations including hyperinsulinemia (214), hyperleptinemia (145, 171) which could 
induce alterations in a number of pathways including those critical for folliculogenesis, 
steroidogenesis, ovulation, implantation and embryonic development.  Additionally 
obesity is associated with elevated lipopolysaccharide (LPS) level (43, 241). In females, 
higher levels of LPS have been implicated in induction of preterm labor and premature 
embryonic loss (5, 6, 251).  LPS has also been reported to compromise steroidogenic 
signaling specifically through reduced expression of the P4 and LH receptors (4, 5), 
required for relaying signaling cascades for the hormones critical for maintenance of 
pregnancy and ovulation, respectively.  
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Obesity-induced inflammation 
 
Obesity is also associated with macrophage infiltrations and chronic 
inflammation (212). Macrophages and their derived products can regulate ovarian 
function (228), specifically, ovarian cellular proliferation, apoptosis (20), ovarian 
steroidogenesis and ovulation (166, 243, 250), and are therefore essential accessory cells 
for optimal fertility (38, 55, 181). Derangements in inflammatory signals have been 
implicated in the development of infertility and other obesity-associated adverse 
reproductive health outcomes (29, 49, 177, 183, 193, 194, 201, 218). For example, 
aggravated activation of inflammatory cytokines has been associated with detrimental 
deposition of excess lipid in extra-ovarian tissues (58, 85, 86), generation of reactive 
oxygen species and oxidative stress, scenarios both of which could have detrimental 
consequences for human fertility (118). In addition, several studies have reported that 
macrophages and/or macrophage-derived product deregulation are implicated in a 
number of ovarian pathologies (175) including polycystic ovary syndrome (80, 151, 
205), endometriosis (47) and premature ovarian failure (250). Importantly, obesity is 
associated with hypertrophic expansion of intra-abdominal adipose tissue which could 
be could potentially impact ovarian physiology due to the proximity of this tissue and 
the ovary.  Adipose tissue is associated with microphage infiltration and inflammation 
which could impact ovarian physiology. Despite this realization, little is known about 
how changes that obesity induces in this tissue could impact ovarian tissue and function. 
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Hyperthermia 
 
Like obesity, heat stress (HS) is associated with elevated plasma insulin and LPS 
(13, 182, 196, 197, 220, 248), metabolic perturbations that may have direct effects on 
reproductive performance (91). In production animals including cows, sheep, chicken, 
and pigs, HS can compromise the animals’ productive and reproductive efficiency (13, 
79, 82). Heat stressed animals normally display phenotypes including decreased 
spermatogenesis (91, 247), impaired folliculogenesis (21, 146), steroidogenesis (22, 146, 
216, 217), dysregulated estrous cycles (187, 223), reduced conception rate (32, 91, 146), 
higher frequency of embryonic death (161, 237), and impaired fertility (32, 36, 146, 148, 
199). Moreover, these animals, specifically sows, experience a prolonged period of 
seasonal infertility for which the effects last from July to December, perhaps due to 
compromised conception rates and increased embryonic lethality induced by HS, 
particularly during summer hot months (185, 238). Although these deleterious 
phenotypes have been long appreciated, the underlying causative mechanism(s) remain 
largely unknown. Available evidences have implicated photoperiodism as a potential 
causative factor (10), however such a phenomenon does not fully account for the 
occurrences of same phenotypes during elevated ambient temperatures in areas with 
equal days and nights (32). While such scenarios do not rule out the involvement of 
photoperiodism, they are suggestive that other players are causative in seasonal 
infertility (10). Since insulin levels are elevated during HS and insulin influences ovarian 
physiology, investigating how heat stress-induced hyperinsulinemia may be responsible 
for seasonal infertility and poor sow performance during the summer months is critical.  
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Summary 
 
The literature reviewed so far indicates that ideal reproduction requires a balance 
between folliculogenesis and steroidogenesis in addition to proper ovarian inflammatory 
signaling and ovotoxicant chemical metabolism. Alterations in these processes are likely 
to alter ovarian function and consequently lead to impaired fecundity and other 
associated reproductive pathologies. The literature also reveal that the reproductive 
disorders-induced during central metabolic states like during obesity and HS are 
phenotypes that could be related to the derangements in molecular pathways controlling 
ovarian folliculogenesis and steroidogenesis in addition to inflammatory and chemical 
metabolism processes. Although this correlation is provoking, little is known of how 
changes to central metabolism could impact such ovarian processes. This dissertation 
research therefore focused on investigating impacts of metabolic perturbations on 
ovarian folliculogenesis, steroidogenesis and xenobiotic biotransformation. We 
hypothesized that hyperinsulinemia induced during central metabolic perturbations, 
alters ovarian insulin-mediated PI3K signaling, negatively impacting ovarian 
folliculogenesis, steroidogenesis and xenobiotic biotransformation. To test this 
hypothesis, mRNA and/or protein expression profiles of insulin, PI3K, steroidogenic, 
inflammatory and chemical metabolism members were quantified using qRT-PCR, 
Western blot or immunohistochemistry techniques using three models: 1) high fat diet 
(HFD)-induced obesity, 2) a transgenic mouse model of progressive obesity and 3) a 
porcine model of hyperinsulinemia.     
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Figure 1.  Model of the mammalian ovary.  The dynamic ovarian structures are 
follicles and corpora lutea.  The most immature form of follicle growth is termed the 
primordial stage, composed of an oocyte surrounded by a single layer of squamous 
shaped pre-granulosa cells.  Once activated, the primordial follicle develops into a 
primary follicle, an oocyte still surrounded by a single layer of cuboidal granulosa cells.  
The follicle progresses to the secondary stage in which granulosa cells proliferate to 
form a multicellular layer surrounding the oocyte.  At this stage, the follicle also obtains 
a layer of theca interna cells which encompass the granulosa cell layer.  The theca 
interna and granulosa cells co-operate to produce 17β-estradiol (E2), the major ovarian 
estrogen.  As follicular development continues, a fluid-filled antral cavity forms at which 
point the follicle is termed antral pre-ovulatory. The majority of follicles do not progress 
to ovulation and die by a process of atresia (apoptosis).   Following ovulation, the oocyte 
is extruded from the follicle and ovary and enters the oviduct, surrounded by several 
layers of granulosa cells known as the corona radiata.  Within the ovary residual 
follicular cells undergo a process known as luteinization to form the mature corpus 
luteum (CL) which is required for progesterone (P4) production.  Should pregnancy 
occur, the CL will be maintained through an endocrine signal from the blastocyst known 
as the maternal recognition of pregnancy (human chorionic gonadotrophin in humans, 
E2 in pigs).  In a non-pregnant female, the corpus luteum regresses due to lack of this 
signal and the ovarian cycle resumes (from Keating, A.F. and Hoyer, P.B. 2009.  
Mechanisms of reproductive toxicity.  In: Drug metabolism in pharmaceuticals; 
Concepts and Applications. Chapter 24: 697-734.), with copyright permission. 
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Abstract 
 
Insulin regulates ovarian phosphatidylinositol-3-kinase (PI3K) signaling, 
important for primordial follicle viability and growth activation. This study investigated 
diet-induced obesity impacts on: 1) insulin receptor (Insr) and insulin receptor substrate 
1 (Irs1); 2) PI3K components (Kit ligand (Kitlg), kit (c-Kit), protein kinase B alpha 
(Akt1) and forkhead transcription factor subfamily 3 (Foxo3a)); 3) xenobiotic 
biotransformation (microsomal epoxide hydrolase (Ephx1), Cytochrome P450 isoform 
2E1 (Cyp2e1), Glutathione S-transferase (Gst) isoforms mu (Gstm) and pi (Gstp)) and 4) 
microRNA’s 184, 205, 103 and 21 gene expression. INSR, GSTM and GSTP protein 
levels were also measured. Obese mouse ovaries had decreased Irs1, Foxo3a, Cyp2e1, 
MiR-103, and MiR-21 but increased Kitlg, Akt1, and miR-184 levels relative to lean 
littermates. These results support that diet-induced obesity potentially impairs ovarian 
function through aberrant gene expression. 
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Introduction 
 
Globally, the prevalence of overweight and obesity is increasing, predisposing 
female to health hazards including diabetes, cardiovascular disease, cancer and 
compromised reproductive capacity [1-4]. 1.5 billion adults are overweight of whom 200 
million men and 300 million women are obese. Further, approximately 43 million 
children (age 5-19) are overweight [5-10].  About 65% of the world’s population live in 
countries where being overweight is more responsible for morbidity than underweight, 
and currently about 2.8 million adults globally die every year as a result of being 
overweight or obese [1]. Formerly considered a problem of developed countries, this 
epidemic is now dramatically on the rise in low- and middle-income countries which 
have had a long incidence of food insecurity, now squaring them up for a binary 
affliction of disease. While toiling with infectious disease and under-nutrition, they are 
also paradoxically experiencing a rapid upsurge in non-communicable disease risk 
factors including obesity and overweight [11-13].  
 
The mammalian ovary is the female gonad responsible for gamete production, as 
well as the female sex steroids, 17β-estradiol and progesterone. The ovary contains a 
finite number of primordial follicles at the time of birth, which serve as the follicular 
pool. Once depleted, primordial follicles cannot be replaced [14-22]. Though this theory 
has been to a certain extent challenged in recent years [23-25], it remains that the 
number of primordial follicles declines over the female lifetime. This is because the 
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process of follicular growth is an irreversible process; once follicles are recruited from 
the resting pool into the growing pool they will undergo cell death if not selected for 
further growth to ovulation [26-33]. Unlike the cyclic recruitment of follicles to 
ovulation, initial follicular activation is independent of the pituitary gonadotropins [17, 
18, 34, 35]. The intrinsic ovarian mechanism(s) triggering individual follicle activation 
are not yet fully known, however, several lines of evidence have identified potential 
candidate factors including phosphatidylinositol-3 kinase (PI3K). An overall balance 
among dormancy, activation and death of primordial follicles is believed to be the 
determining factor which decides the female reproductive lifespan [29, 31, 36-38]. Any 
external factor that could accelerate follicle activation could hasten the rate at which the 
ovary become devoid of the follicular pool, thus threatening the reproductive potential of 
the female. 
 
Obesity has been demonstrated to have detrimental effects on female 
reproductive function. Obese women have an increased likelihood to display signs of 
polycystic ovarian syndrome (PCOS), ovulation defects, reduced fecundity and poor 
quality oocytes [4, 39, 40]. There is also an association between obesity and an increased 
risk of birth defects, premature and still-births, and gestational diabetes [4, 41], however, 
the molecular mechanisms involved are still lacking. Obesity is a contributing factor for 
development of type 2 diabetics, characterized by elevated blood glucose and impaired 
insulin signaling [42]. Diet-induced obesity with concomitant diabetes is a stimulus that 
provokes alterations in insulin level and its subsequent sensitivity on its target tissues. It 
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has been long postulated that obesity not only compromises insulin sensitivity in 
classical tissues like muscle and liver but also in other insulin responsive tissues like the 
ovary [42-44]. This theory has recently been challenged in a diet-induced obesity model, 
where ovaries from female mice fed on 60 % kcal of fat for 12 weeks maintained insulin 
sensitivity, despite that other classical tissue like muscle and liver became insulin 
resistant [45].  
 
The ovary possesses both insulin and insulin-like growth factor 1 (IGF-1) 
receptors which can be directly stimulated by their hormone ligands. Insulin not only 
controls critical energy functions such as glucose and lipid metabolism but also plays a 
crucial role in reproductive function. Insulin receptor (INSR) is a heterodimer comprised 
of two alpha subunits and two beta subunits [46, 47]. Insulin binds to the alpha subunits 
which activates the insulin receptor tyrosine kinase in the beta subunits, with subsequent 
auto phosphorylation and recruitment of different substrate adaptors such as the Insulin 
receptor substrate (IRS 1-4) family of proteins. Tyrosine phosphorylated IRS then 
display binding sites for numerous signaling partners including the PI3K/Protein kinase 
B (PKB/AKT) signaling pathway. Defects in IRS, more specifically IRS1 and IRS2, 
have been implicated in female infertility and rodent models with such defects have been 
found to display both ovarian and hypothalamic dysfunction [48-50].  
 
Several lines of evidence have identified the importance of PI3K signaling in 
ovarian function [51]. Once PI3K is activated, AKT is recruited to the cell membrane 
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where it becomes phosphorylated (pAKT), and mediates many downstream events [52-
54]. PI3K/AKT has been implicated in regulating follicular activation [36, 38] 
recruitment, survival [29, 31], and development throughout the female reproductive 
lifespan [31, 51, 55-57]. PI3K also plays a role in proliferation and differentiation of 
granulosa cells (GC) in response to gonadotropins [29, 58] and it has been associated 
with ovarian carcinoma [31, 37, 38, 51, 55, 57-60]. In rodent models, Akt-/- mice were 
found to have reduced primordial follicle viability [57]. AKT has the ability to 
phosphorylate and inactivate several targets including forkhead transcription factors 
(FoxO). FoxO3 is critical for early stages of follicular growth [55] and it has been 
reported to trigger apoptosis through either up-regulation of genes necessary for cell 
death or down-regulation of anti-apoptotic genes [61-64]. FOXO3-/- mice had global 
primordial follicle activation by postnatal day 14, leading to oocyte death, early 
depletion of functional ovarian follicles and secondary infertility [55] while in 
FOXO3OE mice, no activation of primordial follicle pool was observed [65].  
 
Insulin-mediated PI3K activation has been also suggested to regulate xenobiotic 
biotransformation genes [66]. Inhibition of ovarian PI3K increases both mRNA and 
protein levels of microsomal epoxide hydrolase (Ephx1)[67] Glutathione S-transferase 
Pi (Gstp) [68] and Glutathione S-transferase Mu 1 (Gstm) [69] suggesting that these 
enzymes could be downstream members of the PI3K signaling pathway. GSTP and 
GSTM are members of the GST protein family involved in phase II metabolism of 
xenobiotic compounds by converting a variety of electrophilic and hydrophobic 
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compounds into more soluble, easily excretable compounds through catalyzing their 
conjunction with glutathione (GSH) [70]. EPHX1 and Cytochrome P450 isoform 2E1 
(CYP 2E1) ensure the rapid detoxification of epoxides generated during the oxidative 
metabolism of xenobiotics, thus providing cellular protection against free radical and 
carcinogenic compounds [66, 71-73]. Any alteration in expression patterns of genes that 
encode for ovarian chemical biotranformation enzymes can pose a risk for the onset of 
ovarian dysfunction. This is because exposure to a number of chemical classes can 
destroy follicles of all types threatening the reproductive potential of exposed females 
through accelerated premature ovarian insufficiency, premature ovarian failure 
(menopause) and other associated health problems [22, 67, 74-77].  
 
Several genes that are components of the PI3K pathway also are regulated by 
MicroRNAs (miR’s) [78-80]. MiR’s are small (19 – 25 bp) non-coding RNA that can 
positively or negatively regulate gene expression [81-85].  It is known that miR-21 
inhibits phosphatase and tensin homolog (PTEN), an antagonist of PI3K [86, 87].  In 
vivo loss of miR-21 has been reported to increase ovarian apoptosis and as well 
compromise ovulation rates in rodent models [86, 88]. MiR-184 is believed to play a 
critical role in development as well as a mediator of apoptosis [79]. Up regulation of 
miR-184 can interfere with AKT action, repressing PI3K action [78, 85]. Also, miR-103 
has been implicated in insulin sensitivity [89]. Thus, miR’s may mediate the response to 
insulin signaling, through the PI3K pathway.   
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In summary, obesity results in reproductive dysfunction and an increase in 
negative consequences for offspring, and insulin signaling is impaired in obesity.  
Additionally, insulin can activate PI3K signaling, which is critical for controlling the 
rate of activation of primordial follicles, and is an upstream regulator of xenobiotic 
metabolism gene expression. There remains a dearth of knowledge regarding whether 
obesity can influence ovarian xenobiotic metabolism, thus we hypothesized that obesity 
caused by a high fat diet would alter ovarian PI3 kinase signaling with subsequent 
effects on genes encoding xenobiotic metabolism enzymes in female mice.   
 
Materials and Methods 
Reagents  
2-β-mercaptoethanol, 30% acrylamide/0.8% bis-acrylamide, ammonium 
persulfate, glycerol, N′,N′,N′,N′-Tetramethyl-ethylenediamine (TEMED), Tris base, Tris 
HCl, sodium chloride, Tween-20, bovine serum albumin (BSA), ascorbic acid (Vitamin 
C), phosphatase inhibitor, protease inhibitor and transferrin were purchased from Sigma-
Aldrich Inc. (St. Louis, MO). Hanks' Balanced Salt Solution (without CaCl2, MgCl2, or 
MgSO4), DAPI nuclear stain and superscript III one-step RT-PCR System were 
obtained from Invitrogen Co. (Carlsbad, CA). miRNeasy Mini Kit, miScrip Reverse 
Transcription Kit, miScrip SYBR Green PCR Kit, RNeasy Mini kit, QIAshredder kit, 
RNeasy MinElute kit, TaqMan® microRNA Reverse Transcription Kit and 
QuantitectTM SYBR Green PCR kit were purchased from Qiagen Inc. (Valencia, CA). 
Goat anti-rabbit and goat anti-mouse secondary antibodies were purchased from Pierce 
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Biotechnology (Rockford, IL). Custom designed primers were obtained from the DNA 
facility of the Office of Biotechnology at Iowa State University. Ponceau S was 
purchased from Fisher Scientific (Waltham, MA, USA). ECL plus chemiluminescence 
detection kit was obtained from GE Healthcare, Amersham (Buckinghamshire, UK). 
Anti-GSTP and anti-GSTM antibodies were purchased from Millipore (Temecula, CA, 
USA).  Anti-pAKTSer473 and β-Actin antibodies were from Cell Signaling Technology 
and anti-insulin receptor (INSR) antibody was purchased from Abcam (Cambridge, MA, 
USA).  Secondary antibodies were obtained from EMD Millipore (Billerica, MA).     
 
Animal and diets 
Ovarian tissues were obtained from a study at the University of Missouri. The 
experimental protocols were approved and performed in accordance with the guidelines 
of the University of Missouri Institutional Animal Care and Use committee as previously 
described [90]. Briefly, twelve 6 weeks old C57Bl/6J female mice were randomized into 
two groups (n = 6 per group). The control group was fed a standard chow mice diet 
(Purina 5001; 4.5g/100g fat) while the treatment group was fed a high-fat diet (HFD; 
Research Diets D12492; 35g/100g fat) for approximately 7 months. The animals were 
housed at constant room temperature, 12h light:12h darkness cycle, diet and water were 
provided ad libitum.  Body weight for the control and HFD mice were 24.8g ± 0.45 and 
46.5g ± 2.0, respectively.  Gonadal adipose tissue weight was 0.44g ± 0.05 and 3.74g ± 
0.35 in the control and HFD mice, respectively [90].  After 7 months glucose tolerance 
testing confirmed that HFD-fed mice had elevated blood glucose, relative to their 
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control-diet fed littermates [90]. There was no impact of HFD on plasma estradiol [90]. 
The HFD mice are subsequently referred to as obese, and their non-HFD fed littermates 
are referred to as lean.  
 
Tissue collection 
Animals were euthanized by CO2 asphyxiation.  Ovaries were removed, trimmed 
of excess fat, weighed and snap frozen for gene expression analysis or fixed in 4% 
paraformaldehyde for histological analysis.  
 
RNA Isolation  
Total ovarian RNA was isolated using Qiagen RNeasy® Mini Kit (n = 6 per 
dietary treatment). Briefly, ovaries were lysed and homogenized using a hand held 
homogenizer. The homogenate was then applied to a QIAshredder column placed in a 
collection tube and centrifuged at 16100 RCF for 2 minutes at room temperature. The 
flow through was then applied to an RNeasy Mini column, allowing RNA to bind to the 
filter cartridge.  Following washing, RNA was eluted from the filter and concentrated 
using an RNeasy MinElute kit. RNA was eluted using 14 µl of RNase-free water and 
quantified using an ND-1000 Spectrophotometer (λ = 260/280 nm; NanoDrop 
technologies, Inc., Wilmington, DE).  
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First Strand cDNA synthesis and quantitative Real-Time quantitative polymerase 
chain reaction (qRT-PCR) 
Total RNA (0.5 µg) was reverse transcribed to cDNA using InvitrogenTM 
Superscript III Reverse Transcriptase according to the manufacturer’s protocol. Diluted 
cDNA (2 µl; 1:20 dilution) were amplified on an Eppendorf Mastercycler using 
Quantitect™ SYBR Green PCR kit and primers specific for mouse Actb, Insr, Irs1, Kit 
Ligand (Kitlg), c-Kit, Akt1, Foxo3a, Cyp2e1, Ephx1, Gstp, and Gstm (See table 1 for 
primer sequences). The PCR cycling program consisted of a 15 min hold at 95 oC and 
40 cycles of: denaturing for 15 at 95 oC, annealing for 15s at 58 oC and extension at 72 
oC for 20s. Product melt conditions were determined using a temperature gradient from 
72 oC to 99 oC with a 1 oC increase at each step. Three replicates of each sample (n = 6 
per dietary treatment) were included. Statistical analysis was performed on the cycle 
numbers at which each sample reached a threshold level.  The relative mRNA 
expression for each of the above genes was normalized using mouse Actb as a 
housekeeping gene and relative fold change calculated using the 2-ΔΔCT method.  The 
results are presented as mean fold change ± standard error relative to the control group. 
 
mirScript miRNA PCR array 
Purification of miRNA-enriched fractions was performed using a miRNeasy 
Mini Kit according to manufacturer’s protocol (n = 3 per dietary treatment).  MiRNA-
enriched fractions (250 ng) in a reverse-transcription reaction of 20 µl were converted to 
cDNA using miScrip Reverse Transcription Kit. cDNA was then diluted by adding 200 
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µl of RNase-free water, from which, 100 µl was used as template cDNA for real-time 
PCR quantification of multiple microRNAs using miScrip SYBR Green PCR Kit. Data 
analysis was performed using the web-based miScript miRNA PCR Array Data Analysis 
package. TaqMan® microRNA Reverse Transcription Kit was used to validate the 
expression of miR-21. The amount of target miRNA was normalized using RNU43 as a 
housekeeping miRNA. 
 
Histological analysis of ovarian tissue 
One ovary from each animal was fixed in 4% paraformaldehyde, embedded in 
paraffin, and serially sectioned (5 µM) at the Iowa State University Veterinary Medicine 
Histopathology laboratory. Sections were mounted (3-4 per animal), and one section was 
stained with hematoxylin and eosin (H&E). Digital images were acquired with a Leica 
DMI300B Fluorescent Microscope. 
 
Protein Isolation and Immunoblot analysis 
Total ovarian protein was isolated and immunoblots performed as previously 
described [75]. Briefly, ovaries were homogenized in ~ 200 µl of iced-cold extraction 
buffer containing 50 mM Tris-HCl (pH 8), 150 mM NaCl, 1% NP40 and 1% Protease 
inhibitor, followed by  centrifugation for 30 minutes at 9300 RCF at 4 oC. Protein 
concentration was determined using a standard BCA protocol. Emission absorbance 
values were detected with a λ = 560 nm excitation on a Synergy™ HT Multi-Detection 
Microplate Reader using KC4™ software (Bio-TekR Instruments Inc. Winooski, VT). 
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Total protein (20 µg) was separated using 10% SDS-PAGE and electro-transfer of 
proteins from the gel to a nitrocellulose membrane was performed for 60 minutes at 100 
V. The membranes were stained with Ponceau S to visualize the amount of total protein 
transferred in each lane. To reduce non-specific binding, membranes were pre-incubated 
overnight on a rocker at 4oC in a blocking buffer (5% non-fat dry milk, 5 M NaCl, 20 
mM Tris-HCl, 0.15% Tween-20, pH 8). Membranes were probed using specific primary 
antibodies; Rabbit Anti-INSRα (1:500); Rabbit anti-GSTP (1:200); and mouse Anti-
ACTB (1:2000) diluted in 5% non-fat dry milk in Tris-buffered saline with Tween-20 
(TTBS) overnight at 4 oC. Following washing for three times (10 min each) in TTBS, 
membranes were incubated at room temperature for 1 hour with HRP-conjugated 
suitable secondary antibodies (1:2000) against the primary antibodies. Membranes were 
washed three times in TTBS followed by a single wash in Tris-Buffered Saline (TBS). 
Autoradiograms were visualized on X-ray films in a dark room following 5 min 
incubation of membranes in ECLplus chemiluminescence detecting reagent. 
Densitometry of the appropriate band was quantified using Image J software (NCBI). 
Equal loading was confirmed by Ponceau S staining of membranes and protein 
expression was normalized to ACTB densitometry values.  
 
Immunoflourescence staining 
Two slides per animal were deparaffinized in citrol buffer and rehydrated with 
subsequent washes in ethanol. Antigen retrieval was carried out by microwaving 
sections for 7 min in sodium citrate buffer (1M, pH 6.1). Sections were then blocked in 
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5% BSA for 1 h at room temperature. Sections were incubated with a primary antibody 
directed against pAKTSer473 (1:100) overnight at 4°C. After washing in 1% PBS, 
sections were incubated with a goat anti-rabbit secondary antibody conjugated to 
fluorescein for 1 h. Slides were counterstained with DAPI nuclear stain for 5 min. 
Images were taken using a Leica fluorescent microscope.  Analysis of pAKTSer473 
protein level in small oocytes (pre-antral follicles), large oocytes (antral follicles) and 
theca cells of antral follicles was performed using ImageJ software (NCBI).  Mean 
densitometry value was divided by the cellular area measured.    
 
Statistical analysis 
Statistical analysis was performed using the unpaired t-test function of GraphPad 
Prism 5.5 software with a statistical significance level set at P < 0.05.  P < 0.1 was 
considered a trend for a difference between treatments.  
 
Results 
 
Effect of obesity on ovarian size and weight  
(Figure 1A) yet the ovaries appeared visually smaller relative to their lean littermates 
(Figure 1B and 1C).    
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Effect of obesity on ovarian insulin signaling members  
Obesity decreased mRNA level of the gene encoding the Irs1 (P < 0.05) with a 
trend for a decrease in Insr (P = 0.08; Figure 2A).  Additionally there was a strong trend 
(P = 0.06) for decreased INSR protein levels in ovaries of obese female mice compared 
to lean mice (Figure 2B and 2C).   
 
Effect of obesity on ovarian PI3K signaling 
Relative to lean ovaries, obesity increased the mRNA levels of Kitlg by 0.6-fold 
(P < 0.05) and there was a trend for increased mRNA level of the KITLG receptor, c-Kit 
of 0.4-fold (P = 0.07; Figure 3). Obesity also induced a 1.1-fold increase (P < 0.05) in 
mRNA levels of Akt1, with a concomitant 0.6-fold decrease (P < 0.05) in mRNA levels 
of Foxo3a relative to lean ovaries (Figure 3).  pAKTSer473 protein was localized to the 
oocyte of pre-antral and antral follicles and also to the theca cells (Figure 4A,B).  Obese 
females had a strong trend (P = 0.056) for decreased pAKTSer473 protein in the oocytes 
of pre-antral follicles (Figure 4C), with no impact observed in the antral follicle oocytes 
(Figure 4D).  Interestingly, there was a trend (P = 0.09) for increased pAKTSer473 
protein in theca cells from obese females (Figure 4E).    
 
Effect of obesity on ovarian expressed xenobiotic metabolism genes 
There was decreased mRNA level for the gene encoding Cyp2e1 (P < 0.05).  In 
addition a trend (P < 0.1) for increased Ephx1 and decreased Gstp1 and Gstm1 mRNA 
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levels was observed (Figure 5A).  No impact of obesity on GSTM protein was observed, 
however, there was a trend for decreased GSTP protein level (P < 0.1).      
 
Effect of obesity on ovarian expression of miR-103, miR-21, miR-184 and miR-205 
Ovaries from obese mice had decreased (P < 0.05) miR-21, and miR-103 (P < 
0.05), with a strong trend (P = 0.06) for increased miR-205.  In contrast, obesity up-
regulated (P < 0.05) miR-184 levels (Figure 6A). The obesity-induced decrease in miR-
21 was validated using qRT-PCR (P < 0.05; Figure 6B).    
 
Discussion 
 
Several studies have highlighted a strong correlation between obesity, infertility 
and adverse reproductive health outcomes, however, the underlying mechanisms remain 
unclear [91-95], thus comprehension of the mechanisms by which obesity affects 
ovarian function is of significant relevance. We hypothesized that obesity could alter 
factors regulating both primordial follicular activation and xenobiotic biotransformation.  
The females in this study were approximately 8.5 months of age, and did not differ in 
levels of plasma estradiol [90].       
 
Previous studies in humans and rat models have reported that hyperinsulinemia 
down-regulates ovarian Insr expression [96, 97]. Similar studies in insulin-resistant and 
hyperinsulinemic mice demonstrated altered duration of estrous cycles as well as 
aberrant distribution and morphology of ovarian follicles [42, 49, 98]. The metabolic 
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effects of insulin mainly involve tissue-specific actions which result in changes in gene 
expression, protein phosphorylation and function of the INSR and its downstream 
adaptor proteins, IRS1-4 [99]. Phosphorylation of IRSs lead to activation of downstream 
mediators including the PI3K/AKT serine/threonine kinase [50]. There are several 
pathological effects associated with dysregulated PI3K pathway in the ovary. For 
instance, over activation of PI3K in oocytes has been associated with premature ovarian 
failure (POF), while, on the other hand, over activation of the pathway in granulosa cells 
is highly correlated with defects in follicle cyclic recruitment and ovulation and 
carcinogenesis derived from ovarian surface epithelium [29-31, 37, 58, 100]. 
 
In order to determine the molecular effects of obesity on ovarian function, we 
first investigated the effect of obesity on expression of genes encoding the insulin 
signaling members, INSR and IRS1, both of which are critical for the response to 
insulin. Obesity decreased the mRNA level of Irs1 concomitant with a trend for a 
reduction in total ovarian Insr mRNA and protein expression. The effect of obesity on 
expression of insulin signaling members in other tissues is well reported but most 
ovarian studies have reported inconsistent results. For instance consistent with our 
findings, reductions in expression of INSR and IRS1 during obesity [101-103] or 
hyperinsulinemia [96, 97] have been reported, while in contrast, increased 
phosphorylation of both IRS1 and IRS2 with obesity have been also observed in other 
cell types [45, 96, 104-107]. Additionally, other studies have observed no effect of 
obesity on INSR [3, 42] or IRS1 [3, 108, 109]. Taken together, these results implicate 
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the effect of obesity on insulin signaling members to be a complex mechanism that may 
be species-, tissue- and/or time-specific.  
 
Following these observations we postulated the insulin-mediated PI3K/AKT 
pathway could be compromised. To our surprise our results demonstrated that reduction 
in mRNA encoding insulin signaling factors did not inactivate the PI3K/AKT pathway 
in ovaries of obese mice. Obese mice had increased Akt1 mRNA levels with a 
concomitant decrease in Foxo3a mRNA compared to lean mice. Several other studies 
show that insulin could have a tissue-isoform and species specific differential effect on 
Akt isoforms [53, 110]. In obese rodent models, insulin-stimulated AKT1 activity was 
reported to decrease in muscle and adipose tissue but increased in liver, in contrast, 
AKT2 activity was decreased in muscle and liver but increased in adipose tissue [53].  
Thus, our data indicate that ovarian AKT1 responds in a similar fashion to hepatic tissue 
in the face of changing insulin levels.  Whether these changes are direct interactions 
between the IRS or involve other signaling mediators is difficult to surmise from the 
current data.    
 
Since obesity mildly reduced expression of Insr and Irs1 in mice ovaries while 
the PI3K signaling pathway is markedly up-regulated compared to lean mice in our 
study, we asked what other insulin-independent pathways involved in activation of the 
ovarian PI3K/AKT pathway were altered in the obese mouse ovary. Stem cell growth 
factor receptor (c-KIT), a receptor protein tyrosine kinase is expressed by the oocyte 
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[111, 112] and its ligand, Kit Ligand (KITLG; also called Stem cell factor or Steel 
factor), is expressed by granulosa cells [113]. Several lines of evidence have indicated 
that KITLG/c-KIT signaling is essential for oocyte viability and survival and that this 
pro-survival pathway also regulates follicle recruitment [114-116]. Once c-KIT is bound 
by KITLG the PI3K pathway is activated [36-38, 55, 56, 59]. Based on those previous 
reports and our data we asked if HFD-induced obesity affected the ovarian mRNA level 
of genes encoding c-KIT and KITLG. Our data shows that obesity increased Kitlg 
mRNA levels with a trend for increased mRNA encoding its receptor, c-Kit. To the best 
of our knowledge this is the first study to demonstrate that HFD-induced obesity can 
alter the expression of the c-Kit ligand in murine ovaries. In oocytes of cultured neonatal 
mouse and rat ovaries, it has been demonstrated that KITLG leads to phosphorylation of 
FOXO3a through the action of pAKT [36]. Based on the results presented herein 
hyperactivation of KITLG/c-KIT-PI3K/AKT could be a potential mechanism underlying 
obesity related infertility problems. It is known that hyperstimulation of primordial 
follicles into the growing follicular pool leads to their eventual destruction [55, 57, 59]. 
Over-activation of the KITLG/c-KIT dependent PI3K/AKT pathway could imply that in 
obese female mice, there is over stimulation of primordial follicles into the growing 
follicular pool; a scenario that could accelerate the rate at which mice become infertile, 
although it should be noted that follicle numbers were not classified in our study.  
Interestingly, we also noted a trend for increased theca cell pAKTSer473, and it is 
known that the interaction between KITLG and c-KIT has a regulatory role in 
steroidogenesis in rat granulosa cells [117].   
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Several studies have demonstrated that insulin and other growth factors regulate 
xenobiotic chemical metabolizing enzyme gene expression, including cytochromes 
p450, GSTs and EPHX1 through several kinases including PI3K/AKT signaling 
pathway [66, 118, 119]. The ovary has the capacity to metabolize ovotoxic compounds 
[60, 67, 68, 75, 76, 120-122], however to date, there is a dearth of literature examining 
potential effects of obesity on expression of xenobiotic metabolizing enzymes in the 
ovary. Since diet-induced obesity can alter insulin levels and/or sensitivity, we 
hypothesized that obesity may alter the ovarian expression of ovotoxicant metabolizing 
enzymes genes. Previous studies have demonstrated that diabetes is strongly associated 
with increased hepatic Cyp2e1 [123] and on the other hand decreased Ephx1 [124]. 
Also, Cyp2e1 mRNA expression is decreased in a dose dependent manner by insulin in 
rat cultured hepatocytes [123, 125, 126]. PI3K inhibitors such as wortmannin and 
LY294002 were shown to reverse the insulin-mediated down-regulation of Cyp2e1 
mRNA levels [127].  Furthermore, in cultured neonatal ovaries, inhibition of PI3K 
signaling using LY294002 resulted in increased mRNA and protein levels of Ephx1, 
Gstp and Gstm [67-69]. In the present study decreased mRNA encoding Cyp2e1 was 
observed in ovaries of obese mice compared to the lean mice. In contrast to Cyp2e1, 
there was a trend for increased Ephx1 mRNA level. This differential effect of a 
physiological paradigm on ovarian Cyp2e1 and Ephx1 expression has been previously 
reported [76, 128]. Studies on the GSTs have reported both increased and decreased 
gene expression during diabetes [66]. In rat cultured hepatocytes, neither insulin nor 
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glucagon affected the mRNA levels of Gstm while, on the other hand, glucagon reduced 
Gstp mRNA levels [129]. In the current study there was a trend for decreased Gstp 
mRNA and protein level in the obese ovary.  These results suggest that obese females 
may have altered xenobiotic metabolism and therefore if such females are exposed to 
ovotoxicants, the rate at which they would approach premature ovarian insufficiency and 
failure would be accelerated. Further still, these results suggest that obese females may 
have increased risks from exposure to carcinogens and teratogens which could also 
potentially explain the increased rates of miscarriage and increased offspring birth 
defects in obese mothers. 
 
PI3K signaling can be regulated through posttranscriptional gene silencing by the 
action of miRs [78, 80, 89, 130].  In order to evaluate if obesity had any effect on miR’s 
that could at least partially explain the effects observed on PI3K signaling, levels of 
miR-103, miR-21, miR-184 and miR-205 were measured.  It was found that the ovaries 
from obese mice had decreased miR-21 and miR-103; however, miR-184 levels were 
increased. Recent reports have indicated that miR-21 expression is important for 
regulation of apoptosis [131, 132]. Decreased expression of miR-21 expression has been 
reported to increase cell apoptosis in a variety of cell culture systems including the 
granulosa cells from mouse pre-ovulatory follicles both in vivo and in vitro [86]. In 
addition, miR-21 has been identified as promoting follicular cell survival during 
ovulation and miR-21 inhibition also has been reported to reduce ovulatory rates [86]. 
Although many different cell types undergo apoptosis in response to inhibition of miR-
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21 action, the miR-21 targets implicated vary widely for different cells and the 
mechanism by which miR-21 suppresses apoptosis in GCs remain to be identified [133-
135].  
miR-184 has been shown to act as a physiological suppressor of general 
secretory activity of progesterone and estradiol [135, 136]. Additionally, miR-184 is 
believed to play a critical role in development as well as being a mediator of apoptosis. 
Up-regulation of miR-184 has been reported to interfere with the ability of miR-205 to 
lead to repression of AKT signaling [78]. Though in this study we observed an elevated 
level of miR-184 with a trend for a decrease in miR-205 level, there was an up-
regulation of Akt1 mRNA levels together with a subsequent decrease in Foxo3a mRNA 
levels thus indicating that Akt1 activation is not being compromised by miR-205 action. 
Several studies from both human and rodent models have reported that miR-103 is up-
regulated during obesity [89, 137, 138]. It has been further suggested that silencing miR-
103 improves insulin sensitivity in adipocytes mainly through increased caveolin-1 
expression, which in turn leads to stabilization of the INSR and thus enhancing insulin 
signaling [89]. In contrast to the above reports miR-103 expression has also been found 
to be down-regulated in the mouse model of genetic insulin resistance and obesity (ob/ob 
mice) [139]. This is consistent with our findings, where obesity decreased miR-103 
levels in mice ovaries. These results further confirm miRNA cell and tissue specific 
actions  [140]. 
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Conclusions 
 
In summary, the data presented herein, though preliminary in nature, demonstrate 
perturbations to ovarian PI3K signaling caused by obesity in females.  Under basal 
conditions, AKT1 is positively regulated by both KITLG and IRS1.  In addition, AKT1 
is positively regulated by miR21 and negatively regulated by miR184.  Our data 
collectively indicates that obesity decreases IRS1 levels but increases KITLG which can 
then result in increased AKT1 levels.  Although miR21 is decreased, which should result 
in decreased AKT1, we propose that increased levels of miR184 may counteract 
decreased miR21 to result in AKT1 activation (summarized in Figure 7).  One 
consequence of obesity-induced altered PI3K includes changes in the downstream 
components Akt1 and Foxo3a that may alter the rate of primordial follicle activation, 
leading to fertility problems.  Another result of altered PI3K observed is that expression 
of major xenobiotic biotransformation enzymes that are important in the ovarian 
response to ovotoxicant exposure, are changed.  Thus, obesity may have negative 
consequences for follicle activation and oocyte viability, as well as altering how the 
ovary responds to chemical exposures.  All of these scenarios can lead to impairment of 
ovarian function, and may at least partially explain why reproduction is compromised in 
obese females.       
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Table 1. Sequences of primers used 
 
 
 
Primer name Sequence 
Insr-for ATGGGCTTCGGGAGAGGAT 
Insr-rev GGATGTCCATACCAGGGCAC 
Irs1-for GGATGTCCATACCAGGGCAC 
Irs1-rev CAGCCCGCTTGTTGATGTTG 
Cyp2e1-for CCCAAGTCTTTAACCAAGTTGGC 
Cyp2e1-rev CTTCCATGTGGGTCCATTATTGA 
c-kit-for GCCACGTCTCAGCCATCTG 
c-kit-rev GTCGGGATCAATGCACGTCA 
Kitlg-for GAATCTCCGAAGAGGCCAGAA 
Kitlg-rev GCTGCAACAGGGGGTAACAT 
Akt1-for CCACCTGTCTCTAGGGTCCA 
Akt1-rev CATGGGACACAGCAACAAAC 
Gstp-for CCCAAGTTTGAGGATGGAGA 
Gstp-rev CAGGGCCTTCACGTAGTCAT 
Gstm-for GAGAGGATCCGTGCAGACAT 
Gstm-rev ACTTGGGCTCAAACATACGG 
Foxo3a-for GGTACCAGGCTGAAGGATCA 
Foxo3a-rev CAGTCTCTGCTGGGTTAGGG 
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Figure 1. Obesity does not alter ovarian weight in mice. Six weeks old C57Bl/6J 
female mice (n = 6 per treatment group) were fed either a standard chow mice diet or a 
high-fat diet for approximately 7 months and were euthanized by CO2 asphyxiation.  
Ovaries were removed, trimmed of excess fat and weighed. (A) Ovarian weight; (B) lean 
and (C) obese ovarian sections stained with hematoxylin and eosin (H&E).  
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Figure 2. Obesity decreases ovarian Irs1 mRNA levels in mice. Ovaries were 
removed from lean and obese mice (n = 6 per treatment group).  (A) RNA was isolated 
and Insr and Irs1 mRNA levels were evaluated by quantitative RT-PCR. Values 
represent fold-change relative to a control value of 1 ± SE, normalized to Actb.  (B) 
Total protein was isolated and Western blotting performed to measure INSR level.  
Values represent fold-change relative to a control value of 1 ± SE, normalized to ACTB. 
Different from control, *P < 0.05. (C) Representative Western blot for INSR and ACTB; 
Lean = L, Obese = O.   
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Figure 3. Obesity enhances ovarian KITLG/KIT-PI3K/AKT1 signaling pathway in 
mice. Ovaries were removed from lean and obese mice (n = 6 per treatment group). 
RNA was isolated and Kitlg, cKit, Akt1 and Foxo3a mRNA levels were evaluated by 
quantitative RT-PCR.  Values represent fold-change relative to a control value of 1 ± 
SE, normalized to Actb. Different from control, *P < 0.05.  
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Figure 4.  Altered pAKTSer473 levels are observed in the ovaries of obese mice.  
Ovaries were removed from (A) lean and (B) obese mice, serially sectioned and 
mounted onto slides (n = 6 per treatment group).  Immunoflourescence staining to detect 
pAKTSer473 was performed, with counterstaining to detect the nucleus.  Image J 
software was used to quantify levels of pAKTSer473 in (C) small (pre-antral; indicated 
by arrowhead) and (D) large oocytes (antral; indicated by broken arrow) and (E) theca 
cells (indicated by unbroken arrow).   
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Figure 5. Obesity down-regulates ovarian Cyp2e1 mRNA levels. Ovaries were 
removed from lean and obese mice and RNA isolated (n = 6 per treatment group).   (A) 
Cyp2e1, Ephx1, Gstp and Gstm mRNA levels were measured by quantitative RT-PCR. 
Values represent fold-change relative to a control value of 1 ± SE, normalized to Actb. 
Different from control, *P < 0.05. (B) Western blotting was performed to determine any 
impact of obesity on GSTP. (C) Representative Western blot for GSTP and ACTB; Lean 
= L, Obese = O.   
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Figure 6. Obesity alters levels of ovarian miR. Ovaries were removed from lean and 
obese mice and RNA isolated (n = 3 per treatment group). (A) Enriched miR fractions 
were analyzed using a miR array.  (B) qRT-PCR was performed on miR-21 to confirm 
the array data.  Values represent fold-change relative to a control value of 1 ± SE, 
normalized to RAU43. Different from control, *P < 0.05.   
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Figure 7.  Proposed model of obesity effects on AKT1 signaling. Under basal 
conditions, AKT1 is positively regulated by both KITLG and IRS1.  In addition, AKT1 
is positively regulated by miR21 and negatively regulated by miR184.  Our data 
indicates that obesity decreases IRS1 levels but increases KITLG leading to increased 
AKT1 levels.  The increased levels of miR184 may counteract the decreased miR21 in 
AKT1 activation.  AKT regulates xenobiotic metabolism, primordial follicle activation 
and viability as well as ovarian steroidogenesis.  Thin arrows indicate positive 
regulation, negative regulation is indicated by the broken arrow.  Block arrows indicate 
the impact of obesity.   
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CHAPTER 3: DIET-INDUCED OBESITY ALTERS IMMUNE CELL 
INFILTRATION AND EXPRESSION OF INFLAMMATORY CYTOKINE 
GENES IN MOUSE OVARIAN AND PERI-OVARIAN ADIPOSE DEPOT 
TISSUES. 
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SUMMARY 
 
Dysregulation of immune cells and/or altered inflammatory signaling have been 
implicated with reproductive dysfunction. Physiological changes leading to perturbations 
in the profile of immune cells and/or pro-inflammatory cytokines in, or around, female 
reproductive tissue could potentially have profound effects on ovarian function.  Obesity 
is associated with chronic low-grade inflammation due, in part, to increased immune cell 
infiltration and inflammation in visceral adipose depots.  This study investigated the 
impact of diet-induced obesity on immune cell infiltration and inflammation in peri-
ovarian adipose tissue and mRNA expression of key inflammatory markers and Micro-
RNAs (miR) in ovarian tissue.  Six week old female C57Bl/6J mice were fed a standard 
chow or high-fat diet (HFD; 60% kcal fat) for approximately 7 months at which time 
peri-ovarian adipose tissue and ovarian tissues were collected for analysis.  Histological 
analysis of obese peri-ovarian adipose tissue, revealed increased (P < 0.05) adipocyte 
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size and the presence of crown-like structures, the morphological presentation of 
infiltrating immune cells in adipose tissue, along with increases (P < 0.05) in the mRNA 
levels of markers of T-cells, activated macrophages, inflammatory cytokines and 
chemokines.  Ovarian mRNA levels of Il1b, Il6, Tnfa, p55, p75, Ccl2, Ikbkb and Rela 
were increased by obesity (P < 0.05), with a strong trend (P = 0.06) for an increase in 
Nos2 and RELA protein.   Additionally, ovarian miR125b and miR143 levels were 
decreased (P = 0.1). These data demonstrate that diet-induced obesity elevates 
expression of inflammatory mediator genes in both the ovary and surrounding adipose 
depot, potentially negatively affecting ovarian function.  
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INTRODUCTION 
 
The mammalian ovary is a heterogeneous tissue, containing follicles at different 
developmental stages (Hirshfield 1991). Regulation of the ovarian cycle is primarily 
dependent on proper interaction between ovarian steroids and the pituitary 
gonadotropins, however, it is suggested that macrophages can also regulate ovarian 
cellular proliferation, apoptosis (Benyo and Pate 1992), inflammation and 
steroidogenesis (Wu et al. 2004), and are therefore essential accessory cells for optimal 
fertility (Brännström et al. 1994; Cohen et al. 1999; Norman and Brannstrom 1994). 
Macrophages and/or macrophage-derived product deregulation are implicated in a 
number of ovarian pathologies (Moller 2000) including polycystic ovary syndrome 
(Gazvani et al. 2000; Ma et al. 2010; Qiao and Feng 2011), endometriosis (Carlberg et 
al. 2000) and premature ovarian failure (Wu et al. 2004). Physiological changes which 
could lead to perturbations in the profile of immune cells and/or pro-inflammatory 
cytokines in, or in close proximity to, the female reproductive tract could potentially 
have profound effects on ovarian function.  
 
Obesity is an independent risk factor for a range of metabolic complications 
including reproductive disorders (Malnick and Knobler 2006; Rachoń and Teede 2010; 
Raj and Kumar 2010; Teede et al. 2010).  The exact mechanism(s) by which obesity 
affects ovarian function remain poorly understood.  Low-grade systemic inflammation 
has been implicated in the development of infertility and other obesity-associated 
adverse reproductive health outcomes (Blencowe et al. 2012; Carmichael et al. 2010; 
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Nestler 2000; Ogbuji 2010; Pasquali and Gambineri 2006; Pasquali et al. 2003; 
Pettigrew and Hamilton-Fairley 1997; Rubens et al. 2010).  Inflammation originating 
from intra-abdominal adipose tissue contributes significantly to systemic inflammation 
and is due in large part to the pro-inflammatory actions of bone marrow-derived immune 
cells that infiltrate obese adipose tissue and selectively localize to dead adipocytes 
forming a crown-like structure (CLS) (Cinti et al. 2005; Strissel et al. 2007; Weisberg et 
al. 2003a).  CLS’s are predominantly found in intra-abdominal fat depots, whereas 
subcutaneous adipose tissue appears to be protected from inflammatory increases 
(Strissel et al. 2007); however, these depot-specific differences in the distribution of 
immune cells and inflammatory factors have yet to be investigated in peri-ovarian 
adipose tissue.   
 
Chronic inflammation has also been reported to alter MicroRNA (miRNA) levels 
Aggravated activation of inflammatory cytokines has been associated with detrimental 
deposition of excess lipid in extra-ovarian tissues (Cummings and Schwartz 2003; 
Guilherme et al. 2008; Gustafson et al. 2009), generation of reactive oxygen species and 
oxidative stress scenarios both of which could have detrimental consequences for human 
fertility (Jabbour et al. 2009).  In addition, several studies have reported that a variety of 
cytokines can regulate ovarian function (Adashi 1990; Andreani et al. 1991; Salmassi et 
al. 2001; Spangelo et al. 1995).  Interleukin-6 (Il6) is a pleiotropic cytokine with diverse 
roles including regulation of ovarian steroid production and ovulation (Mikuni 1995; 
Van der Hoek et al. 1998).  Nitric oxide synthase 2 (Nos2) is an oxidative stress marker 
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involved in a number of biological processes including insulin signal transduction, 
fertility, embryogenesis, and fetal development (Agarwal et al. 2005a; Agarwal et al. 
2005b; Agarwal et al. 2006; Osborn et al. 2002; Rosselli et al. 1998). Tumor necrosis 
factor-alpha (Tnfa) is a pleiotropic cytokine that acts on multiple tissues via two distinct 
membrane receptors (a 55-kDa isoform (p55) and a 75-kDa isoform (p75)) that activate 
both unique and synergistic responses (Crespo et al. 2010; Erickson et al. 1994; 
Sakumoto and Okuda 2004; Schreyer et al. 1998; Tartaglia et al. 1991).  In the ovary, 
TNFa has been reported to regulate cell differentiation, proliferation and apoptosis 
(Amsterdam et al. 2003a; Amsterdam et al. 2003b; Roby and Terranova 1990), 
inflammation (Roby et al. 1990) as well as steroid production (Amsterdam et al. 2003a).  
The nuclear factor kappa B (RelA) transcription factor is a heterodimer protein 
composed of two subunits; p50 and p65, which can be induced by TNFa (Dhanalakshmi 
et al., 2002) and which can activate inflammatory components such as IL6 (Albertini et 
al., 2012).  RELA is maintained in an inactive state in the cytoplasm through interaction 
with members of the IκB kinase (IKK), until IKK phosphorylation results in 
ubiquitination of IKK and subsequent release of RELA by the action of CHUK and/or 
IKBKB (Mercurio et al., 1999).    
In recent years, miRNAs have been shown to regulate the activity of key cellular 
processes, including insulin release in pancreatic β cells, adipocyte differentiation 
(Williams and Mitchell 2012; Xie et al. 2009), and insulin sensitivity (Trajkovski et al. 
2011) and are therefore thought to contribute to the pathologies linked with exacerbated 
inflammatory cytokines.  For instance, miR125b negatively regulates Tnfa mRNA 
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(Huang et al. 2012) whereas increased Tnfa itself down-regulates miR143 (Xie et al. 
2009).  
 
In this study, we examined the impact of high fat diet (HFD)-induced obesity on 
peri-ovarian adipose tissue morphology and mRNA expression of immune cell markers 
and inflammation therein.  Relative mRNA expression of key inflammatory mediators 
and miRNAs were also investigated in ovarian tissue.  We hypothesized that HFD-
induced obesity results in elevated immune cell infiltration and expression of 
inflammatory cytokine genes in these two tissues and contribute to obesity-induced 
reproductive dysfunction.  
 
RESULTS 
 
Obesity increases adipocyte size and relative gene expression of markers of immune 
cells and inflammation in the peri-ovarian fat pad. 
Consistent with reported changes in the epididymal adipose tissue of obese male 
mice (Strissel et al. 2007; Weisberg et al. 2003b), the peri-ovarian adipose tissue of 
obese female mice was characterized by increased adipocyte size and elevations in 
markers of immune cells and pro-inflammatory cytokines.  Average adipocyte size 
within obese peri-ovarian adipose tissue was more than twice that of the lean adipose 
tissue (Figure 1A).  A frequency distribution graph of adipocyte size shows that this 
increase was associated with a reduction in the proportion of small adipocytes and a 
distribution pattern that was more Gaussian in appearance (Figure 1B).  An increase in 
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adipocyte size is typically associated with an increased presence of immune cells in 
adipose tissue.  CLS’s are clusters of immune cells that localize to dead adipocytes in 
adipose tissue and are the predominant source of inflammatory cytokines in obese 
adipose tissue (Cinti et al. 2005; Lumeng et al. 2007a; Lumeng et al. 2007b; Nguyen et 
al. 2007; Strissel et al. 2007).  The frequency of CLS in obese peri-ovarian adipose 
tissue was increased dramatically as compared to lean peri-ovarian adipose tissue 
(Figure 2). This increase in CLS abundance was associated with an increase in the 
relative gene expression of T cell (Cd3, Cd4 and Cd8), macrophage (F4/80) and 
dendritic cell (Itgax) markers in obese peri-ovarian adipose tissue (Figure 3A).  
Consistent with an increased infiltration of immune cells, gene expression of pro-
inflammatory cytokines (Il1b, Il6, Tnfa) and chemokines (Ccl2 and Ccl5) were also 
increased in obese peri-ovarian adipose tissue (Figure 3B).   
 
Obesity increases mRNA levels of genes encoding inflammatory cytokines and 
chemokines in ovarian tissue  
In a similar manner to the peri-ovarian fat depot, obesity increased ovarian 
mRNA encoding Il1b, Il6, Tnfa, the TNFa receptor genes p55 and p75, and the 
chemokine Ccl2 (P < 0.05; Figure 4A). Also, a tendency for increased (0.6-fold increase; 
P = 0.06) Nos2 mRNA expression was observed in ovaries from obese females 
compared to their lean littermates (Figure 4).  Furthermore, obesity increased mRNA 
levels of RelA, a downstream target of TNFa signaling, and increased Ikbkb (Figure 4).  
No impact of obesity on Chuk was observed.  Further, in agreement with the changes 
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observed in the TNFa receptor genes, RELA tended to be increased (25% increase; P = 
0.051) in the obese ovaries, relative to those from lean females (Figure 5).    
  
Effect of obesity on ovarian levels of miR125b and miR143  
Since Tnfa mRNA was increased we next examined the effect of obesity on a 
microRNA known to negatively regulate Tnfa expression, miR125b (Huang et al., 2012).  
Also, we determined if a microRNA that is regulated by TNFa, miR143 (Xie et al. 
2009), was altered by obesity.  There was a trend for decreased (P = 0.1) levels of both 
miR125b (74% decrease) and miR143 (96% decrease) in ovaries from obese females 
compared to lean littermates (Figure 7).    
 
DISCUSSION 
 
Obesity, activation of pro-inflammatory macrophages and compromised 
reproductive function are associated pathologies (Ferrante 2007; Hotamisligil 2006; 
Wellen and Hotamisligil 2003). In a number of obesity models, local and systemic 
markers of inflammation and oxidative stress are increased coincident with an increased 
presence of immune cells (Hofmann et al. 1994; Hotamisligil et al. 1995; Hotamisligil et 
al. 1993; Kern 1997; Kern et al. 1995; Nickelson et al. 2012; Saghizadeh et al. 1996). 
However, there is currently limited information regarding the effects of obesity on the 
inflammatory state of the peri-ovarian adipose tissue and the ovary it surrounds.  
Understanding potential changes in these tissues is important as exacerbated activation 
of these inflammatory pathways in the ovary could alter ovarian physiology (Carlberg et 
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al. 2000; Ma et al. 2010; Qiao and Feng 2011; Wu et al. 2004). In the present study we 
therefore determined the impact of HFD-induced obesity on the expression profiles of 
select pro-inflammatory cytokines in the murine peri-ovarian fat pad and ovarian tissue.  
 
Obese female mice had increased adipocyte size in the peri-ovarian fat pad 
compared to the lean littermates. Additionally, there was an increased presence of 
immune cells in peri-ovarian adipose tissue as evidenced by an increase in the number of 
CLS and the mRNA expression of immune cell markers. Consistent with increased cell 
size and immune cell infiltration, relative mRNA expression of inflammatory markers 
were also elevated in peri-ovarian adipose tissue.  These data are the first, as far as the 
Authors are aware, to demonstrate that hypertrophic expansion of obese peri-ovarian 
adipose tissue is associated with CLS formation and inflammation in obese female mice.  
While the observed changes are consistent with reported changes in other intra-
abdominal adipose tissue depots of obese male and female mice (Strissel 2007 and 
(Nickelson et al. 2012), this confirmation is important given the proximity of the adipose 
tissue to the ovary and the ability of estrogen to regulate adipose tissue expansion and 
inflammation (Heine et al. 2000; Stubbins et al. 2012).  Although humans and mice 
differ in the deposition of fat around the ovary, inflammatory cytokines produced in 
intra-abdominal adipose tissue in humans could potentially impact the ovary due to the 
proximity of both tissues.    
Although Il6 mRNA levels were unchanged with obesity in peri-ovarian adipose 
tissue, there were elevated Il6 mRNA levels in the ovaries of obese mice compared to 
96 
 
lean mice. Elevated levels of IL6 have been reported in patients with ovarian 
hyperstimulation syndrome (Buyalos et al. 1992; Loret de Mola et al. 1996a; Loret de 
Mola et al. 1996b), epithelial ovarian cancer (Lane et al. 2011) as well as other forms of 
ovarian cancer (Costanzo et al. 2005; Nilsson et al. 2007).  IL6, together with TNFa and 
IL1β, has also been reported to be part of the cytokine network implicated in ovarian 
cancer (Anglesio et al. 2011; Coward et al. 2011; Kulbe et al. 2007). Additionally, IL6 
activation has been associated with enhanced tumor cell activation (Chou et al. 2005), 
survival, and increased resistance to chemotherapy (Duan et al. 2006).  Thus, aberrant 
expression of Il6 caused by HFD-induced obesity as observed in our study may have 
negative consequences for ovarian function.   
 
In addition to elevated Tnfa in the peri-ovarian fat depot, obese mice had 
elevated ovarian mRNA levels of Tnfa and both TNFa receptors as compared with lean 
mice. These findings are in agreement with other studies which reported obesity-induced 
increased Tnfa mRNA or protein expression in human adipose and muscle tissues 
(Hotamisligil et al. 1995; Kern et al. 1995; Saghizadeh et al. 1996), rat adipose tissue 
(Hotamisligil et al. 1993) and mouse muscle and adipose tissue (Hofmann et al. 1994).  
Whether the temporal pattern of Tnfa induction differs between the tissues measured 
remains unclear from the current study.   Further, RELA protein level was increased in 
the obese ovaries, relative to lean controls, confirming that the TNFa pathway was 
activated by obesity, and the Ikbkb gene was increased in obese ovaries but not the Chuk, 
supporting that Ikbkb is involved in RELA activation in obese ovaries.     
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Aggravated oxidative stress in the ovary could adversely affect ovarian function 
(Agarwal et al. 2005b; Hefler and Gregg 2002; Pierce et al. 2004; Szczepańska et al. 
2003) and hence compromise the female reproductive potential.  We observed a strong 
trend for increased Nos2 mRNA in association with elevated Tnfa mRNA levels in 
ovaries of obese mice compared to their lean littermates, potentially indicating increased 
macrophage infiltration to the ovary.   These data are in agreement with previous studies 
which showed that Nos2 expression is elevated in both genetic and diet-induced models 
of obesity and is activated in response to pro-inflammatory cytokines including TNFa 
(Agarwal et al. 2005b; Lee et al. 2000; Perreault and Marette 2001; Rosselli et al. 1998).   
 
Given their roles in regulation of the activity of key cellular processes; including 
insulin release in pancreatic β cells, differentiation of adipocytes (Williams and Mitchell 
2012; Xie et al. 2009), and insulin sensitivity (Trajkovski et al. 2011), miRNA’s may 
contribute to the pathologies associated with exacerbated inflammatory cytokines 
(Huang et al. 2012; Sonkoly and Pivarcsi 2009). The observed elevation of Tnfa 
expression in the obese ovary led us to query if obesity modulated the expression of 
miR125b; which is known to negatively regulate Tnfa mRNA (Huang et al. 2012), and 
miR143 whose expression is suppressed by elevated TNFa (Xie et al. 2009).   Decreased 
circulating miR125b associated with increased fat mass has been reported in morbidly 
obese men (Ortega et al. 2013).  Also, miR143 is reported to be critical for formation of 
the primordial follicle pool in utero (Zhang et al. 2013), raising concerns about the 
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impact of obesity on the neonatal ovary.  While our data cannot confirm a direct 
involvement of miR125b and miR143 with the TNFa pathway, taken together with the 
mRNA and protein changes observed, these data support that miR125b and miR143 may 
be involved in physiological alterations that occur in ovarian tissue during obesity.   
 
It is worth noting that a thorough evaluation of the reproductive status of lean 
and obese females was not performed in this study however plasma estradiol 
concentrations were not different between the age-matched groups of mice (Nickelson et 
al. 2012).  Whole ovary samples were used to determine if broad changes in the 
inflammatory profile of the organ were occurring during obesity, and our lack of 
controlling for cycle stage may certainly have introduced additional variation to the 
ovarian data resulting in an underestimation of the significance of the data reported.  
However, future studies that control for stage of estrous cycle would shed light on the 
impact of changing hormone profiles on the ovarian inflammatory profile during obesity.   
 
In summary, HFD-induced obesity resulted in increased adipocyte size, immune 
cell infiltration and increased mRNA expression of inflammatory markers in peri-
ovarian adipose tissue. Changes in peri-ovarian adipose tissue were associated with 
increased mRNA levels of pro-inflammatory cytokines, TNFa, RELA, Il6 and the 
oxidative stress marker, Nos2 in the ovaries of obese mice. While the current study 
established that obesity is associated with inflammatory changes in the ovary, future 
studies will be required to address the cellular origin and cause-effect relationship 
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between observed changes in peri-ovarian adipose tissue and the ovary and the 
implications of these changes on ovarian function. Improved understanding of the 
mechanisms that are involved in the onset and progression of obesity-associated changes 
in the ovary will be of value in order to develop improved strategies to mitigate 
reproductive dysfunction in obese females.    
 
MATERIALS AND METHODS 
 
Reagents  
2-β-mercaptoethanol was purchased from Sigma-Aldrich Inc. (St. Louis, MO). 
Hanks' Balanced Salt Solution (without CaCl2, MgCl2, or MgSO4) and superscript III 
one-step RT-PCR System were obtained from Invitrogen Co. (Carlsbad, CA). miRNeasy 
Mini Kit, miScrip Reverse Transcription Kit, miScrip SYBR Green PCR Kit, RNeasy 
Mini kit, QIAshredder kit, RNeasy MinElute kit, TaqMan® microRNA Reverse 
Transcription Kit and QuantitectTM SYBR Green PCR kit were purchased from Qiagen 
Inc. (Valencia, CA). RELA primary antibody was purchased from Cell signaling 
(Danvers, MA).  Custom designed primers were obtained from the DNA facility of the 
Office of Biotechnology at Iowa State University.  
 
Animal and diets 
Ovarian tissues were obtained from a study at the University of Missouri. The 
experimental protocols were approved and performed in accordance with the guidelines 
of the University of Missouri Institutional Animal Care and Use committee as previously 
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described (Nickelson et al. 2012). Briefly, 6 weeks old C57Bl/6J female mice were 
randomized into two groups. The control group (lean) was fed a standard chow mice diet 
(Purina 5001; 4.5g/100g fat) while the treatment group (obese) was fed a high-fat diet 
(Research Diets D12492; 35g/100g fat) for approximately 7 months. The animals were 
housed at constant room temperature, 12h light:12h darkness cycle, diet and water were 
provided ad libitum. Body weights were measured weekly and a glucose tolerance 
testing confirmed that obese mice were less glucose tolerant than their lean littermates 
(Nickelson et al. 2012).  
 
Tissue collection 
Animals were euthanized by CO2 asphyxiation followed by exsanguination via 
cardiac puncture. Ovaries and the surrounding peri-ovarian adipose tissue were removed 
and separated from each other.  Both the ovaries and peri-ovarian adipose tissue were 
snap frozen for gene expression analysis or fixed in 4% paraformaldehyde for 
histological analysis.  
 
RNA Isolation  
Total RNA was isolated from ovaries using the Qiagen RNeasy® Mini Kit and 
from peri-ovarian adipose tissue using the Qiagen RNeasy® Lipid Mini Kit. Briefly, 
tissues were lysed and homogenized using a hand held homogenizer. The homogenate 
was then applied to a QIAshredder column placed in a collection tube and centrifuged at 
16100 RCF for 2 minutes at room temperature. The flow through was then applied to an 
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RNeasy Mini column, allowing RNA to bind to the filter cartridge.  Following washing, 
RNA was eluted from the filter and concentrated using an RNeasy MinElute kit. RNA 
was eluted using RNase-free water and quantified using an ND-1000 Spectrophotometer 
(λ = 260/280 nm; NanoDrop technologies, Inc., Wilmington, DE).  
 
First Strand cDNA synthesis and quantitative Real-Time quantitative polymerase 
chain reaction (qRT-PCR) 
0.5µg of total RNA was reverse transcribed to cDNA using InvitrogenTM 
Superscript III Reverse Transcriptase according to the manufacturer’s protocol. 2 µl of 
diluted cDNA (1:25) were amplified on an Eppendorf Mastercycler using Quantitect™ 
SYBR Green PCR kit and primers specific for mouse Actb, Rps3, Itgax, Cd3, Cd4, Cd8, 
Emr1, Il6, Tnfa, Nos2, Il1B, Mcp1 and Ccl5. The PCR cycling program consisted of a 15 
min hold at 95 oC and 40 cycles of: denaturing for 15 at 95 oC, annealing for 15s at 58 oC 
and extension at 72 oC for 20s. Product melt conditions were determined using a 
temperature gradient from 72 oC to 99 oC with a 1 oC increase at each step. Three 
replicates of each sample (n = 6) were included. The relative mRNA expression for each 
of the above genes was normalized using mouse housekeeping genes Actb (ovary) and 
Rps3 (peri-ovarian adipose tissue) and relative fold change calculated using the 2-ΔΔCT 
method.  The results are presented as mean fold change ± standard error relative to the 
lean control group. 
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mirScript miRNA PCR array 
Purification of miRNA-enriched fractions was performed using a miRNeasy 
Mini Kit according to manufacturer’s protocol. 250 ng of miRNA-enriched fractions in a 
reverse-transcription reaction of 20 µl were converted to cDNA using miScrip Reverse 
Transcription Kit. cDNA was then diluted by adding 200 µl of RNase-free water, from 
which, 100 µl was used as template cDNA for real-time PCR quantification of multiple 
microRNAs using miScrip SYBR Green PCR Kit. Data analysis was performed using 
the web-based miScript miRNA PCR Array Data Analysis package.   
 
Protein Isolation and Immunoblot analysis 
Total ovarian protein was isolated and immunoblots performed as follows. 
Briefly, ovaries were homogenized in ~ 200 µl of iced-cold extraction buffer containing 
50 mM Tris-HCl (pH 8), 150 mM NaCl, 1% NP40 and 1% Protease inhibitor, followed 
by  centrifugation for 30 minutes at 9300 RCF at 4 oC. Protein concentration was 
determined using a standard BCA protocol. Emission absorbance values were detected 
with a λ = 560 nm excitation on a Synergy™ HT Multi-Detection Microplate Reader 
using KC4™ software (Bio-TekR Instruments Inc. Winooski, VT). Total protein (20 µg) 
was separated using 10% SDS-PAGE and electro-transfer of proteins from the gel to a 
nitrocellulose membrane was performed for 60 minutes at 100 V. The membranes were 
stained with Ponceau S to visualize the amount of total protein transferred in each lane. 
To reduce non-specific binding, membranes were pre-incubated overnight on a rocker at 
4oC in a blocking buffer (5% non-fat dry milk, 5 M NaCl, 20 mM Tris-HCl, 0.15% 
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Tween-20, pH 8). Membranes were probed using a specific primary antibody against 
RELA (1:500 dilution) diluted in 5% non-fat dry milk in Tris-buffered saline with 
Tween-20 (TTBS) overnight at 4 oC. Following washing for three times (10 min each) in 
TTBS, membranes were incubated at room temperature for 1 hour with HRP-conjugated 
suitable secondary antibodies (1:2000) against the primary antibodies. Membranes were 
washed three times in TTBS followed by a single wash in Tris-Buffered Saline (TBS). 
Autoradiograms were visualized on X-ray films in a dark room following 5 min 
incubation of membranes in ECLplus chemiluminescence detecting reagent. 
Densitometry of the appropriate band was quantified using Image J software (NCBI). 
Equal loading was confirmed by Ponceau S staining of membranes and protein 
expression was normalized to ACTB densitometry values.  
 
Histological analysis of peri-ovarian adipose tissue 
A portion of the peri-ovarian adipose tissue was fixed in 4% paraformaldehyde, 
embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E). Digital 
images were acquired with an Olympus BX51 light microscope using an Olympus DP70 
camera. For each animal, images of three distinct regions within two or three sequential 
histologic sections were used to determine frequency of crown-like structures (CLSs) 
and cell size.  All CLS and adipocytes within an image were counted and the percentage 
of CLS was calculated as (number CLS/number total adipocytes) x 100.  Adipocyte size 
(volume) was determined using the cross-sectional area obtained from perimeter tracings 
using Image J software (Sun Microsystems, Santa Clara, CA, USA).  Frequency 
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distribution for adipocyte size was calculated as (number of cells within a specific size 
range/total adipocytes) x 100.  
 
Statistical analysis 
Statistical analysis was performed using the unpaired t-test function of GraphPad 
Prism 5.5 software with a statistical significance level set at P < 0.05.  A trend for a 
biological change was considered if the P-value was below 0.1.   
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Table 1. Primer Sequences 
Gene name Forward Sequence Reverse Sequence 
Tnfα CCAGACCCTCACACTCAGATCA CACTTGGTGGTTTGCTACGAC 
p55 AGCCACACCCACAACCTTAG ATCTCCCTGCCCTGCCACTCACAAG 
p75 AATGCTAGGCAAACGCAATC GGAACTGCTGCTTTGGAGTC 
Ikbkb AGCCTGTCTGCTTTGGACTC CATCGCCATCACTACAGCAT 
Chuk TTTCGGGAACGTCAGTCTGT GCACCATCGCTCTCTGTTTT 
Rela GCTCCTGTTCGAGTCTCCAT TAGGTCCTTTTGCGCTTCTC 
Il1b TCACAGCAGCACATCAACAA TGTCCTCATCCTGGAAGGTC 
Il6 CCAGAGATACAAAGAAATGATGG ACTCCAGAAGACCAGAGGAAAT 
Nos2 AATCTTGGAGCGAGTTGTGG CAGGAAGTAGGTGAGGGCTTG 
Cd3 TCGTCACTGTCTAGAGGGCA CCTCCTAGTGTTGGCACTT 
Cd4 CAAGCGCCTAAGAGAGATGG CACCTGTGCAAGAAGCAGAG 
Cd8 ACGGGCATTGCTTCTTCTT ACAGGGACGAAGCTGACTGT 
Emr1 CTTTGGCTATGGGCTTCCAGTC GCAAGGAGGACAGAGTTTATCGTG 
Ccl2 ACTGAAGCCAGCTCTCTCTTCCTC TTCCTTCTTGGGGTCAGCACAGAC 
Ccl5 CAGCAGCAAGTGCTCCAATCTT TTCTTGAACCCACTTCTTCTCTGG 
Itgax CTGGATAGCCTTTCTTCTGCTG GCACACTGTGTCCGAACTG 
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Figure 1. Obesity increases adipocyte size in the peri-ovarian fat pad in mice. The 
peri-ovarian fat pad was removed from lean or obese C57Bl/6J female mice.  H&E 
stains of lean and obese peri-ovarian adipose tissue were used to determine average 
adipocyte area (A) and the overall size distribution of adipocytes (B) from both lean and 
obese peri-ovarian adipose tissue. Data are reported as mean ± SE; n = 6 per group; *P < 
0.05. 
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Figure 2. Obesity increases the presence of crown-like structures in peri-ovarian 
adipose tissue. Representative H&E stains of peri-ovarian adipose tissue from lean (A) 
and obese (B) female mice.  Sections were used to quantify the presence of crown-like 
structures (C).  Arrows identify CLSs in the adipose tissue; scalebar = 100 µm.  Data are 
reported as mean ± SE; n = 6 per group. *P < 0.05.    
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Figure 3. Obesity increases mRNA expression of immune cell and pro-
inflammatory markers in peri-ovarian adipose tissue. The peri-ovarian adipose tissue 
was removed from lean or obese C57Bl/6J female mice.  Total RNA was isolated and 
qRT-PCR performed.  Relative mRNA expression of markers for immune cell 
infiltration (A) and inflammation (B) were determined.  Data are reported as mean ± SE; 
n = 6 per group; Values represent fold-change relative to a control value of 1 ± SE, 
normalized to Rps3, *P < 0.05.  
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Figure 4. Obesity up-regulates pro-inflammatory cytokine mRNA expression in 
ovarian tissue. Ovaries were removed from lean or obese C57Bl/6J female mice. Total 
RNA was isolated, followed by quantification of Il1b, Il6, Nos2, Tnfa, TNFa receptors 
p75 and p55, Ccl2, Chuk, Ikbkb and RelA mRNA levels by quantitative RT-PCR. Data 
are reported as mean ± SE; n = 6 per group; Values represent fold-change relative to a 
control value of 1 ± SE, normalized to Actb, *P < 0.05.    
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Figure 5.  Obesity increases the downstream target of TNFa, RELA. Ovaries were 
removed from lean (L) or obese (O) C57Bl/6J female mice.  Total protein was isolated, 
followed by quantification of RELA by (A) Western blotting. (B) Data are reported as 
densitometric mean, normalized to ACTB ± SE; n = 4 per group; Difference from 
control are indicated by *P < 0.05.  
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Figure 6. Obesity down-regulates levels of miR125b and miR143 associated with 
inflammatory cytokine signaling in the ovary. Ovaries were removed from lean or 
obese C57Bl/6J female mice. Enriched miR fractions were analyzed using a miR array. 
Data are reported as mean; n = 6 per group; Values represent fold-change relative to a 
control value of 1; †P ≤ 0.1.   
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Abstract 
 
Diet-induced obesity induces immune cell infiltration and inflammation in peri-
ovarian adipose tissue and mRNA expression of inflammatory markers in ovarian tissue. 
Whether these changes are associated with the onset or progression of obesity remains 
unknown.  In the present study, qRT-PCR and Western blot techniques were utilized to 
compare ovarian mRNA and protein expression of ovarian immune cell and 
inflammation markers, along with NF-ҡB and steroidogenic pathway members in 
normal wild type non-agouti (a/a; lean) and lethal yellow mice (KK.CG-Ay/J; obese) at 
6, 12, 18 or 24 weeks of age. Our data revealed that, beginning at 12 weeks of age, 
NFҡB inflammatory signaling members were elevated (P < 0.05) in obese females. 
Interestingly obesity had contrasting effects on steroidogenic members. Obesity 
decreased (P < 0.05) STAR protein at 12, 18 and 24 weeks of age. CYP11A1 and 
CYP19A1 proteins were increased (P < 0.05) at 12 weeks but decreased (P < 0.05) at 18 
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and 24 weeks. Interestingly, CYP19A1 was increased in obese mouse ovaries at 6 weeks 
of age, potentially indicating early puberty onset. These data demonstrate that obesity 
alters expression of ovarian inflammatory and steroidogenic pathway genes in ways 
which could adversely affect ovarian function.  
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Introduction 
 
The mammalian ovary is essential for production of oocytes and the steroid 
hormones, 17β-estradiol (E2) and progesterone (P4). E2 and P4 are essential for ovarian 
function and development of female secondary sex characteristics (45, 65, 91, 107, 125). 
Circulating lipoproteins (54) and de novo biosynthesis (83) provide the steroid hormone 
precursor, cholesterol, to the theca (TC) and granulosa (GC) cells  under the influence of 
luteinizing hormone (LH) and follicle stimulating hormone (FSH), respectively (65, 91, 
105, 107). Steroidogenic acute regulatory protein (STAR), mediates the transfer of 
cholesterol from the outer to the inner mitochondrial membranes of the TC or GC, where 
cytochrome P450 side chain cleavage (CYP11A1) catalyzes its conversion to 
pregnenolone (55, 77, 89, 90, 118). Pregnenolone then exits the mitochondrion matrix to 
the cytoplasm where 3-beta-hydroxysteroid dehydrogenase (3β-HSD) converts it to P4 
(5, 76). The GC lack critical enzymes (17α-Hydroxylase and C17,20-lyase) for androgen 
production, thus, P4 diffuses to the TC where conversion to androstenedione under the 
action of 17α-Hydroxylase and C17,20-lyase enzymes occurs  (13, 55, 65, 119, 125). 
Likewise, the TC lack CYP19A1 (aromatase), required for conversation of androgens to 
estrogen. Therefore, androstendione will diffuse into the GC where CYP19A1 catalyzes 
its’ conversion to estrone and subsequently E2 by the action of 17β-hydroxysteroid 
dehydrogenase (17β-HSD). Alternatively, androstenedione can be converted to 
testosterone by 17β-HSD which diffuses to the GC to be aromatized to E2 by CYP19A1 
(55, 65, 76).  
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Obesity is a complex metabolic disorder associated with reproductive 
impairments (99, 102, 104, 109, 123). The deleterious effects of obesity on reproduction 
including polycystic ovarian syndrome (PCOS), poor oocyte quality, abridged fertility 
(21, 109) and increased risk of birth defects and still-birth (17, 29, 53, 111) have been 
long appreciated, however, the underlying molecular mechanisms involved are unclear. 
Obesity is linked with low grade systematic inflammation which is implicated in 
infertility (93, 99, 103). Additionally, obesity alters ovarian steroid hormone synthesis 
and metabolism (104) potentially by modifying the expression and activity of 
steroidogenic enzymes. Macrophages and inflammatory pathways can serve as 
modulators of ovarian function (1, 2, 9, 19, 24, 37, 64, 95, 128). The chemoattractants 
interleukin 8 (Il-8) and chemokine (C-C motif) ligand 2 (Ccl2), are major inflammatory 
response mediators, and are involved in ovarian follicular development, steroidogenesis, 
ovulation and atresia (19). Furthermore, interleukin 6 (Il-6), through its ability to 
modulate cyclic AMP (cAMP) (19), potentially  also regulates ovarian steroid 
production. Similarly, tumor necrosis factor and interleukin 1 (Il-1) can stimulate 
ovarian P4 production (19). Additionally, the pro-inflammatory cytokines TNFα and 
interleukins have been implicated in a number of ovarian pathologies (64, 82, 88) 
including polycystic ovarian syndrome (108), ovarian hyperstimulation (79, 80), ovarian 
cancer (8, 33, 72, 74), endometriosis (28) and impaired steroid production (9, 11, 128). 
Therefore it is possible that derangements in ovarian proinflammatory cytokine cues 
could compromise ovarian function and consequently lead to suboptimal fertility.  
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The lethal yellow mouse has a deletion mutation in the normal wild type non-
agouti (a/a) background which results in ectopic expression of agouti in various tissues 
including the hypothalamus and adipose tissue (30, 44, 71, 87). Hypothalamic agouti 
overexpression interferes with the alpha-melanocyte-stimulating hormone (α-MSH) and 
cocaine- and amphetamine-regulated transcript (CART) by inhibiting melanocyte 
stimulating hormone (MSH) receptor (20, 81), leading to hyperphagia (71, 81). Hence 
this serves as a useful model for understanding the effects of progressive obesity on 
ovarian function. The main objective of the present study was to determine the effects of 
obesity onset and progression on expression of ovarian pro-inflammatory and 
steroidogenesis pathway members in mice. To achieve this objective, changes in gene 
expression between the normal wild type non-agouti -a/a (lean) and lethal yellow 
KK.CG-Ay/J (obese), mice at 6, 12, 18 and 24 weeks of age were compared using qRT-
PCR and Western blotting techniques. 
 
Materials and Methods 
 
Reagents 
Custom designed primers were obtained from the DNA facility of the Office of 
Biotechnology at Iowa State University. D-Glucose, 2-β-mercaptoethanol, 30% 
acrylamide/0.8% bis-acrylamide, ammonium persulfate, glycerol, N′,N′,N′,N′-
Tetramethylethylenediamine (TEMED), Tris base, Tris HCl, sodium chloride, Tween-
20, bovine serum albumin (BSA), ascorbic acid (Vitamin C), phosphatase inhibitor, 
protease inhibitor and transferrin were purchased from Sigma-Aldrich Inc. (St. Louis, 
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MO, USA). Bayer Contour Blood Glucose meter and glucose strips (Bayer Ag, 
Leverkusen, Germany). RNAlater was obtained from Ambion Inc (Austin, TX, USA). 
Hanks' Balanced Salt Solution (without CaCl2, MgCl2, or MgSO4) and superscript III 
one-step RT-PCR System were obtained from Invitrogen Co. (Carlsbad, CA, USA). 
RNeasy Mini kit, QIAshredder kit, RNeasy MinElute kit and QuantitectTM SYBR 
Green PCR kit were purchased from Qiagen Inc. (Valencia, CA, USA). Ponceau S was 
purchased from Fisher Scientific (Waltham, MA, USA). Goat anti-rabbit and rabbit anti-
mouse secondary antibodies along with anti-STAR, anti-CYP11A1, anti-CYP19A1, 
anti-pIҡBαSer32/36, anti-pIKKα/βSer176/180, anti-pNFҡBp65Ser536 primary antibodies and 
SignalFire™ ECL Reagent were from Cell Signaling Technology® (Danvers, MA, 
USA). The anti-3β-HSD antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA). Donkey anti-goat secondary antibody was purchased from Pierce Biotechnology 
(Rockford, IL, USA). Restore™ PLUS Western Blot Stripping Buffer was purchased 
from Thermo SCIENTIFIC (Rockford, IL, USA). 
 
Animal procedures 
All experimental protocols and procedures were approved by the Iowa State 
University Animal Care Committee (IACUC). At 4 weeks of age, female normal wild 
type non-agouti (a/a; designated lean; n = 20) and agouti lethal yellow (KK.Cg-Ay/J; 
designated obese; n = 20) mice were purchased from the Jackson Laboratory (Bar 
Harbor, Maine) and housed at the animal facility at Iowa State University under 
controlled room temperature (21-22oC) and lighting (12h light:12h darkness cycle). All 
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animals had ad libitum access to feed and water. Body weight was measured once 
weekly. Glucose tolerance testing followed by euthanasia and ovary collection was 
performed at 6, 12, 18 or 24 weeks of age (n = 5 per group). 
 
Estrous cyclicity monitoring 
To determine any changes in the estrous cycle, fresh, wet unstained vaginal 
smears were examined daily using a Leica DMI300B Fluorescent Microscope for 14 
consecutive days prior to the end of each time point (at 12, 18 and 24 weeks). 
Classification of estrous cycle stages was based on the presence or absence of 
leucocytes, nucleated epithelial, and cornified epithelial cells as previously described in 
(26). Briefly, a stage was classified as proestrus if the vaginal smears were characterized 
with mostly small, round nucleated epithelial cells, some cornified epithelial cells and 
none to a few leucocytes. Estrus was when vaginal smears were characterized by the 
presence of numerous large cornified cells with degenerate nuclei. During metestrus 
vaginal smears were primarily characterized by the presence of many leucocytes and a 
few cornified cells. In diestrus, vaginal smears were largely populated by many 
polymorphonuclear leucocytes and few nucleated epithelial cells. 
 
Glucose tolerance testing 
At the end of each experimental time point (6, 12, 18 and 24 weeks of age; n = 4 
per treatment per time point), a glucose tolerance test was performed. Mice were 
weighed and placed in separate cages with access to water but not feed for 16 hours 
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(overnight) prior to the test. Glucose solution (0.25 g/ml; 2.5 g of D-glucose in 10 ml 
milliQ water) was prepared the day before the test and left to stand at room temperature 
overnight. Blood from the lateral saphenous vein was collected to determine fasting 
blood glucose (at time designated 0 min) followed by intraperitoneal injection (1g/kg 
body weight) of glucose solution. Blood from the lateral saphenous vein was used to 
measure blood glucose concentration at 30, 60, 90, and 120 min after the injection using 
a hand held glucometer. 
 
Tissue collection 
At the end of each experimental time point (6, 12, 18 and 24 weeks of age; n = 4 
per treatment per time point), mice were euthanized by CO2 asphyxiation. Ovaries were 
collected, trimmed of excess fat and weighed. One ovary was fixed in 4% 
paraformaldehyde for histology and follicle counts while the other ovary was stored in 
RNAlater at -800C for RNA and protein expression studies. 
 
RNA isolation  
Total RNA was isolated from one half of each sample ovary using the Qiagen 
RNeasy® Mini Kit (n = 4 per treatment per time point) according to the manufacturer’s 
procedure. Briefly, tissues were lysed and homogenized using a hand held homogenizer. 
The homogenate was then applied to a QIAshredder column placed in a collection tube 
and centrifuged at 10000 rpm for 2 minutes at room temperature. The flow through was 
then applied to an RNeasy Mini column, allowing RNA to bind to the filter cartridge.  
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Following washing, RNA was eluted from the filter using RNase-free water and 
concentrated using an RNeasy MinElute kit. The concentration was determined using an 
ND-1000 Spectrophotometer (λ = 260/280 nm; NanoDrop technologies, Inc., 
Wilmington, DE).  
 
First strand cDNA synthesis and quantitative real-time polymerase chain reaction (qRT-
PCR) 
Equal amount (0.5µg) of total RNA was reverse transcribed to cDNA using 
InvitrogenTM Superscript III Reverse Transcriptase according to the manufacturer’s 
protocol. Two microliters of diluted cDNA (1:25) were amplified on an Eppendorf 
Mastercycler using Quantitect™ SYBR Green PCR kit and primers specific for mouse 
Tnfa, Tnfr1(p55), Tnfr2(p75), Il1b, Il6, Nos2, Cd3e, Cd4, Cd8b, Emr1, Ccl2, Ccl5, Chuk, 
Ikbkb, Rela (for sequences see (97)), Gapdh, Il1rn, Il10, Ikbkg, Nfkb1, Star, Cyp11a1, 
Cyp19a1, Erα, and Erβ (for sequences see Table 1). The PCR cycling program consisted 
of a 15 min hold at 95 oC and 40 cycles of: denaturing for 15 at 95 oC, annealing for 15s 
at 58 oC and extension at 72 oC for 20s. Product melt conditions were determined using a 
temperature gradient from 72 oC to 99 oC with a 1 oC increase at each step. Three 
replicates of each sample (n = 4) were included. The relative mRNA expression for each 
of the above genes was normalized using the housekeeping gene Gapdh and relative fold 
change calculated using the 2-ΔΔCT method.  The results are presented as mean fold 
change ± standard error relative to the lean matched control group. 
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Protein isolation and Western blot analysis 
Total ovarian protein was isolated and Western blotting performed as previously 
described (97). Briefly, ovaries were homogenized in 300 µl of ice-cold extraction buffer 
followed by two rounds of centrifugation each for 15 minutes at 9300 RCF at 4 oC. 
Protein concentration was determined using a standard BCA protocol and absorbance 
values were detected with a λ = 560 nm excitation on a Synergy™ HT Multi-Detection 
Microplate Reader using KC4™ software (Bio-TekR Instruments Inc. Winooski, VT). 
Total protein (25 µg) was separated using 10-12% SDS-PAGE and electro-transfer of 
proteins from the gel to a nitrocellulose membrane was performed for 1.2hrs at 100 V. 
The membranes were stained with Ponceau S to visualize the amount of total protein 
transferred in each lane. To reduce non-specific binding, membranes were pre-incubated 
for 2 hours on a rocker at room temperature in a blocking buffer containing 5% non-fat 
dry milk, 5 M NaCl, 20 mM Tris-HCl, 0.15% Tween-20, pH 8. Membranes were probed 
using a specific primary antibody against anti-STAR (1:1000), anti-CYP11A1 (1:1000), 
anti-3β-HSD (1:500), anti-Aromatase (1:500), anti-pIҡBαSer32/36 (1:500), anti-
pIKKα/βSer176/180 (1:250), anti-pNFҡBp65Ser536 (1:100) diluted in 5% BSA in Tris-
buffered saline with Tween-20 (TTBS) overnight at 4 oC. Following washing for three 
times (5 min each) in TTBS, membranes were incubated at room temperature for 1 hour 
with HRP-conjugated suitable secondary antibodies (1:10,000) against the primary 
antibodies. Membranes were washed three times in TTBS followed by a single wash in 
Tris-Buffered Saline (TBS). Autoradiograms were visualized on X-ray films in a dark 
room following 5-10 min incubation of membranes with 1X SignalFire™ ECL reagent. 
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Densitometry of the appropriate sized bands was measured using Carestream molecular 
imaging software version 5.0 (Carestream Health Inc., Rochester, NY) which eliminates 
background noise.  Values were normalized to Ponceau S staining.  
 
Histology and follicle counting 
Ovaries were fixed in 4% paraformaldehyde overnight, transferred to 70% 
ethanol, and processed at the Iowa State University Veterinary Medicine Histopathology 
laboratory. Each ovary was dehydrated and embedded in paraffin blocks. The entire 
ovary was serially sectioned (5 µM) and every 6th section was mounted, and stained with 
hematoxylin and eosin (H & E). The number of healthy follicles in every 6th section was 
determined using direct counts on all consecutive 5 µm sections in both lean and obese 
female mice using a Leica DMI300B Fluorescent Microscope. A follicle was considered 
healthy if it contained a distinct oocyte nucleus. A follicle was classified as a primordial 
follicle if its nucleated oocyte was surrounded by a partial or complete layer of 
squamous granulosa cells. A primary follicle contained a single layer of cuboidal 
granulosa cells surrounding its oocyte. A follicle whose nucleated oocyte was 
surrounded by multiple layers of granulosa cells was classified as a secondary follicle. A 
follicle was classified as a pre-ovulatory follicle if its nucleated oocyte was surrounded 
with at least two layers of granulosa cells and a fluid-filled antrum. 
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Statistical analysis 
Statistical analysis was performed using the unpaired t-test function of GraphPad 
Prism 5.5 software with a statistical significance level set at P < 0.05. 
 
Results 
 
Increased body weight and temporal increased fasting blood glucose in the lethal 
yellow mice relative to their controls 
There was no difference in body weight between control and lethal yellow mice 
at 6 weeks. From 12 weeks of age onward, a progressive increase (P < 0.05) in body 
weight was observed in the lethal yellow mice compared to their controls (Table 2), thus 
from this point onwards the controls are designated as lean and the lethal yellow mice 
are designated as obese. Increased (P < 0.05) fasting blood glucose was observed in 
obese compared to lean females from 12 weeks onward (Table 2). In addition, glucose 
tolerance testing revealed that relative to lean mice, obese mice had reduced clearance of 
glucose following two hours of a glucose bolus challenge at 12, 18, and 24 weeks (Data 
unpublished). There was no impact of obesity on ovarian weight across the time points 
of this study (Table 2). 
 
Progressive obesity alters estrus and diestrus phases without altering overall length of 
the estrous cycle 
To evaluate the impact of progressive obesity on estrous cyclicity, fresh, wet 
unstained vaginal smears obtained daily for 14 consecutive days prior to the end of each 
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time point (12, 18 and 24 weeks) from both lean and obese mice were examined (Table 
3). There was no impact of obesity on proestrus, metestrus, or the overall length of the 
estrous cycle; however, at both 18 and 24 weeks, obese mice displayed a decrease (P < 
0.05) in the length of the estrus phase and an increase (P < 0.01) in diestrus phase length 
relative to their lean counterparts (Table 3). 
 
Obesity decreases the number of healthy primordial and primary follicles in female 
mice 
The impact of obesity advancement on the number of ovarian healthy follicle 
populations was determined (Figure 1). Ovaries from obese mice had decreased (P < 
0.05) numbers of healthy primordial (Figure 1A) and primary (Figure 1B) follicles at 12, 
18, and 24 weeks of age as compared to ovaries from their lean matched controls. 
Although there was no impact of obesity on secondary follicles across time points, at 18 
weeks, there was a tendency (P = 0.07) for an increased number of healthy secondary 
follicles in ovaries of obese mice relative to their lean counterparts (Figure 1C). 
Interestingly, obesity increased (P < 0.05) the number of antral follicles at 12 and 24 
weeks but not at 18 weeks (Figure 1D). To rule out any impact of genotype on follicle 
number, ovaries examined at 6 weeks of age, when there is no difference in body weight, 
and no difference in any follicle type number was observed between the two strains of 
mice (Figure 1A-D).  Interestingly, the numbers of primordial and small primary 
follicles were decreased in lean mice with aging (Figure 1A and B).  
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Obesity alters mRNA expression of ovarian steroidogenic members in mice 
The impact of continuing obesity on mRNA expression of genes encoding 
enzymes involved in ovarian steroidogenesis (Figure 2) was examined. At 6 and 24 
weeks, there was no difference in Star mRNA levels between ovaries from lean and 
obese mice, however at both 12 (P < 0.0001) and 18 (P < 0.05) weeks, obesity reduced 
ovarian Star mRNA abundance (Figure 2A). There was no impact of obesity on ovarian 
Cyp11a1 mRNA levels at any time point tested in this study (Figure 2B). We observed a 
decrease in Cyp19a1 mRNA levels in ovaries obtained from obese mice relative to their 
matched controls across all time points (Figure 2C). We further investigated the impact 
of progressive obesity on the two estrogen receptors (Figure 1D & E). At 6 and 12 but 
not at 18 or 24 weeks of age, ovaries from obese mice had increased (P < 0.05). Erα 
mRNA levels compared to their respective lean controls (Figure 2D). Furthermore, 
progressive obesity increased (P ≤ 0.01) Erβ mRNA expression from 12 weeks onward 
(Figure 2E). 
 
Progressive obesity alters protein expression of ovarian steroidogenic members in 
mice 
No difference in STAR protein expression between the two groups was observed 
at 6 weeks of age, however, ovaries from obese mice had decreased STAR protein levels 
compared to ovaries from their matched lean controls at 12 (P < 0.01), 18 (P < 0.05), 
and 24 (P < 0.01) weeks of age (Figure 3A). While there was no difference in CYP11A1 
protein expression between the two groups at 6 or 18 weeks, a decrease (P < 0.01) in 
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CYP11A1 protein levels was observed at 24 weeks of age in ovaries from obese females 
(Figure 3B). In contrast, at 12 weeks of age, ovaries from obese mice had increased (P < 
0.001) CYP11A1 protein levels compared to those from lean mice (Figure 3B). We did 
not find any differences between lean and obese females in 3β-HSD protein levels for all 
time points tested during this study (Figure 3C). Interestingly, at 6 weeks of age 
increased (P < 0.05) ovarian CYP19A1 protein levels were observed in the obese 
relative to the lean group (Figure 3D). Although there was no impact of obesity on 
CYP19A1 protein level at 12 weeks; there was a tendency (P < 0.1) for decreased 
CYP19A1 protein expression in the obese mice compared to their lean counterparts at 18 
and 24 weeks (Figure 3D).  
 
Impact of progressive obesity on relative mRNA expression of ovarian immune cells, 
inflammation and NF-ҡB pathway members in mice 
The expression profiles of immune cell infiltration and inflammatory marker 
genes were investigated over the temporal pattern of obesity onset and advancement 
(Table 4). The mRNA level of Tnfα, p55, p75, Cd3e, Cd8eb1, F4-80, Ikbkb, Ikbkg and 
RelA were not impacted by obesity (Table 4). However, the mRNA levels of Nos2, a 
marker for oxidative stress was increased at 6 (P < 0.01), 18 (P < 0.01), and 24 (P < 
0.001) weeks of age (Table 4). Additionally, the mRNA expression of the anti-
inflammatory gene, Il10, was increased (P < 0.05) with obesity at both 18 and 24 weeks 
(Table 4). Further still, the mRNA expression of Il1b was decreased at 12 and 24 (P < 
0.05) weeks, but increased at 18 (P < 0.01) weeks with obesity. Ovaries from obese mice 
135 
 
also showed a marked decrease in Il1ra mRNA at 12 (P < 0.0001), 18 (P < 0.0001), and 
24 (P < 0.01) weeks compared to ovaries from lean matched mice. Cd3 mRNA was 
increased (P < 0.05) by obesity only at 24 weeks. At 12 weeks, obesity decreased (P < 
0.01) Cd4 mRNA but at 18 weeks, Cd4 mRNA was slightly increased (P < 0.05) with 
obesity. Although Mcp1 (P < 0.001) and Ccl5 (P < 0.01) mRNA levels were decreased 
by obesity at 12 weeks, at 24 weeks only Mcp1 was decreased (P < 0.001) by obesity. Of 
the NF-ҡB pathway members tested in this study, only Ikaka (P < 0.001) and Nfkb1 (P < 
0.05) mRNA levels were decreased by obesity at 18 weeks (Table 4). 
 
Progressive obesity increases ovarian protein expression of NF-ҡB pathway members 
in mice 
There was no impact of progressive obesity on phosphorylated IKKα/β Ser176/180 
protein levels across time points, (Figure 4A). However, phosphorylated IҡBSer32/36 
protein level was decreased (P < 0.01) at 6 weeks, but increased at 12 (P < 0.01) and 24 
(P < 0.05) weeks in obese females relative to their lean littermates (Figure 4B). 
Similarly, ovarian pNFҡBp65Ser536 was reduced by obesity at 6 weeks (P < 0.05), but 
increased (P < 0.01) from 12 weeks onwards (Figure 4C). 
 
Discussion 
 
Obesity is associated with impaired fertility (21, 36, 47, 48, 130). Although the 
reasons for this association are not fully known, available evidence suggest that obese 
females have higher incidences of poor oocyte quality (27, 40, 66), irregular menstrual 
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cycles (31, 42, 56), anovulation (35), and increased miscarriage rates (15, 49, 67), 
phenotypes suggestive of derangements in ovarian folliculogenesis and steroidogenesis. 
Additionally, obesity is associated with low grade inflammation which if not properly 
regulated can lessen reproductive function (50, 61, 127). The main objective of this 
study was to determine the impact of obesity onset and progression on the expression 
profiles of immune cell and inflammation markers as well as the NF-ҡB and 
steroidogenic pathway members in murine ovaries. The lethal yellow mouse, a model of 
progressive obesity was utilized to compare gene expression beginning at 6 weeks of age 
when there is no reported difference in body weight between genotypes (129), which we 
confirmed in this study.   
 
Beginning at 12 weeks of age, a progressive increase in body weight among the 
lethal yellow mice compared to their a/a matched controls was observed. Increased 
fasting blood glucose was also evident as body weight increased from 12 weeks 
onwards.  Glucose tolerance testing revealed that relative to their age matched controls, 
obese mice had reduced clearance of glucose following a glucose bolus challenge at 12, 
18, and 24 weeks (Data not shown). While we did not measure blood insulin levels in 
these animals, previous data showed that the lethal yellow mice have increased 
circulating insulin and leptin levels compared to the age-matched lean controls from 12 
weeks onwards (129), matching our phenotypic data. Thus, elevated fasting blood 
glucose, insulin levels (129) and reduced glucose clearance rate indicate that these mice 
have compromised insulin sensitivity. 
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Obesity impacted ovarian cyclicity by decreasing the length of time spent in 
estrus with a concomitant increase in the length of the diestrus phase. The impact of 
obesity on the estrous cycle has been previous reported in rats (7, 14). In agreement with 
our results, HFD-fed obese rats exhibited longer diestrus but shorter estrus stages 
compared to chow fed lean animals (7). Physiologically, the ovarian steroids 
predominantly associated with estrus and diestrus phases are E2 and P4, respectively 
(84). Therefore, shorter estrus stages would imply lower E2 levels while longer diestrus 
stages would imply higher P4 levels in obese females. In premenopausal females, an 
inverse relationship between E2 and body mass index has also been reported (51, 110, 
121), and higher P4 levels have also been observed in obese rodent models (7). Taken 
together these data suggest that alterations in the estrous cycle during obesity could 
impact ovulation and subsequently compromise the reproductive capacity of obese 
females. 
 
In order to separate the effects of obesity from the Ay/J genotype, we included a 
6 week old group in which we observed no differences in body weight from the a/a 
genotype mice. Importantly, also at this time point, there was no difference in the 
number of all follicular stages. However, despite a lack of any impact of progressive 
obesity on ovarian weight, fewer primordial and primary follicles and increased numbers 
of tertiary follicle subtypes was present as body mass increased. These data are in 
agreement with a previous study from our group in which 20 week old obese mice which 
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were found to have reduced primordial and small primary, but increased numbers of 
secondary and antral follicles (96). Furthermore, Sprague-Dawley rats fed a HFD for 18 
weeks demonstrated a decreased number of primordial follicles but increased number of 
developing and atretic follicles (126). This difference in follicle populations could 
indicate increased activation of follicles from the primordial follicle pool. This scenario 
is possible because obesity is associated with elevated insulin levels, obese females have 
higher levels of insulin in their follicular fluid (112), and insulin administration 
promoted primordial to primary transition in neonatal rat ovaries (70).  
 
Several studies have reported an inverse relation between steroid hormone level 
and primordial follicle activation (22, 23, 32, 69). Estradiol levels are lower in HFD-
induced obese rats (14) and obese females (51, 110, 121) and reduced E2 levels 
stimulated primordial follicle activation from the resting into the growing follicular pool 
(22, 23).  In mice (22, 32) and in neonatal rats (69), administration of E2 or P4 was 
associated with impaired primordial follicle assembly, and decreased numbers of both 
primordial and primary follicles. Further still, increased activation of ovarian 
phosphatidylinositol-3 kinase (PI3K) signaling (45, 78, 101), which we have previously 
reported to be altered during HFD-induced obesity (98), is involved in early stages of 
folliculogenesis. Therefore it is possible that the observed low numbers of primordial 
follicles and higher numbers of growing follicles observed in ovaries from obese relative 
to lean mice is indicative that obesity triggers changes in the intrinsic ovarian signals 
responsible for initiation of follicle activation and recruitment. 
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Ovarian steroidogenesis is mediated by FSH and LH through the action of 
several enzymes including STAR, CYP11A1, 3β-HSD, and CYP19A1.  In the testes, 
during PI3K activation, insulin inhibited cAMP-induced STAR, CYP11A1 and 3β-HSD 
gene expression (6). In the present study, we found that obesity has differential effects of 
the expression profiles of genes involved in ovarian steroidogenesis. With the exception 
of CYP19A1 protein expression, which was increased at 6 weeks of age in the lethal 
yellow mice, potentially indicating early onset of puberty, there was no impact of 
genotype (6 weeks of age) on levels of ovarian steroidogenic members (mRNA or 
protein).  Progressive obesity decreased both Star mRNA and protein levels indicating 
that the rate limiting step in steroidogenesis could be compromised during an obese 
state. Additionally, despite its increase in the early stages of obesity (at 12 weeks), 
CYP11A1 protein expression was markedly downregulated with progressive obesity, 
reaching a 50% reduction by 24 weeks of age. Erα mRNA levels were increased at 6 and 
12 in obese females, while Erβ mRNA levels were elevated from 12 onwards due to the 
obese phenotype, suggesting a temporal pattern of E2 receptor response to increased 
body mass. 3β-HSD protein levels were unchanged, but Cyp19a1 mRNA and protein 
were both negatively impacted by obesity. Taken together, these results indicate that 
obesity may alter ovarian steroidogenesis contributing to the reproductive disorders 
experienced by obese females. Our data also reveal a temporal effect of obesity on 
ovarian steroidogenic genes underscoring the importance of considering the timepoint at 
which data is collected when interpreting obesity-associated ovarian impacts.  
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Ovarian steroids may vary depending on energetic conditions of the cell (46) and 
inflammatory changes (34) both of which are impacted by obesity. Elevated TNFα and 
IL-6 levels have been reported in the follicular fluid of obese women (73), while obesity-
induced increased Tnfα expression has been observed in human adipose tissue (62, 68), 
muscle (116), rat adipose tissue (63), mouse muscle and adipose tissues (60). IL-6 
through its ability to modulate cAMP, can regulate ovarian steroid production (19) and 
ovulation (88, 124). TNFα and Il-1 can also stimulate ovarian P4 production (9, 19), 
regulate ovarian cell differentiation, proliferation and apoptosis (9, 10, 113) as well as 
inflammation (114). Derangements in these inflammatory pathways have been linked to 
various reproductive disorders (1, 11, 64, 117, 120). For example, elevated levels of IL-6 
have been associated with ovarian hyperstimulation syndrome (25, 79, 80), tumor cell 
activation (33), and chemotherapeutic resistance (43). Furthermore, IL-6, in conjunction 
with TNFα and IL-1β, has been associated with ovarian neoplasia (12, 38, 39, 72, 74, 
94). 
 
Similar to previously reported elevations in Nitric oxide synthase 2 (Nos2) 
mRNA in animal models of obesity (4, 75, 106, 115), we observed a temporal increase 
in Nos2 mRNA in ovaries of obese mice compared to their lean littermates. Nos2 is a 
marker for oxidative stress, dysregulation of which has been linked to impaired 
ovulation (58), ovarian cancer (59), endometriosis (122), and infertility (3, 100, 115). 
Similarly, ovarian mRNA expression of the anti-inflammatory gene, Il10, was increased 
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by obesity. In contrast, obesity decreased Il1ra mRNA, a modulator of the pro-
inflammatory actions of IL-1. Interestingly, although Il1b mRNA was decreased at 12 
and 24 weeks, it was subsequently increased at 18 weeks with obesity. Also, although 
Mcp1 and Ccl5 mRNA levels were both decreased by obesity, only the decrease in 
Mcp1was maintained at the time points studied. MCP1 is involved in ovarian follicular 
development, steroidogenesis, ovulation and atresia (19). Interpreted locally, these 
mRNA results would suggest a downward trend in expression profiles of both immune 
cell infiltration and inflammatory markers. Taken together these results indicate that 
progressive obesity alters inflammatory members and that these changes may have 
negative consequences for ovarian function. 
 
The mammalian NF-ҡB family, is made of five proteins; RelA (p65), RelB, c-
Rel, NF-ҡB1 and NF-ҡB2 carrying a Rel-homology domain (18). Currently, there are 
two known activation pathways for the NF-ҡB activity; the canonic pathway which is 
activated by proinflammatory cytokines including TNFα and other TNF cytokines (18). 
Before activation, the inactive NF-ҡB complex is localized in the cytoplasm bound to 
IҡB proteins such as IҡBα, IҡBβ, and IҡBγ, which block its nuclear localization 
sequence function of the Rel-homology domain (18). During the canonic activation 
pathway, proinflammatory cytokines, work through different TNF receptors (TNFR) and 
Toll-like receptor-interleukin-1 receptor (IL-1R) superfamilies to activate the IҡB 
kinases (IKKs) (18). Like the IҡB complex, the IKK complex is mainly made up of two 
catalytic subunits, IKKα and IKKβ and a regulatory subunit IKKγ. Activated IKK 
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proteins can catalyze the phosphorylation of IҡB proteins mainly at the serine 32 and 36 
sites of IҡBα, leading to proteasome degradation of the IҡB complex and subsequent 
release and translocation of the NF-ҡB proteins to the nucleus (18, 57). Once in the 
nucleus, the NF-ҡB proteins will bind and activate transcription of several genes 
particularly those involved in immune and inflammatory cascades (18, 57). 
 
Although progressive obesity did not impact the mRNA expression profiles of 
TNFα-NF-ҡB pathway members as previously observed during HFD-induced obesity 
(97), we found that obesity advancement increased abundance of protein expression of 
NF-ҡB pathway member proteins, pIҡBSer32/36 and pNFҡB p65Ser536 indicating 
increased activation of NF-ҡB signaling pathway in ovaries of obese mice.  Surprisingly, 
before the onset of obesity (at 6 weeks of age), ovaries from the lethal yellow mice 
displayed a marked decrease in pIҡBSer32/36  and pNFҡB p65Ser536 proteins 
compared to non-agouti (a/a) mice, potentially indicating that the Ay/J genotype has 
some culpability – it is more likely, however, that even though no differences in body 
weight are detectable at this age point, that changes in central metabolism have been 
activated, this is strengthened by the fact that the lethal yellow mice displayed increased 
CYP19A1, a marker that puberty onset is impending at an earlier time than the control 
genotype.    
NF-ҡB pathway is activated in response to inflammatory responses (18, 85, 86), 
therefore its sustained activation in ovaries from obese mice is indicative of aggravated 
inflammatory signaling, which in turn is associated with a number of ovarian pathologies 
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(28, 82, 92) including polycystic ovary syndrome (52, 108), endometriosis (28, 41) and 
premature ovarian failure (128). Additionally, since inflammatory signals can influence 
generation of reactive oxygen species and oxidative stress (64), ovarian steroid 
production and ovulation (9, 10, 88, 124, 128) as well as cell differentiation, 
proliferation and apoptosis (9, 10, 16, 113), deregulation of inflammatory signals in the 
ovary may adversely impact tissue function and pose dire consequences for female 
fertility.     
 
In conclusion, our results indicate that progressive obesity alters the expression 
of inflammatory and steroidogenesis signaling pathway members in ways which could 
alter optimal ovarian function.  
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Table 1. Primer sequences used in this study 
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Table 2. Progressive obesity effects on fasting blood glucose and ovarian weight. 
Body weights were measured once per week starting at 6 weeks of age across the entire 
experimental period. At each time point (6, 12, 18 or 24 weeks of age; n = 4 per 
treatment per time point), fasting blood glucose was determined using the hand held 
glucometer from blood collected from the lateral saphenous vein of mice fasted for 16 
hours (overnight). To determine the impact of progressive obesity, mice were euthanized 
at the end of each experimental time point; ovaries were collected, trimmed of excess fat 
and weighed. 
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Table 3. Impact of progressive obesity on estrous cyclicity. Fresh, wet unstained 
vaginal smears were obtained once a day (8 – 9 AM) for 14 consecutive days prior to the 
end of 12, 18, and 24 weeks from both lean and obese mice. The stage of estrous cycle 
was determined based on presence or absence of leucocytes, cornified epithelial, and 
nucleated epithelial cells as detailed in the materials and methods section. 
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Table 4. Impact of progressive obesity on mRNA level of markers of immune cells, 
inflammation and NF-ҡB pathway members. Ovaries were removed from lean or 
obese female mice at the end of each experimental time point (6, 12, 18, and 24 weeks of 
age). Total RNA was isolated, reverse transcribed to cDNA and relative mRNA of target 
genes quantified by qRT-PCR using specific primer sets as detailed in the materials and 
methods section. After normalization to Gapdh the relative fold change was calculated 
using the 2-ΔΔCT method. The results are presented as mean fold change ± standard error 
relative to the lean matched control value of 1 ± SE.  * indicates different from control at 
P < 0.05. 
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Figure 1: Effect of obesity on follicle number. At 6, 12, 18 or 24 weeks of age, mice 
were euthanized and ovaries collected. One ovary was fixed in 4% paraformaldehyde, 
complete serial sections were mounted and healthy follicles was classified and counted 
in both lean and obese (Figure 1A-D); (A) healthy primordial follicle number; (B) 
healthy primary follicle number; (C) healthy secondary follicle number; and (D) healthy 
antral follicle number. Bars represent means ± SEM. * indicate significant (P < 0.05; n = 
4) difference from respective lean group. 
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Figure 2. Obesity alters mRNA expression of ovarian steroidogenic members in 
mice. At the end of each experimental time point (6, 12, 18, and 24 weeks of age) 
ovaries were removed from lean or obese mice, total RNA isolated (n = 4 per treatment 
per time point) and reverse transcribed to cDNA. mRNA level of Star, Cyp11a1, 
Cyp19a1, Erα, and Erβ were quantified by quantitative RT-PCR. After normalization to 
Gapdh relative fold change was calculated using the 2-ΔΔCT method. The results are 
presented as mean fold change ± standard error relative to the lean matched control 
value of 1 ± SE.  * indicates different from control at P < 0.05. † indicate P < 0.1. 
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Figure 3. Obesity impacts protein abundance of ovarian steroidogenic members. At 
the end of each experimental time point (6, 12, 18, and 24 weeks of age), ovaries were 
removed from lean (L) or obese (O) female mice and total ovarian protein isolated (n = 
3-4 per treatment group per time point). Western blotting was performed to measure (A) 
STAR, (B) CYP11A1, (C) 3β-HSD, and (D) CYP19A1 protein levels. Densitometry of 
the appropriate bands was performed using Carestream molecular imaging software and 
normalized to Ponceau S staining prior to statistical analysis. Bars represent means ± 
SEM and * indicate significant difference from respective lean group at P < 0.05. 
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Figure 4. Ovarian NF-ҡB pathway member protein level are affected by obesity. At 
each time point (6, 12, 18, and 24 weeks of age), total ovarian protein was isolated from 
both lean (L) and obese (O) female mice. Western blotting was performed to quantify 
(A) pIKKα/βSer176/180, (B) pIҡBSer32/36, and (C) pNFҡB p65Ser536 protein levels. 
Densitometry of the appropriate bands was performed using Carestream molecular 
imaging software and normalized to Ponceau S staining prior to statistical analysis. Bars 
represent means ± SEM and * indicate significant difference from respective lean group 
at P < 0.05. 
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CHAPTER 5: OVARIAN XENOBIOTIC BIOTRANSFORMATION ALONG 
WITH INSULIN AND PHOSPHATIDYLINOSITOL-3 KINASE  
SIGNALING PATHWAYS ARE ALTERED DUE TO OBESITY 
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Abstract 
 
Mechanisms underlying obesity-associated reproductive impairment are ill-
defined, however, the presence of hyperinsulinemia as well as other metabolic 
perturbations are well recognized.  Insulin activates phosphatidylinositol 3-kinase 
(PI3K) signaling, which plays roles in ovarian folliculogenesis, steroidogenesis as well 
as xenobiotic metabolism. The impact of progressive obesity on expression profiles of 
ovarian genes involved in insulin-mediated PI3K activation and signaling along with 
xenobiotic biotransformation, insulin receptor (Insr), insulin receptor substrate 1 (Irs1), 
2 (Irs2), and 3 (Irs3); kit ligand (Kitlg), stem cell growth factor receptor (Kit), protein 
kinase B (AKT) alpha (Akt1), beta (Akt2), forkhead transcription factor (FOXO) 
subfamily 1 (Foxo1), and subfamily 3 (Foxo3a), microsomal epoxide hydrolase (Ephx1), 
cytochrome P450 family 2, subfamily E, polypeptide 1 (Cyp2e1), glutathione S-
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transferase (GST) class Pi (Gstp1) and class mu 1 (Gstm1) were determined in normal 
wild type non-agouti (a/a; lean) and lethal yellow mice (KK.CG-Ay/J; obese) at 6, 12, 18 
or 24 weeks of age. At 6 weeks, ovaries from obese mice had increased (P < 0.05) Insr 
and Irs3 but decreased (P < 0.05) Kitlg, Foxo1 and Cyp2e1 mRNA levels. Interestingly, 
starting at 12 weeks, a temporal increase (P < 0.05) in Kitlg and Kit mRNA, pIRS1Ser302, 
pAKTThr308, EPHX1, and GSTP1 protein level was observed due to obesity. In contrast, 
reduced Cyp2e1 mRNA and CYP2E1 protein occurred with progressive obesity. Taken 
together progressive obesity affected PI3K signaling as well as ovarian xenobiotic 
metabolism which could participate in obesity-associated reproductive disorders. 
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Introduction 
 
The mammalian ovary is a female gonad responsible for production of oocytes 
and steroid hormones (28, 54, 95). At birth, a female is born with a finite number of 
primordial follicles, arrested in the diplotene stage of prophase 1 (35, 50). Once 
primordial follicles are depleted, the female enters into ovarian senescence. Primordial 
follicles are composed of a nucleated oocyte surrounded by squamous granulosa cells 
(GC), which become cuboidal and proliferate as the follicle matures toward ovulation. 
Pre-ovulatory follicles are the major source of steroids and under the influence of 
gonadotropins, a selected cohort of dominant antral follicles become capable of 
ovulation. Following ovulation, the GC and theca cells (TC) luteinize to form the corpus 
luteum (CL) which produces progesterone, essential for implantation and pregnancy 
maintenance. Adverse reproductive outcomes including anovulation, impaired fecundity 
and premature ovarian failure can result from unregulated folliculogenesis.  
  
In the absence of ovarian function, females have a greater risk for development 
of gynecological cancers, osteoporosis and cardiovascular disease (54-56). A number of 
chemical exposures can result in follicle depletion leading to early ovarian senescence 
(5, 6, 13, 54, 65). In addition, DNA damage (101) and altered folliculogenesis (63) due 
to ovotoxicant exposure have been reported. The ovary has the capacity to respond to 
such exposures through increased biotransformation gene expression, including 
cytochrome P450 isoform 2E1 (CYP 2E1) (19, 64, 104), microsomal epoxide hydrolase 
(EPHX1) (20, 58), glutathione S-transferase Pi (GSTP1) (7, 65) and glutathione S-
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transferase Mu 1 (GSTM1) (8) whose expression and activity levels are altered during 
xenobiotic exposure. These enzymes are principally involved in the detoxification of 
xenobiotic compounds (12, 46, 48, 53, 68), however, their expression may also lead to 
bioactivation of some environmental compounds (5, 6, 19, 55, 57, 104).   
 
The adverse effects of obesity on reproductive health and fecundity have been 
documented, and include reduced conception and implantation (17, 73), impaired 
fecundity (29, 73, 103, 132), increased infertility (17, 108), and an increase in offspring 
birth defects (10, 27, 34).  The phosphatidylinositol-3 kinase (PI3K) signaling pathway 
plays a pivotal role in regulating ovarian folliculogenesis (61, 86, 105, 107) and 
steroidogenesis (24, 78, 85, 133).  Additionally, the PI3K pathway regulates ovarian 
genes encoding xenobiotic metabolism enzymes (1, 9, 62, 63).  We (94) and others (2, 
84, 123, 128), have found that obesity alters insulin mediated signaling pathways, 
including PI3K. Altered expression of genes involved in these pathways could sabotage 
proper ovarian function and consequently lead to impaired fertility. Despite a strong 
positive correlation between obesity and impairments in reproductive capacity, the 
underlying mechanisms have not been clearly defined. To understand the onset and 
duration of these changes during obesity, we designed a temporal study using the agouti 
lethal yellow (KK.Cg-Ay/J) mice, an excellent model for progressive human obesity (22, 
72, 129). The impact of obesity onset and progression on expression of ovarian genes 
encoding PI3K pathway members and enzymes involved in ovarian xenobiotic 
biotransformation were investigated.   
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Materials and Methods 
 
Reagents 
D-Glucose, 2-β-mercaptoethanol, 30% acrylamide/0.8% bis-acrylamide, 
ammonium persulfate, glycerol, N′,N′,N′,N′-Tetramethyl-ethylenediamine (TEMED), 
Tris base, Tris HCl, sodium chloride, Tween-20, bovine serum albumin (BSA), ascorbic 
acid (Vitamin C), phosphatase inhibitor, protease inhibitor and transferrin were 
purchased from Sigma-Aldrich Inc. (St. Louis, MO). Custom designed primers were 
obtained from the DNA facility of the Office of Biotechnology at Iowa State University. 
Hanks' Balanced Salt Solution (without CaCl2, MgCl2, or MgSO4) and superscript III 
one-step RT-PCR System were purchased from Invitrogen Co. (Carlsbad, CA, USA). 
RNAlater was obtained from Ambion Inc (Austin, TX, USA). RNeasy Mini kit, 
QIAshredder kit, RNeasy MinElute kit and QuantitectTM SYBR Green PCR kit were 
purchased from Qiagen Inc. (Valencia, CA). Ponceau S was purchased from Fisher 
Scientific (Waltham, MA, USA). Restore™ PLUS Western Blot Stripping Buffer was 
purchased from Thermo Scientific (Rockford, IL, USA). SignalFire™ ECL Reagent, 
goat anti-rabbit secondary antibody, anti-pAKTThr308 and anti-pIRS1Ser302 antibodies 
were from Cell Signaling Technology® (Danvers, MA, USA). Anti-FOXO3 and anti-
GSTP1 antibodies were purchased from Millipore (Temecula, CA, USA). Donkey anti-
goat secondary antibody was purchased from Pierce Biotechnology (Rockford, IL). 
Anti-CYP2E1 antibody was purchased from Abcam (Cambridge, MA, USA). Anti-mEH 
(EPHX1) antibody was purchased from Detroit R&D, Inc. (Detroit, MI, USA). 
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Animal procedures and tissue collection 
All experimental animal protocols used in this study were approved by the Iowa 
State University Animal Care Committee (IACUC). Four week old female normal wild 
type non-agouti (a/a; designated lean; n = 20) and agouti lethal yellow (KK.Cg-Ay/J; 
designated obese; n = 20) mice were purchased from the Jackson Laboratory (Bar 
Harbor, Maine). The mice were housed at the animal facility at Iowa State University 
under identical conditions of room temperature (21-22oC), lighting (12h light:12h 
darkness cycle) and ad libitum access to feed and water until 6, 12, 18 or 24 weeks of 
age. Phenotypically, the lethal yellow mice had elevated body weight, and fasting 
glucose levels from 12 weeks onwards (Nteeba et al., under review).  Estrous cyclicity 
was also impacted by shorter time spent in estrus and longer time in diestrous. In 
addition, primordial and small primary follicle numbers were decreased, while 
secondary and antral follicle numbers were increased in number with progressive obesity 
(Nteeba et al., under review). At the end of each experimental time point, mice were 
euthanized by CO2 asphyxiation. Ovaries were collected, cleaned off excess fat, and 
stored in RNAlater at -800C for RNA and protein analyses. 
 
RNA isolation, first strand cDNA synthesis and quantitative real-time polymerase chain 
reaction (qRT-PCR) 
Total RNA was isolated from both lean and obese mice using Qiagen RNeasy® 
Mini Kit (at 6, 12, 18 and 24 weeks, n = 3-4 per group per time point) per the 
manufacturer’s protocol. Briefly, ovaries were lysed and homogenized using a hand-held 
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homogenizer followed by applying the homogenate to a QIAshredder column with 
subsequent centrifugation at 16100 RCF for 2 minutes at room temperature. The 
resulting supernatant was applied to an RNeasy Mini column, allowing RNA to bind to 
the filter cartridge. Following washing, RNA was eluted from the filter and concentrated 
using an RNeasy MinElute Kit according to the manufacturer’s protocol. The total RNA 
was eluted using 14 µl of RNase-free water and concentration determined using an ND-
1000 Spectrophotometer (λ = 260/280 nm; NanoDrop technologies, Inc., Wilmington, 
DE). For cDNA synthesis, RNA (0.5µg) was reverse-transcribed using InvitrogenTM 
Superscript III Reverse Transcriptase according to the manufacturer’s protocol. cDNA (2 
µL; 1:25 dilution) were amplified on an Eppendorf Mastercycler using a Quantitect™ 
SYBR Green PCR kit and primers specific for mouse Gapdh, Insr, Irs1, Kitlg, cKit,  
Akt1, Gstm1, Gstp1, Ephx1 and Cyp2e1 (see sequences in (94)), Irs2, Irs3, Akt2, Foxo1 
and Foxo3a (for sequences see Table 1). The PCR cycling program consisted of a 15 
min hold at 95 oC and 40 cycles of: denaturing for 15 at 95 oC, annealing for 15s at 58 oC 
and extension at 72 oC for 20s. Product melt conditions were determined using a 
temperature gradient from 72 oC to 99 oC with a 1 oC increase at each step. Three 
replicates of each sample (n = 3- 4) were included. The relative mRNA expression for 
each gene was normalized using the housekeeping gene Gapdh and relative fold change 
calculated using the 2-ΔΔCT method.  The results are presented as mean fold change ± 
standard error relative to the lean matched control group. 
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Protein isolation and Western blot analysis 
At each time point (6, 12, 18 or 24 weeks of age, n = 3-4 per group per time 
point), total ovarian protein was isolated and Western blotting performed as previously 
described (93) with the following modifications. Ovaries were homogenized in 300 µl of 
ice-cold tissue lysis buffer and protein concentration quantified using a standard BCA 
protocol on a 96-well assay plate. Equal total protein (20 µg) was separated on a 10-12% 
SDS-PAGE and subsequently transferred to nitrocellulose membranes. Ponceau S 
staining was performed to visualize and confirm equal amount of protein loading and 
transfer. Following blocking for 2 hours at room temperature, membranes were probed 
with specific primary antibodies [Rabbit Anti-GSTP1 (1:200), Goat anti-EPHX1 
(1:500), Rabbit anti-pIRS1Ser302 (1:200), Rabbit anti-pAKTThr308 (1:250), Rabbit anti-
FOXO3 (1:250), Rabbit anti-CYP2E1 (1:200)] in 5% BSA in TTBS for 24-48 h at 4oC. 
HRP-conjugated secondary antibodies (1:10000 – 1:20000) were added for 1h at room 
temperature, and then membrane-bound HRP were washed three consecutive times for 5 
minutes each time in TTBS. Autoradiograms were visualized on X-ray films following 
10 min incubation of membranes with 1X SignalFire™ ECL reagent. Densitometry of 
the appropriate sized bands was measured using Carestream molecular imaging software 
version 5.0 (Carestream Health Inc., Rochester, NY) which eliminates background noise. 
Densitometric values of appropriate target proteins were normalized to Ponceau S 
staining prior to statistical analysis. 
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Statistical Analysis 
Statistical analyses were performed using the unpaired t-test function of 
GraphPad Prism 5.5 software with a statistical significance level set at P < 0.05. Bars 
represent means ± SEM. 
 
Results 
 
Obesity temporally increases ovarian mRNA expression of insulin signaling members  
Since obese mice displayed reduced glucose clearance rate in addition to having 
higher fasting blood glucose levels (Nteeba et al., under review), we sought to determine 
the impact of progressive obesity on ovarian mRNA expression of insulin signaling 
members (Figure 1, n = 4 per group per time point). At 6 weeks of age, ovaries from the 
obese mice had increased Insr (Figure 1A, P < 0.05) and Irs3 (Figure 1D, P < 0.01) but 
showed no difference in either Irs1 or Irs2 mRNA levels relative to ovaries from the lean 
mice. At 12 weeks, only Irs1 mRNA was increased (Figure 1B, P < 0.001) with obesity 
but other members were not impacted by obesity (Figure 1). Similarly, ovaries from 
obese mice displayed increased Irs1 (Figure 1B, P < 0.001) and Irs3 (Figure 1D, P < 
0.05) without significant effect on Insr (Figure 1A) and Irs2 (Figure 1C) mRNA levels 
at 18 weeks of age. In the 24 week old group, obesity increased ovarian expression of 
Insr (Figure 1A, P = 0.05), Irs1 (Figure 1B, P < 0.0001), Irs2 (Figure 1C, P < 0.01), 
and Irs3 (Figure 1D, P < 0.01). 
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Progressive obesity increases ovarian phosphorylated insulin receptor substrate 1 
protein  
Following the impact of obesity on ovarian mRNA levels of insulin signaling 
members, we investigated protein levels of pIRS1Ser302 (Figure 2). Although there was 
no difference in  phosphorylation of IRS1 protein at the serine302 site at 6 weeks, 
relative to lean matched controls, ovaries from obese mice showed a tendency for 
increased pIRS1Ser302 protein levels at 12 weeks (P = 0.07), and increased protein at 18 
(P < 0.05) and 24 (P < 0.01) weeks (Figure 2).  
 
Ovarian Kitlg/cKit-PI3K pathway members are elevated during obesity 
At 6 weeks, ovaries from the obese group had lower (P < 0.01) Kitlg (Figure 3A) 
and Foxo1 (Figure 3E) but not cKit, Akt1, Akt2 or Foxo3a mRNA levels than ovaries 
from lean females (Figure 3). At 12 weeks, there was a marked increase in ovarian Kitlg 
(Figure 1A, P < 0.05), cKit (Figure 1B, P < 0.05), and Foxo1 (Figure 1E, P < 0.0001) 
in obese compared to lean females, but there was no impact of obesity on Akt1 (Figure 
3C), Akt2 (Figure 3D) or Foxo3a (Figure 3F) mRNA expression. Likewise, at 18 
weeks, obesity did not affect ovarian Akt1 (Figure 3C), Akt2 (Figure 3D) and Foxo1 
(Figure 3E) mRNA levels, but increased Kitlg (Figure 1A, P < 0.001), cKit (Figure 1B, 
P < 0.0001), and Foxo3a (Figure 1E, P < 0.01) mRNA levels. There was increased (P < 
0.01) Kitlg, cKit, Akt1, Akt2, Foxo1 and Foxo3a mRNA levels in ovaries from obese 
compared to lean mice at 24 weeks (Figure 3A-F). 
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Ovarian phosphorylated AKT is increased by obesity without impacting FOXO3 
protein levels 
There was no differences in ovarian pAKTThr308 protein levels between lean and 
obese females at 6 and 12 weeks, but obesity increased (P < 0.01) pAKTThr308 protein 
expression at 18 and 24 weeks (Figure 4A, n = 4 per group per time point). Total 
ovarian FOXO3A protein levels did not differ between lean and obese groups at any 
time points (Figure 4B). 
 
Progressive obesity alters mRNA expression of ovarian xenobiotic metabolism genes  
Despite lack of a genotype effect on Gstm1, Gstp1 and Ephx1 mRNA levels at 6 
weeks (92), obesity increased (P < 0.001) ovarian Gstm1 (Figure 5A) and Ephx1 
(Figure 5C) mRNA expression at 12, 18 and 24 weeks. On the contrary, ovarian Cyp2e1 
mRNA expression was lower (P < 0.001) in the obese group at all of the time points 
investigated (Figure 5D). Gstp1 mRNA levels were decreased (P < 0.05) by obesity at 
12 weeks, however, at 24 weeks there was a tendency (P = 0.06) for increased ovarian 
Gstp1 in obese verses lean females (Figure 5B). At 18 weeks there was no difference 
between lean and obese females in ovarian Gstp1 mRNA levels (Figure 5B). 
 
Abundance of ovarian xenobiotic metabolism proteins is impacted by increased body 
mass 
At 6 weeks, there was no difference in ovarian EPHX1, CYPE1 and GSTP1 
protein levels between the two groups of mice (Figure 6). In a similar manner to the 
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mRNA results, ovaries from obese mice had increased ovarian EPHX1 protein levels 
relative to their lean counterparts at 12 (P < 0.05), 18 (P < 0.01), and 24 (P < 0.0001) 
weeks (Figure 6A). Likewise, CYP2E1 protein expression was reduced in ovaries from 
obese females compared to their lean littermates at 12 (P < 0.01), 18 (P < 0.05) and 24 
(P < 0.01) weeks (Figure 6B). Relative to their matched lean controls, obese females 
displayed a higher (P < 0.05) expression of ovarian GSTP1 at 18 and 24 weeks (Figure 
6C). 
 
Discussion 
 
Obese mothers have increased risk for miscarriage (96), poor oocyte quality 
(102), and birth defects in their offspring (96). In a recent study, we discovered that 
ovaries from obese females may have increased susceptibility to environmental 
exposures due to increased levels of EPHX1 and altered GST levels (92). Although the 
mechanism(s) remain unclear, we propose that ovarian biotransformation capacity may 
be altered during obesity, leading to increased susceptibility to ovotoxicant effects.  We 
also hypothesize that these impacts may be mediated through altered insulin-regulated 
PI3K signaling, thus we chose a model of progressive obesity in which to determine 
impacts of obesity onset and establishment on these endpoints.     
 
Many rodent models of obesity have mutations in the satiety hormone leptin 
(ob/ob) (134) or its receptor (db/db) (114). While these mutations result in rapid onset of 
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obesity, mutations of this kind which result in complete dysregulation of body weight 
control are rare in the human population (14, 22). The lethal yellow mouse has a deletion 
mutation in the normal wild type non-agouti (a/a) background which results in ectopic 
expression of agouti (22, 33, 72, 87). Hypothalamic agouti overexpression inhibits the 
melanocyte stimulating hormone (MSH) receptor (81) leading to hyperphagia due to 
hindering of the inhibitory effects of feeding imparted by alpha-melanocyte-stimulating 
hormone (α-MSH) and cocaine- and amphetamine-regulated transcript (CART) (16, 81). 
Subsequently, hyperphagia coupled with reduced energy expenditure results in the 
development of progressive obesity (72, 81). Starting at 12 weeks of age, these mice are 
hyperinsulinemic (129), hyperleptinemic (15), and display insulin (72) and leptin (44) 
resistance. Additionally, premature reproductive failure is a common phenotype of the 
lethal yellow mouse (15, 41, 51, 92). Elevated insulin levels have been reported in both 
serum and follicular fluids of obese females (109, 121). However, studies investigating 
whether the ovary retains insulin sensitivity during hyperinsulinemia are contradictory 
(2, 18, 94, 128).  
 
We found that progressive obesity was associated with a temporal pattern of 
increased Irs1, Irs2 and Irs3 mRNA as well as pIRS1Ser302 protein levels, perhaps 
indicating that ovarian insulin signaling pathway retains activity in ovaries from obese 
mice, supporting our previous data with both high fat diet (HFD) fed mice (94) and the 
lethal yellow mouse (92). The IRS1 contains several tyrosine/serine phosphorylation 
sites that serve as docking sites for numerous downstream mediators of insulin’s growth-
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promoting and metabolic functions (39, 43, 90, 113). Although most serine 
phosphorylations of IRS lead to insulin signaling attenuation (43), phosphorylation of 
IRS1 at serine 302 in rodents, which corresponds to serine 307 of the human IRS1 (30, 
135), is associated with insulin stimulation and it is believed to have a positive action in 
subsequent IRS1 tyrosine phosphorylations (30, 39, 135). In several studies, inhibition of 
pIRS1Ser302 by glucose starvation or deprivation of short term amino acid correlates with 
decreased IRS1 tyrosine phosphorylation and subsequent reduced insulin activity (39, 
43, 124). Also increased pIRS1Ser302 has been observed during peripheral insulin 
resistance in the skeletal muscle of both rodents (49) and humans (110, 125). Whether 
the observed temporal increase in ovarian pIRS1Ser302 protein levels during progressive 
obesity in this study represents positive or negative feedback to insulin stimulation is 
hard to discern.  
 
In cultured human ovarian cortex, insulin alone or in combination with IGF-I and 
IGF-II increased the percentage of primordial follicles transitioning to the primary stage 
(80). In canines (111) and fetal hamster cultured ovaries (131), elevated insulin 
concentrations promoted preantral follicular growth and viability.  Insulin promoted the 
transition from primordial to primary follicle stage in rat ovaries (66) and bovine cortical 
pieces (36).  Moreover, insulin had an additive effect with KITLG on increasing follicle 
activation in cultured neonatal rat ovaries (66, 91). These studies suggest a functional 
role for insulin signaling in ovarian folliculogenesis regulation.  Insulin acting through 
its receptor and the receptor substrate proteins can activate the PI3K-AKT dependent 
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signaling pathway (70). AKT activation involves two phosphorylations, one at threonine 
308 (Thr308) normally by phosphoinositide dependent kinase (PDPK1) and the other at 
serine 473 (Ser473) by mammalian target of rapamycin complex 2 (mTORC2) (11, 118, 
122). In mouse liver (31) or skeletal muscle (79) lacking IRS1 or IRS2, AKT Thr308 
phosphorylation (pAKTThr308) is undetectable; however, AKT phosphorylation at Ser473 
(pAKTSer473) is retained (25), thus pAKTSer473 appears not to be a suitable indicator of 
IRS-mediated PI3K-AKT signaling (26, 122). We demonstrate a temporal pattern of 
increased pAKTThr308 with obesity progression indicating increased PI3K-AKT 
activation in obese females. FOXO3 is a downstream AKT target that is negatively 
regulated upon AKT activation (3, 11, 61, 106). We noted a trend for a 60% and 70% 
reduction in this protein in ovaries from obese mice at 12 and 24 weeks, respectively, 
suggestive of increased activation of insulin-PI3K/AKT signaling pathway during 
progressive obesity. Hyperactivation of the PI3K-AKT-FOXO3 signaling pathway, has 
been shown to increase the rate of primordial follicles activation and recruitment into the 
growing pool with eventual death of most of those follicles, leading to accelerated 
ovarian senescence (23, 60, 76, 77, 107).    
  
In addition to insulin, PI3K-AKT-FOXO3a can be activated by Kit ligand, 
KITLG, through its protein-tyrosine kinase receptor, cKIT (71, 75, 106). cKit is 
expressed in the oocyte (52, 82, 83), whereas Kitlg originates from the GC and TC (32, 
36, 59). In the ovary, KITLG binding to cKIT induces phosphorylation of the regulatory 
subunit of PI3K and subsequent activation of AKT1 (71, 75, 106). We previously found 
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that that HFD-induced obesity increased Kitlg concomitant with increased Akt1 and 
decreased Foxo3a mRNA expression in murine ovaries (94). In the present study we 
also observed a temporal pattern of increased ovarian Kit and Kitlg mRNA concomitant 
with increased pAKTThr308 protein in obese mice relative to their lean littermates. The 
ovarian KITLG-cKIT pathway plays a pivotal role in regulation of ovarian 
folliculogenesis (32, 37, 97-100, 130) and steroidogenesis (88). In human ovarian 
follicles, blocking the KIT receptor using an anti-KIT antibody, ACK2 induced ovarian 
follicular atresia (21). KITLG supplementation promoted the transition of primordial to 
the primary follicle stage in bovine ovarian cortical pieces (37), and stimulated follicle 
activation in rodents (100, 130). Taken together, our data support that activation of 
insulin-KITLG-KIT-AKT1 signaling pathway is induced by obesity, and this could be a 
potential mechanism underlying obesity-induced over-activation of primordial follicles 
into the growing follicular pool previously noted in both this mouse model (92) and rats 
(123). 
   
In primary cultured rat hepatocytes, insulin administration decreased Cyp2e1 
mRNA expression in a dose dependent manner, and this was reversible by either 
addition of glucagon or PI3K inhibitors (Wortmannin or LY294002) (126, 127).  
Increased Cyp2e1 mRNA and/or CYP2E1 protein abundance have been reported during 
diabetes (4, 40, 112), glucagon treatment (127) and starvation (40, 68); physiological 
states that are normally associated with decreased insulin activity. Interestingly, EPHX1 
expression pattern is opposite to CYP2E1 during these physiological states. Insulin 
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treatment or re-feeding increases Ephx1 mRNA, EPHX1 protein expression and enzyme 
activity (68, 69, 117), however, diabetes (68, 117), glucagon (69) or starvation (68, 117) 
or PI3K inhibition (69), decreases Ephx1 expression. Similar to the liver, opposing 
expression patterns of ovarian EPHX1 and CYP2E1 expression have been previously 
reported (64, 94). In the present study, similar to the mRNA results, there was a temporal 
increase in ovarian EPHX1 with a concomitant decrease in CYP2E1 protein levels in 
ovaries from obese females compared to their age matched lean counterparts.  
 
In a similar manner to EPHX1 and CYP2E1, the expression and activities of 
GST enzymes can be mediated through PI3K/AKT signaling (7, 38, 67). In male rats, 
addition of insulin reversed decreased hepatic GST activity that had been induced by 
diabetes (117). Also, re-feeding (associated with insulin stimulation), restored 
starvation-induced reduced liver GST enzyme activities (117). We recently observed 
increased ovarian levels of Gstm1 mRNA, GSTM1 and GSTP1 proteins due to an obese 
phenotype (92). In the data reported herein, we observed a temporal increase in ovarian 
Gstm1 mRNA and GSTP1 protein expression with progressive obesity. GST’s are 
critical for detoxification of a number of xenobiotic compounds (7, 47, 74).  In addition, 
ovarian GSTP1 (Bhattacharya et al., 2012) and GSTM1 (Bhattacharya and Keating, 
2012) negatively regulate pro-apoptotic proteins, thus their increased level in obesity 
may reflect a reduction in apoptosis during obesity.  Both of these functions are in 
agreement with GSTP1 and GSTM1 being implicated in susceptibility toward and poor 
prognosis from various forms of gynaecological tumours (38, 42, 45) and development 
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of anti-cancer drug resistance (89, 115, 116, 119, 120). Therefore increased abundance of 
ovarian GSTM1 and GSTP1 during obesity could be part of the underlying mechanisms 
behind obesity-induced reproductive disorders in obese females. 
 
Taken together, our data demonstrates that progressive obesity increased mRNA 
and/or protein of ovarian signaling pathways that regulate folliculogenesis as well as 
ovotoxicant metabolism.  These findings are of concern since dysregulated activation of 
follicles into the growing pool will eventually result in their depletion, accelerating entry 
into ovarian senescence.  In addition, altered ovarian capacity to biotransform chemicals 
could pose a threat to both folliculogenesis and stability of the germ line.   
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Table 1: Primer Sequences used for quantitative RT-PCR 
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Figure 1: Obesity temporally increases ovarian mRNA expression of insulin 
signaling members. Total ovarian RNA was isolated from lean or obese mice at 6, 12, 
18 or 24 weeks (n = 4, per group per time point), reverse transcribed and qRT-PCR 
performed to quantify mRNA levels of (A) Insr, (B) Irs1, (C) Irs2, and (D) Irs3. Target 
gene mRNA expression values were normalized to Gapdh as a housekeeping gene. 
Results are presented as relative fold-change means ± SEM. * indicates significant 
difference from age matched lean females at P < 0.05. 
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Figure 2: Progressive obesity increases ovarian phosphorylated insulin receptor 
substrate 1 protein.Total ovarian protein was isolated from lean (L) and obese (O) mice 
at 6, 12, 18, or 12 weeks (n = 3-4 per group per time point). Protein expression of pIRS1 
(Ser302) was determined by Western blotting, followed by densitometric quantification 
of the appropriate protein band using Carestream molecular imaging software. Bars 
represent means ± SEM in arbitrary units. * indicates significant difference from age 
matched lean females at P < 0.05. 
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Figure 3: Ovarian Kitlg/cKit-PI3K pathway members are elevated during obesity. 
Total ovarian RNA was isolated from lean or obese mice at 6, 12, 18 or 24 weeks (n = 4, 
per group per time point), reverse transcribed and qRT-PCR performed to quantify the 
mRNA levels of (A) Kitlg, (B) Kit, (C) Akt1 (D) Akt2 (E) Foxo1 and (G) Foxo3a. Target 
gene mRNA expression values were normalized to Gapdh as a housekeeping gene. 
Results are presented as relative fold-change means ± SEM. * indicates significant 
difference from age matched lean females at P < 0.05. 
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Figure 4: Ovarian phosphorylated AKT is increased by obesity without impacting 
FOXO3 protein levels. Total ovarian protein was isolated from lean (L) and obese (O) 
mice at 6, 12, 18, or 12 weeks (n = 3-4 per group per time point). Protein expression was 
determined by Western blotting, followed by densitometric quantification of the 
appropriate protein bands using Carestream molecular imaging software.  (A) 
pAKTThr308 and (B) FOXO3 protein levels. Bars represent means ± SEM in arbitrary 
units. * indicates significant difference from age matched lean females at P < 0.05. 
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Figure 5: Progressive obesity alters mRNA expression of ovarian xenobiotic 
metabolism genes. Total ovarian RNA was isolated from lean or obese mice at 6, 12, 18 
or 24 weeks (n = 4, per group per time point), reverse transcribed and qRT-PCR 
performed to quantify the mRNA levels of (A) Gstm1, (B) Gstp1, (C) Ephx1, and (D) 
Cyp2e1. Target gene mRNA expression values were normalized to Gapdh as a 
housekeeping gene. Results are presented as relative fold-change means ± SEM. * 
indicates significant difference from age matched lean females at P < 0.05. 
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Figure 6: Abundance of ovarian xenobiotic metabolism proteins is impacted by 
increased body mass. Total ovarian protein was isolated from lean (L) and obese (O) 
mice at 6, 12, 18, or 12 weeks (n = 3-4 per group per time point). Protein expression was 
determined by Western blotting, followed by densitometric quantification of the 
appropriate protein band using Carestream molecular imaging software.  (A) GSTP1, (B) 
EPHX1, and (C) CYP2E1 protein levels. Bars represent means ± SEM in arbitrary units. 
* indicates significant difference from age matched lean females at P < 0.05. 
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CHAPTER 6: IMPACT OF OBESITY ON OVOTOXICITY INDUCED BY  
7,12-DIMETHYLBENZ[A]ANTHRACENE IN MICE 
 
A paper accepted by Biology of Reproduction 
Nteeba, J., Ganesan, S., Keating, A.F. 
Contribution Statement: 
I performed the animal studies, all analyses on ovarian tissue, designed the experiments, 
interpreted data and wrote the paper.  Ganesan, S. aided in glucose tolerance testing and 
tissue collection; Keating, A.F. designed experiments, aided in data interpretation and 
edited the manuscript.   
 
 
Summary sentence: Ovaries from obese mice have altered capacity for chemical 
biotransformation and increased DMBA-induced ovotoxicity. 
 
Abstract 
 
Insulin, elevated during obesity, regulates xenobiotic biotransformation enzymes, 
potentially through phosphatidylinositol 3-kinase (PI3K) signaling, in extra-ovarian 
tissues.  PI3K regulates oocyte viability, follicular activation and ovarian chemical 
biotransformation. 7,12-dimethylbenz[a]anthracene (DMBA), a carcinogen and 
ovotoxicant, destroys all stage follicles, leading to premature ovarian failure. Obesity has 
been reported to promote DMBA-induced tumors, but it remains unknown whether 
obesity impacts ovarian xenobiotic metabolism. Therefore, we investigated ovarian 
expression of xenobiotic metabolism genes (microsomal epoxide hydrolase (Ephx1), 
Glutathione S-transferase (GST) class Pi (Gstp1) and class mu 1 (Gstm1)) and PI3K 
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signaling members (protein kinase B (AKT) alpha (Akt1), beta (Akt2), and the forkhead 
transcription factor subfamily 3 (Foxo3)) in lean and obese female mice after DMBA 
exposure (1 mg/Kg; intraperitoneal injection for 14 days).  Relative to lean, obese mice 
had decreased (P < 0.05) healthy primordial and primary follicle numbers but increased 
(P < 0.05) secondary and pre-ovulatory follicles numbers. Obesity increased (P < 0.05) 
Akt1, Akt2, Gstm1, Ephx1 mRNA and pAKTSer473/Thr308, GSTM1, GSTP1 and EPHX1 
protein levels. DMBA decreased (P < 0.05) ovarian weight in lean and obese mice, 
however, obese DMBA-treated females had a greater reduction (P < 0.05) in ovarian 
weight. In both lean and obese mice, DMBA decreased (P < 0.05) all stage healthy 
follicle numbers, increased Gstp1, Ephx1 mRNA and GSTM1, GSTP1 and EPHX1 
protein levels and decreased Akt1, Akt2 mRNA, pAKTSer473 or pAKTThr308, FOXO3 and 
pFOXO3Ser253 protein expression. There was an additive effect between obesity and 
DMBA exposure for increased Gstm1, Ephx1 mRNA, and GSTM1 and EPHX1 protein 
expression.  
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Introduction 
 
Obesity is positively correlated with a number of health hazards some of which, 
including diabetes [1-5], cardiovascular disease [6-9] and cancer [10-14], are the leading 
causes of preventable death. The prevalence of obesity and obesity-related health 
complications, such as type 2 diabetes, which were previously considered “adult 
diseases”, are now also rising dramatically in children [8, 15, 16] leading to premature 
death and infertility. In recent years, a strong association between increased body mass 
index with enhanced incidence in reproductive health impairments has been reported 
[12, 17-20]. Obese women have an increased likelihood to display signs of polycystic 
ovarian syndrome (PCOS), reduced fecundity and poor quality oocytes [19, 21]. There 
has also been a strong link between obesity and an increased risk of birth defects, 
premature and still-birth [22-28] and gestational diabetes [29, 30]. Although, there is 
strong association between obesity and compromised reproductive health, the molecular 
mechanisms involved remain ill-defined. Additionally, despite the alarming prevalence 
of obesity and obesity associated maladies, little is known of how this epidemic may 
influence ovarian xenobiotic metabolism. 
 
Ovaries are important for supplying the germ cell necessary for perpetuation of 
species and production of hormones essential for female growth and development [31-
33]. At birth, females are born with a limited number of primordial follicles, which once 
depleted, cannot be replenished [33-35]. It is accepted that the process of 
folliculogenesis is an irreversible process; once follicles are recruited from the resting 
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pool to the growing pool they will undergo atresia if not selected for further growth to 
ovulation [36-38]. Unlike the cyclic maturation of follicles to ovulation, initial 
primordial follicular activation has been identified to be regulated, independent of the 
pituitary gonadotropins, largely by local ovarian factors including the 
phosphatidylinositol 3-kinase (PI3K) pathway [38-41]. A balance between dormancy, 
activation and atresia of primordial follicles is critical for the female reproductive 
lifespan [37, 38, 42]. Any environmental factor(s) that could accelerate the rate of 
primordial follicle activation and the process of atresia, would greatly threaten the 
reproductive potential of the female.  
 
Obesity can alter insulin sensitivity in a number of target tissues including 
muscle, liver, adipose tissue and the ovary [2, 43-46]. Insulin hormone binds to its 
receptor resulting in auto-phosphorylation and recruitment of the insulin receptor 
substrate proteins (Irs) [47-49], which in turn regulate numerous downstream insulin-
mediated signaling pathways including PI3K signaling [2, 43]. PI3K signaling events are 
largely mediated through Protein kinase B (AKT), a subfamily comprising of three 
mammalian isoforms Akt1, Akt2 and Akt3 [50]. Upon PI3K activation, it recruits AKT 
to the membrane where AKT is phosphorylated (pAKT). pAKT dissociates from the 
membrane and shuttles to the cell nucleus where it has the ability to phosphorylate and 
inactivate several targets including forkhead transcription factor subfamily 3 (FOXO3).  
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A number of environmental chemicals can target the ovary and destroy the 
primordial follicles as well as other follicle types, leading to premature ovarian failure, 
infertility and other health impairments [31, 32, 51-53], making ovarian xenobiotic 
metabolism critical for protection of the female germ cell. The polycyclic aromatic 
hydrocarbon, 7,12-dimethylbenz[a]anthracene (DMBA), is an environmental carcinogen 
[54-58] as well as ovotoxicant [51, 52, 59, 60]. Human exposure to DMBA is mainly 
through smoke or fumes from burning of organic substances such as coal, car exhaust 
and cigarette smoke [59, 61]. Relative to non-smokers, women who are cigarette 
smokers undergo early onset of menopause and suffer infertility [62-64]. Studies from 
animal models have demonstrated that DMBA exposure can destroy follicles of all types 
resulting in accelerated premature ovarian insufficiency and other reproductive 
complications [32, 51, 59, 65, 66]. In the liver, the parent compound DMBA is 
bioactivated to its more toxic metabolite, DMBA-3,4-diol-1,2-epoxide by cytochrome 
P450 isoforms 1B1 (CYP1B1)  and 1A1 (CYP1A1) [59, 61, 67, 68] in conjunction with 
microsomal epoxide hydrolase (EPHX1) [69, 70]. Several studies have also 
demonstrated the ovary’s capacity to metabolize DMBA to its more ovotoxic metabolite, 
DMBA-3,4-diol-1,2-epoxide via the action of EPHX1 [51, 59, 61, 68, 70-72].   
 
Insulin can regulate the expression xenobiotic biotransformation genes products 
such as the CYP’s, Glutathione S-transferases (GST) and EPHX1 through PI3K/AKT 
signaling [73, 74]. Inhibition of PI3K has also been reported to alter the expression of 
EPHX1, GSTP1 and GSTM1 genes in postnatal day 4 cultured rat ovaries [75-77].  
207 
 
GSTP1 and GSTM1 are members of the GST superfamily of proteins involved in phase 
II metabolism of xenobiotic compounds. These enzymes function in the detoxification of 
electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins 
and products of oxidative stress, by conjugation with glutathione [78]. Though the 
effects of obesity on DMBA-induced ovotoxicity have not been previously explored, 
regulation of EPHX1 by insulin in non-ovarian tissues has been reported [73, 74]. Since 
obesity can alter insulin action to its target tissues including the ovary, we hypothesized 
that obesity-induced increased insulin could increase PI3K signaling and alter xenobiotic 
gene expression leading to accelerated DMBA-induced ovotoxicity. 
 
Materials and Methods 
 
Reagents 
7,12-dimethylbenz[a]anthracene (>98% DMBA), 2-β-mercaptoethanol, 30% 
acrylamide/0.8% bis-acrylamide, ammonium persulfate, glycerol, N′,N′,N′,N′-
Tetramethyl-ethylenediamine (TEMED), Tris base, Tris HCl, sodium chloride, Tween-
20, bovine serum albumin (BSA), ascorbic acid (Vitamin C), phosphatase inhibitor, 
protease inhibitor and transferrin were purchased from Sigma-Aldrich Inc. (St. Louis, 
MO). RNAlater was obtained from Ambion Inc (Austin, TX). Hanks' Balanced Salt 
Solution (without CaCl2, MgCl2, or MgSO4) and superscript III one-step RT-PCR 
System were obtained from Invitrogen Co. (Carlsbad, CA). RNeasy Mini kit, 
QIAshredder kit, RNeasy MinElute kit and QuantitectTM SYBR Green PCR kit were 
purchased from Qiagen Inc. (Valencia, CA). Custom designed primers were obtained 
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from the DNA facility of the Office of Biotechnology at Iowa State University. Ponceau 
S was purchased from Fisher Scientific (Waltham, MA, USA). SignalFire™ ECL 
Reagent and Anti-pAKTSer473 antibody were from Cell Signaling Technology® 
(Danvers, MA, USA). Anti-FOXO3, anti-pFOXO3Ser253, anti-alpha Tubulin (TUBA), 
anti-GSTP1 and anti-GSTM1 antibodies were purchased from Millipore (Temecula, CA, 
USA). Anti-pAKTThr308 antibody was purchased from Abcam (Cambridge, MA, USA). 
Goat anti-rabbit and donkey anti-goat secondary antibodies were purchased from Pierce 
Biotechnology (Rockford, IL). Restore™ PLUS Western Blot Stripping Buffer was 
purchased from Thermo SCIENTIFIC (Rockford, IL, USA).    
 
Animals 
Four week old female wild type normal non-agouti (a/a; designated lean; n = 15) 
and agouti lethal yellow (KK.Cg-Ay/J; designated obese; n = 15) mice were obtained 
from the Jackson Laboratory (Bar Harbor, Maine) and housed at the animal facility at 
Iowa State University. All experimental protocols and procedures were approved by the 
Iowa State University Animal Care Committee (IACUC). Animals were maintained 
under controlled lighting (12 hr light/12 hr dark) and temperature (21-22oC) conditions. 
Food and water were provided ad libitum. At 6 weeks of age, non-agouti and agouti 
lethal yellow mice (n = 5/genotype) were sacrificed.  At 18 weeks of age, glucose 
tolerance testing confirmed that obese mice were less glucose tolerant than their lean 
littermates and had higher systemic basal glucose level.  Both lean and obese mice (n = 
10/genotype), were intraperitoneally (i.p.) dosed with sesame oil or DMBA (> 98%; 
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1mg/kg/day) for 14 days.  This dose was chosen based on destruction of approximately 
50% of primary and secondary follicles, with a higher loss of primordial follicles [52]. 
 
Tissue collection 
Mice were euthanized at 6 weeks of age or 3 days after the end of dosing 
(approximately 20 weeks of age) during the pro-estrus stage of cyclicity and body 
weight was recorded.  Ovaries were collected, trimmed of excess fat and weighed. One 
ovary was fixed in 4% paraformaldehyde for histological analysis while the other ovary 
was stored in RNAlater at -800C for RNA and protein expression studies. 
 
Histology and Follicle Counting 
The histology work was performed at the Iowa State University Veterinary 
Medicine Histopathology laboratory. Briefly, one ovary from each animal was fixed in 
4% paraformaldehyde overnight, transferred to 70% ethanol, dehydrated, embedded in 
paraffin blocks, serially sectioned (5 µM) and every 6th section (4-6 sections/slide) was 
mounted (15–20 slides per animal), and stained with hematoxylin and eosin (H & E). 
Digital images were acquired with a Leica DMI300B Fluorescent Microscope. Numbers 
of healthy follicles (oocyte-containing follicles showing a distinct oocyte nucleus) were 
classified and counted in every 12th section according to the procedures as previously 
described [79, 80]. Briefly, primordial follicles contained an oocyte surrounded with a 
single layer of squamous-shaped granulosa cells, primary follicles contained an oocyte 
surrounded by a single layer of cuboidal-shaped granulosa cells, secondary follicles 
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contained an oocyte surrounded by multiple layers of granulosa cells and antral follicles 
contained an oocyte surrounded by at least two layers of granulosa cells and a fluid-
filled antral space.   
 
RNA Isolation 
Total RNA was isolated using Qiagen RNeasy® Mini Kit (n = 3 ovaries per 
treatment) according to the manufacturer’s protocol. Briefly, ovaries were lysed and 
homogenized using a hand-held homogenizer followed by applying the homogenate to a 
QIAshredder column with subsequent centrifugation at 16100 RCF for 2 minutes at 
room temperature. The resulting supernatant was applied to an RNeasy Mini column, 
allowing RNA to bind to the filter cartridge. Following washing, RNA was eluted from 
the filter and concentrated using an RNeasy MinElute Kit according to the 
manufacturer’s protocol. The final total concentrated RNA was eluted using 14 µl of 
RNase-free water and RNA concentration determined using an ND-1000 
Spectrophotometer (λ = 260/280 nm; NanoDrop technologies, Inc., Wilmington, DE). 
 
First strand cDNA synthesis and quantitative real-time polymerase chain reaction (qRT-
PCR)  
Total RNA (0.5 µg) was reverse transcribed into cDNA utilizing the 
Invitrogen™ Superscript III Reverse Transcriptase as detailed in the manufacturer’s 
procedures. Two microliters of diluted cDNA (1:25) was amplified on an Eppendorf 
Mastercycler using a Quantitect™ SYBR Green PCR kit and primers specific for mouse 
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Gapdh, Ephx1, Gstp1, Gstm1, Akt1(sequences as indicated in Nteeba et al [81]) and Akt2 
(forward primer: 5′- TGG ACC ACA GTC ATC GAG AG-3′;  reverse primer: 5′-CTT 
GTA ATC CAT GGC GTC CT-3′). The PCR cycling program consisted of a 15 min 
hold at 95°C and 45 cycles of: denaturing at 95°C for 15 sec, annealing at 58°C for 15 
sec, and extension at 72°C for 20 sec at which point data was acquired. Product melt 
conditions were determined using a temperature gradient from 72°C to 99°C with a 1°C 
increase at each step. Three replicates of each sample (n = 3 wells per treatment) were 
included. Statistical analysis was performed on the normalized ∆CT for each sample. 
There was no difference in ovarian Gapdh mRNA level between sesame control and 
DMBA-treated ovaries in lean or obese mice. Therefore, for each sample, relative 
mRNA expression of each of the above genes was normalized using Gapdh as a 
housekeeping gene and relative fold change calculated using the 2-∆∆CT method. The 
results are presented as mean fold change ± standard error relative to the sesame control 
group. 
 
Protein Isolation and Western Blot Analysis 
Total ovarian protein was isolated and immunoblots performed according to the 
procedure of Nteeba et al. [81]. Briefly, ovaries (n = 3 per treatment) were homogenized 
in 300 µl of ice-cold tissue lysis buffer and protein quantified using a standard BCA 
protocol on a 96-well assay plate. Total protein (15 µg) was separated on a 10% SDS-
PAGE and subsequently transferred to nitrocellulose membranes. Following blocking, 
membranes were incubated with specific primary antibodies [Rabbit Anti-GSTP1 
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(1:250); Rabbit Anti-GSTM1 (1:200), Goat Anti-EPHX1 (1:500), Rabbit Anti-
pAKTSer473 (1:500), Rabbit Anti-pAKTThr308 (1:500), Rabbit Anti-FOXO3 (1:500), 
Rabbit Anti-pFOXO3Ser253 (1:1000)] in 5% BSA in TTBS for 15-20 h at 4oC. HRP-
conjugated secondary antibodies (1:2000 – 1:5000) were added for 1h at room 
temperature, and then membrane-bound HRP were washed three times for 5 minutes in 
TTBS. Autoradiograms were visualized on X-ray films in a dark room following 7 min 
incubation of membranes with 1X SignalFire™ ECL reagent. Equal protein loading was 
confirmed by Ponceau S staining of nitrocellulose membranes prior to antibody 
incubation.  Additionally, blots were stripped and probed with an anti-TUBA or anti-
GAPDH antibody.  Densitometry of the appropriate sized bands was measured using 
Carestream molecular imaging software version 5.0 (Carestream Health Inc., Rochester, 
NY) which eliminates background noise.  Values were normalized to the appropriate 
loading control (TUBA, GAPDH, or Ponceau S staining). 
      
Statistical Analysis 
Statistical analyses were performed using either the Two-Way ANOVA followed 
by Bonferroni multiple comparisons to assess interaction between strain and drug or the 
One-Way ANOVA followed by Tukey’s multiple pairwise comparison function of 
GraphPad Prism 5.5 software with a statistical significance level set at P < 0.05. Bars 
represent means ± SEM. Different letters indicate significant difference from respective 
pairs; n = 3 per treatment. 
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Results 
 
Obesity decreases the number of healthy primordial follicles in murine ovaries 
We determined the effect of DMBA exposure on ovarian weight and the number 
of healthy follicles in lean and obese mice (Fig. 1). There was no effect of DMBA on 
body weight (Fig. 1A); however, compared to sesame oil, DMBA decreased ovarian 
weight in both lean (P < 0.05) and obese (P < 0.001) treated groups (Fig. 1B). There was 
no difference between ovarian weight of lean and obese sesame treated groups; however, 
DMBA treatment further reduced (P < 0.05) ovarian weight in the obese compared to 
lean mice (Fig. 1B). In both lean and obese females, DMBA treatment significantly 
decreased (P < 0.0001) the number of healthy follicles compared to sesame-treated 
females (Fig. 1C-1F). Interestingly, ovaries from obese mice had both decreased (P < 
0.0001) number of healthy primordial (Fig. 1C) and primary (Fig. 1D) follicles but 
increased (P < 0.001) secondary (Fig. 1E) and pre-ovulatory (Fig. 1F) follicles 
compared to ovaries from lean sesame-treated mice.  No impact of obesity or DMBA on 
corpora lutea numbers were observed.   
 
DMBA and obesity have an additive effect on ovarian Ephx1 and Gstm1 gene 
expression  
Relative to lean counterparts, ovaries from obese mice had increased ovarian 
Gstm1 (Fig. 2A; P < 0.01) and Ephx1 (Fig. 2C; P < 0.05) mRNA levels. However, 
obesity did not affect Gstp1 (Fig. 2B) mRNA levels in murine ovaries. In lean ovaries, 
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DMBA did not alter Gstm1 mRNA expression.  Gstp1 and Ephx1 mRNA levels were 
increased (P < 0.05) in ovaries of both lean and obese treated groups compared to those 
of their respective control groups (Fig. 2A – 2C). Compared to lean DMBA-treated 
females, ovaries from obese DMBA-treated females displayed increased (P < 0.01) 
Gstm1 and a strong tendency for increased (P = 0.06) Ephx1 but no difference in Gstp1 
mRNA levels (Fig. 2A – 2C).  Lack of any impact of genotype on Gstm1, Gstp1 or 
Ephx1 mRNA level was confirmed in ovaries from 6 week old mice (pre-obese) (Fig. 
2D).  
 
DMBA increases ovarian GSTM1, GSTP1, and EPHX1 protein levels in obese but not 
in lean mice 
Ovaries from obese mice had increased (P < 0.05) basal ovarian GSTM1 protein 
levels relative to their lean counterparts (Fig. 3A). DMBA exposure did not impact 
GSTM1 protein level in lean ovaries however there was increased (P < 0.05) GSTM1 
protein levels in ovaries of obese treated groups compared to their respective control 
groups (Fig. 3A).  Relative to lean counterparts, ovaries from obese mice had increased 
basal ovarian GSTP1 (P < 0.001) protein levels (Fig. 3B). Interestingly, DMBA 
increased (P < 0.05) GSTP1 protein level in ovaries of lean mice, but decreased (P < 
0.05) ovarian GSTP1 protein level in obese treated groups compared to those of their 
respective control groups (Fig. 3B).  Similar to mRNA results, ovaries from obese mice 
had increased (P < 0.05) basal ovarian EPHX1 protein levels relative to their lean 
counterparts (Fig. 3C). DMBA increased (P < 0.05) EPHX1 protein levels in ovaries of 
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both lean and obese treated groups compared to their respective control groups (Fig. 
3C). Relative to lean DMBA treated mouse ovaries; obesity resulted in a greater increase 
(P < 0.01) in EPHX1 protein levels, relative to the obese sesame oil-treated mouse 
ovaries (Fig. 3C). 
 
Obesity and DMBA have opposing effects on ovarian Akt1/2 mRNA expression  
Ovaries from obese females displayed higher (P < 0.05) Akt1 (Fig. 4A) and Akt2 
(Fig. 4B) mRNA levels than lean females; however, DMBA exposure significantly 
reduced ovarian Akt1/2 mRNA levels in both lean (P < 0.001) and obese (P < 0.05) 
treated groups (Fig. 4).  Akt1 and Akt2 mRNA levels were not found to differ between 
genotype in ovaries from 6 week old mice (pre-obese) (Fig. 4C).   
 
Obesity increases ovarian phosphorylated AKT without affecting phosphorylated 
FOXO3 protein levels 
DMBA decreased (P < 0.05) ovarian pAKTSer473 protein in lean mice, while 
obesity increased (P < 0.05) basal pAKTSer473 levels and the reduction observed in the 
lean mice was absent from ovaries of obese mice.  In lean mice, there was no impact of 
DMBA on pAKTThr308 protein, however obesity increased (P < 0.05) basal ovarian 
pAKTThr308 protein levels (Fig. 5).  In contrast to lean ovaries, those from obese mice 
had a decrease in pAKTThr308 when exposed to DMBA.  Lean and obese females did not 
differ in FOXO3 protein level, and although there was a visible reduction in DMBA-
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treated lean mice, this was not significant due to variation.  pFOXO3Ser253 protein 
expression was reduced by DMBA in both lean and obese ovaries, and there was a lower 
level basally (P < 0.05) of pFOXO3Ser253 due to obesity.   
 
Discussion 
 
Obesity is associated with elevated blood glucose and insulin levels, altering 
insulin’s action on a number of organs including the ovary [2, 43-46]. Recently, it has 
been demonstrated that the ovary maintains insulin sensitivity during obesity even 
though other classical tissues including the liver, muscle and adipose tissue develop 
insulin resistance [43, 81]. Insulin has been previously shown to regulate hepatic 
xenobiotic metabolism [73, 74, 82, 83] and in the ovary insulin can activate the 
PI3K/AKT signaling, a pathway that has been demonstrated to play critical roles in 
metabolism and reproduction [84]. Previous work in rodent models has shown the 
involvement of PI3K signaling in insulin-mediated hepatic regulation of xenobiotic 
metabolism [83, 85]. Recently, the involvement of PI3K signaling in ovarian metabolism 
of chemicals including DMBA has been demonstrated [60, 75, 86]. Since obesity is 
associated with elevated plasma insulin levels, we hypothesized that obesity-induced 
increased insulin could increase PI3K signaling and alter xenobiotic gene expression 
leading to accelerated DMBA-induced ovotoxicity. To test this hypothesis, we used the 
lethal yellow mouse, an excellent model for human obesity [87], to investigate whether 
obese females have increased susceptibility to DMBA-induced ovotoxicity.  We 
designed our experiments on the impact of obesity on chemical metabolism when mice 
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were 18 weeks of age because elevated insulin has been shown in this mouse model at 
this timepoint [88].  In addition, we confirmed that the obese mice had elevated basal 
glucose and had a compromised response to a glucose tolerance test (data not shown)  
and that there was no impact of the lethal yellow genotype on follicle numbers at 6 
weeks of age (our unpublished data).  Further, to eliminate any impact of genotype 
outside of the obese phenotype, we characterized gene expression in 6 week old mice; at 
this point there is no difference in body weight and the lethal yellow mice are considered 
pre-diabetic.   
 
Relative to sesame oil, DMBA treatment did not impact body weight; however, 
compared to sesame oil, DMBA decreased ovarian weight in both lean and obese treated 
groups. Interestingly, we observed lower than expected primordial follicle numbers in 
ovaries of both lean and obese sesame oil treated animals, which cold be due to their 
being 20 weeks of age, and potentially this is a time when follicle numbers are naturally 
beginning to decline.  As expected, DMBA treatment significantly decreased the number 
of healthy follicles of all types in both lean and obese treated females compared to 
sesame-treated females.  The observed decrease in ovarian weight and the number of 
healthy follicles in DMBA-treated lean and obese females could be as a result of 
increased follicle loss induced by DMBA exposure as previously reported [59, 61]. 
Surprisingly, though we saw no difference between ovarian weight between lean and 
obese sesame oil-treated groups; there was a significant reduction in ovarian weight of 
obese females treated with DMBA compared to their lean DMBA-treated littermates, 
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indicating that the obese ovaries suffered greater levels of DMBA-induced ovotoxicity, 
outside of follicle depletion.  This data supports that the ovaries from obese, DMBA-
treated mice had greater levels of ovotoxicity than their lean counterparts that received 
the same DMBA exposure.  It was surprising that larger numbers of growing follicles 
did not impact ovarian weight, it has previously been shown that ovaries from mice 
lacking the Arylhydrocarbon receptor had lower numbers of all stage follicles without 
any difference in ovarian weight [89].   Despite lack of ovarian weight differences 
between lean and obese mice, ovaries from obese mice had both decreased number of 
healthy primordial and primary follicles but increased secondary and pre-ovulatory 
follicles compared to ovaries from lean sesame-treated mice.  This difference in follicle 
populations could indicate increased activation of follicles from the primordial follicle 
pool.  Insulin has been shown to activate primordial to primary transition in neonatal rat 
ovaries [90].  Additionally, high fat diet fed rats have been recently demonstrated to 
have increased number of growing and reduced numbers of primordial follicles [91].  
Several studies have also reported an inverse relation between BMI and estradiol levels 
in premenopausal women [92-94]. Decreased estradiol levels have been associated with 
increased activation of primordial follicle in mice [95]. So it is possible that obesity 
could trigger changes in the intrinsic ovarian signals responsible for initiation of follicle 
activation and recruitment.  
 
DMBA has been demonstrated to have both carcinogenic and ovotoxic properties 
in animal models [54, 59, 61]. These two properties are mediated through DMBA’s 
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metabolite 3,4-diol-1,2-epoxide which is formed during DMBA metabolism facilitated 
by CYP1B1, EPHX1 and CYP1B1/1A1 enzymes [59, 96-99]. Although the liver is the 
primary site for xenobiotic metabolism, the ovary has been demonstrated to have the 
capacity to metabolize xenobiotic compounds [60, 32 67, 68, 75, 76] including DMBA 
in absence of hepatic contributions [59, 96-99]. Several studies have confirmed that 
EPHX1 [59, 61, 98] required for DMBA bioactivation, is expressed at high levels in the 
ovary and is increased following DMBA exposure. Although obesity has been reported 
to promote DMBA-induced tumors [100], there is a dearth of literature examining 
potential effects of obesity on ovarian xenobiotic metabolism including DMBA.  
 
Consistent with previous studies, ovaries from obese mice had increased ovarian 
Ephx1 mRNA [81] and EPHX1 protein [59, 61] levels relative to their lean counterparts. 
While DMBA treatment increased Ephx1 mRNA and EPHX1 protein levels in ovaries of 
both lean and obese treated groups compared to their respective control groups, ovaries 
from obese DMBA-treated females displayed a greater increase in Ephx1 mRNA and 
EPHX1 protein expression compared to lean DMBA-treated females. To the best of our 
knowledge, this is the first study to report a DMBA-obesity synergistic effect for 
increased ovarian Ephx1 mRNA and EPHX1 protein expression in mice. In extra-
ovarian tissues, insulin has been demonstrated to increase hepatic EPHX1 expression 
[73, 74, 83] while glucagon to inhibit EPHX1 expression [83]. In rats, conditions of 
insulin deficiency induced by either Type 1 diabetes or starvation were associated with 
decreased EPHX1 enzyme activity yet on the other hand, addition of insulin or re-
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feeding restored EPHX1 activity [74]. Taken together, these data demonstrate that 
insulin plays a role in induction of EPHX1 expression and activity. Since obesity is 
associated with elevated levels of insulin, it is more likely that one of the mechanisms by 
which obesity accelerates ovarian EPHX1 expression is through hyperactivation of 
insulin-mediated EPHX1 induction signaling pathways such the PI3K pathway. In 
cultured primary rat hepatocytes, administration of insulin increased EPHX1 mRNA and 
protein expression in a time- and concentration-dependent manner [83], conversely, 
inhibition of PI3K by Wortmannin and LY294002 or the mTOR inhibitor, rapamycin, 
modulated the insulin-induced increase in EPHX1 [83], supporting the involvement of 
PI3K signaling in insulin-induced hepatic regulation of EPHX1. Furthermore, Ki and 
Kim [85] confirmed the involvement of PI3K signaling in induction of EPHX1 through 
C/EBP transcription factors. With recent reports demonstrating the involvement of PI3K 
signaling in ovarian metabolism of DMBA [60, 75, 86], it is highly probable that the 
observed DMBA-obesity synergistic effect on ovarian Ephx1 mRNA and EPHX1 
protein expression is mediated through insulin/PI3K signaling pathway.  
 
Just like EPHX1, regulation of GSTM1 and GSTP1 by insulin in non-ovarian 
tissues has been reported [73, 74, 101]. Insulin administration is known to increase GST 
gene expression through the PI3K/AKT/mTOR pathway while glucagon decreases such 
gene expression [101]. In alloxan- and streptozotocin-diabetic male Fischer-344 rats, 
diabetes decreased the activities of rat liver soluble GST’s, yet application of insulin to 
alloxan-diabetic individuals approximately restored the initial enzyme activities [74]. 
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Similarly, starvation of Fischer-344 rats, resulted in reduced activities of GST enzymes, 
however, re-feeding restored their initial activities [74]. Taken together, these results 
suggest that insulin also regulates the hepatic activities of GST enzymes. Although in the 
current study we did not measure the activities of these enzymes, we observed increased 
Gstm1 mRNA, GSTM1 and GSTP1 protein levels in ovaries from obese sesame oil-
treated females compared to lean mice, mimicking the trend observed during normal 
insulin activity. Taken together, these results could support the notion that despite 
insulin resistance in other tissues, the ovary maintains insulin sensitivity. 
 
DMBA-induced increases in Gstp1 mRNA and GSTP1 protein levels in PND4 
cultured rat ovaries have been reported [76], however the effect of DMBA on ovarian 
expressed GSTM1 has not been previously reported. In the present study, DMBA 
treatment had contrasting effects on GSTP1 and GSTM1 in both lean and obese treated 
mice. Interestingly, DMBA increased ovarian Gstm1 mRNA and GSTM1 protein levels 
in obese but not in lean mice yet on the other hand DMBA increased ovarian Gstp1 
mRNA in both lean and obese females and GSTP1 protein levels in only lean but 
decreased GSTP1 protein expression in obese females. Furthermore, though there was 
no difference in ovarian Gstp1 mRNA and GSTP1 protein levels between lean DMBA- 
and obese DMBA-treated females, relative to lean DMBA-treated females; ovaries from 
obese females exhibited a greater increase in both Gstm1 mRNA and GSTP1 protein 
expression, following DMBA treatment. Given the divergent roles played by GST 
enzymes, depending on the physiological conditions and type of cells involved, changes 
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in expression of genes encoding for these enzymes could be beneficial or have 
detrimental consequences for the cells. Although best known for their detoxification role 
in metabolism [53, 76, 102-105], GST enzymes have also been implicated in cell 
signaling, intracellular transport and isomerization of steroid hormones [105-107] as 
well as development of chemotherapeutic-drug resistance [104, 105, 108-111] and a 
variety of diseases including cancer, diabetes and inflammatory diseases [101, 104, 110, 
112-114]. In particular, overexpression of GSTP1 has been associated with inactivation 
of cigarette smoke carcinogens [105] including detoxification of DMBA-induced 
toxicity [53, 76, 102], and development of drug resistance [105, 108, 110, 111, 114, 
115], susceptibility to and poor prognosis of several cancers including breast, cervical 
and ovarian cancer [112]. This is could be due to its ability to selectively inhibit pro-
apoptotic p38 and C-Jun N-Terminal Kinase 1 (JNK1) portions of the Mitogen-
Activated Protein Kinase (MAPK) signaling cascades [53, 107, 108, 110, 114]. Like 
GSTP1, there is a growing body of evidence supporting the role of GSTM1 in regulating 
apoptotic pathways through direct protein-protein interactions, with Apoptosis Signal-
regulating Kinase 1 (ASK1), which is upstream of JNK. GSTM1 sequesters ASK1 
through complex formation and subsequent prevention of its induction of the pro-
apoptotic p38 and JNK portions of the MAPK signaling cascade [101, 104, 108, 116]. It 
is important to note that increased expression of GSTs in obese females and during 
DMBA treatment in both lean and obese females did not avert DMBA-induced follicle 
loss. This would imply that the role of overexpressed GSTM1 and GSP1 could be not 
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principally involved in detoxification but rather be involved in other cellular processes 
that are yet to be determined. 
 
Insulin regulates xenobiotic metabolism through PI3K/AKT pathway [83, 85, 
101]. Previous studies have also implicated PI3K/AKT/mTOR pathway in DMBA-
induced ovotoxicity [86]. In the current study, obesity and DMBA had opposing effects 
on PI3K/AKT signaling pathway members’ gene expression. Ovaries from sesame oil-
treated obese females displayed higher Akt1 and Akt2 mRNA levels concomitant with 
upregulated pAKTSer473/Thr308 protein levels, without affecting total FOXO3, but reduced 
pFOXO3Ser253 protein expression compared to their lean counterparts. Surprisingly, 
DMBA treatment significantly reduced ovarian Akt1/2 mRNA levels in both lean and 
obese treated groups, mirrored by decreased pAKTSer473 protein in lean but not obese 
ovaries.  A decrease in pAKTThr308 protein expression was observed in the ovaries from 
obese females. Interestingly, though pFOXO3Ser253 was decreased in both lean and obese 
DMBA-treated mice, FOXO3 protein expression was not impacted by either obesity or 
DMBA.   These alterations to the PI3K pathway may be at least partially responsible for 
the altered dynamics of follicle activation observed in the obese mouse ovary.   
 
In conclusion, the ovary contains a finite number of primordial follicles, which 
once depleted, cannot be replaced; therefore ovarian xenobiotic metabolism of chemical 
compounds like DMBA which can deplete the primordial follicle pool is critical for 
protection of the female germ cell. Since insulin regulates hepatic expressed xenobiotic 
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metabolism enzymes and obesity alters insulin sensitivity in a number of target tissues, 
understanding how obesity might influence the ovary’s capacity to metabolize chemicals 
is critical. Our data is in agreement with previous studies which demonstrated that 
insulin induces the hepatic activities of EPHX1 and GST enzymes [73, 74, 101]. We 
have shown that obesity increased mRNA and protein levels of pAKT, EPHX1, GSTM1 
and GSTP1 compared to lean mice, mimicking the trend observed during insulin 
administration or re-feeding. Therefore, our data support the notion that despite insulin 
resistance in other tissues, the ovary seems to maintain insulin sensitivity and that 
obesity-induced increased insulin could increase PI3K signaling and alter xenobiotic 
gene expression leading to accelerated DMBA-induced ovotoxicity. 
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Figure 1: Effect of DMBA on ovarian weight and follicle numbers in lean and obese 
mice. At 18 weeks of age lean and obese mice were intraperitoneally (i.p) dosed with 
sesame oil or DMBA (95%; 1mg/kg) for 14 days. Mice were euthanized 3 days after the 
end of dosing; body weight measured (A), ovaries collected, trimmed of excess fat and 
weighed (B). One ovary was fixed in 4% paraformaldehyde and complete serial sections 
were prepared and subjected to histological examination for the number of healthy 
follicles in both lean and obese treated groups (C-F); (C) healthy primordial follicle 
number; (D) healthy primary follicle number; (E) healthy secondary follicle number; (F) 
healthy pre-ovulatory follicle number. Bars represent mean follicle number per ovary ± 
SEM. Different letters indicate significant (P < 0.05; n = 3) difference from respective 
pairs. 
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Figure 2: Effects of DMBA on ovarian metabolism gene expression in lean and 
obese mice 18 weeks old lean and obese female mice were treated with sesame oil or 
DMBA (95%; 1mg/kg; i.p) for 14 days. Three days after dosing, ovaries were collected, 
trimmed of excess fat and total ovarian RNA isolated. Using quantitative (q) RT-PCR, 
relative mRNA levels of (A) Gstm1, (B) Gstp1 and (C) Ephx1 were evaluated after 
normalization to the housekeeping gene, Gapdh. (D) Ovarian Gstm1, Gstp1, Ephx1 
mRNA levels in 6 week old lean and obese mice.  Values represent relative fold-change 
means ± SEM. Different letters indicate significant difference from respective pairs, P < 
0.05; n = 3. 
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Figure 3: Effect of DMBA on ovarian GSTM1 protein in lean and obese mice. 18 
weeks old lean and obese female mice were treated with sesame oil or DMBA (95%; 
1mg/kg; i.p) for 14 days. Three days after dosing, ovaries were collected, trimmed of 
excess fat and total ovarian protein was isolated (n = 3 per treatment group) from lean 
control, (LC), lean DMBA (LD), obese Control (OC) and obese DMBA (OD).  (A) 
GSTM1, (B) GSTP1 or (C) EPHX1 proteins were quantified by Western blotting, 
followed by densitometric quantification of the protein band using Carestream molecular 
imaging software version 5.0. Bars represent means ± SEM. Different letters indicate 
significant difference from respective pairs; P < 0.05; n = 3. 
239 
 
 
Figure 4: Effects of DMBA on ovarian Akt1/2 expression in lean and obese mice. At 
18 weeks of age lean and obese mice were intraperitoneally dosed with sesame oil or 
DMBA (95%; 1mg/kg) for 14 days. Ovaries were collected 3 days after the end of 
dosing, trimmed of excess fat, and total ovarian RNA isolated (n = 3 per treatment 
group). Relative mRNA expressions of (A) Akt1 and (B) Akt2 were normalized using 
Gapdh as a housekeeping gene and quantified using qRT-PCR. (C) Ovarian Akt1 and 
Akt2, mRNA levels in 6 week old lean and obese mice.  Bars represent means ± SEM. 
Different letters indicate significant difference from respective pairs, p < 0.05; n = 3. 
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Figure 5: Effect of DMBA on ovarian PI3K proteins in lean and obese mice. 18 
weeks old lean and obese female mice were treated with sesame oil or DMBA (95%; 
1mg/kg; i.p) for 14 days. Three days after dosing, ovaries were collected, trimmed of 
excess fat and total ovarian protein was isolated (n = 3 per treatment group) from lean 
control, (LC), lean DMBA (LD), obese Control (OC) and obese DMBA (OD).  Western 
blotting was performed to measure (A) pAKTSer473, (B) pAKTThr308, (C) FOXO3, and 
(D) pFOXO3Ser253 levels. Densitometry of the appropriate bands was performed using 
Carestream molecular imaging software version 5.0. Bars represent means ± SEM. 
Different letters indicate significant difference from respective pairs; P < 0.05; n = 3. 
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CHAPTER 7: HEAT STRESS ALTERS OVARIAN INSULIN MEDIATED 
PHOSPHATIDYLINOSITOL-3 KINASE AND STEROIDOGENIC  
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Abstract 
Heat Stress (HS) compromises a variety of reproductive functions in several 
mammalian species.  Inexplicably, HS animals are frequently hyperinsulinemic despite 
marked hyperthermia-induced hypophagia.  Our objectives were to determine the effects 
of HS on insulin signaling and key steroidogenic synthetic machinery components in the 
pig ovary.  Gilts (35±4 kg) were exposed to constant thermal neutral (TN; 20°C; 35-50% 
humidity) or HS conditions (35°C; 20-35% humidity; n = 3) for either 7 (n = 3) or 35 d 
(n = 3). After 7d, HS increased (P < 0.05) ovarian mRNA abundance of the insulin 
receptor (IR), insulin receptor substrate 1 (IRS1), protein kinase B subunit 1 (AKT1), low 
density lipoprotein receptor (LDLR), luteinizing hormone receptor (LHR), and aromatase 
(CYP19a).  After 35d, HS increased IR, IRS1, AKT1, LDLR, LHR, CYP19a, 
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steroidogenic acute regulatory protein (STAR), and forkhead box O3 (FOXO3) ovarian 
mRNA levels.  In addition, after 35d HS increased ovarian phosphorylated ISR1 
(pIRS1), phosphorylated AKT (pAKT), STAR and CYP19a protein levels.  
Immunostaining analysis revealed similar localization of IR and pAKT1 in the oocyte 
cytoplasm and cytoplasmic membrane of all stage follicles, and in theca and granulosa 
cells. Taken together, these results demonstrate that HS alters ovarian insulin mediated-
PI3K signaling pathway members which likely impacts follicle activation and viability. 
In summary, environmentally-induced HS is an endocrine disruptor that alters ovarian 
physiology potentially resulting in malproduction of ovarian hormones essential for 
fertility and pregnancy maintenance.  
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Introduction 
 
Ambient temperatures above an animals’ thermoneutral zone can cause heat 
stress (HS) that has detrimental effects on animal welfare and productivity (27). In a 
number of livestock species HS is also associated with a variety of female reproductive 
issues including dysregulated estrous cyclicity (39, 51, 52), reduced conception rate (14, 
28), reduced embryonic survival (58), and higher frequency of stillbirths (28, 58). From 
an agricultural perspective, HS-induced sub-optimal productivity and reproductive 
performance limits the production of high quality protein for human consumption.  
Consequently, HS jeopardizes global food security, and this is especially true for 
developing countries (8).    
 
Several studies have demonstrated that heat-stressed animals have elevated basal 
circulating insulin concentrations (10, 38, 41, 61) and an increased insulin response to a 
glucose tolerance test (11).  Energetically, this is paradoxical as HS causes a well-
conserved decrease in nutrient intake and is generally considered a hypercatabolic 
condition (9).   Reasons for elevated blood insulin (a potent anabolic signal) during HS 
are not yet fully understood, but likely include insulin’s key role in activating and up-
regulating heat shock proteins (32). Though traditionally known for regulating blood 
glucose homeostasis, insulin is a pleiotropic hormone, and it also plays a pivotal role in 
influencing normal follicle development (43, 45) through its ability to stimulate ovarian 
steroidogenesis (7). In insulin responsive cells, insulin binds to its extracellular receptor 
(IR) resulting in autophosphorylation and recruitment of the insulin receptor substrate 
244 
 
(IRS) proteins (16, 43, 57), which in turn regulate numerous downstream insulin-
mediated signaling pathways including the phosphatidylinositol-3 kinase (PI3K) 
pathway (2, 65). In humans, polycystic ovarian syndrome (PCOS) is associated with 
impaired reproduction, and these females are typically hyperinsulinemic and have hyper-
secretion of luteinizing hormone (LH) (3-5). Elevated circulating LH increases 17β-
estradiol (E2), decreases oocyte maturation and fertilization, impairs embryo quality, 
increases embryo loss and decreases overall fecundity (29).  Additionally, both insulin 
and LH regulate ovarian E2 synthesis, thus altered insulin and/or LH action could 
profoundly affect E2 physiology and consequently reduce follicle recruitment from the 
primordial pool through a negative feedback system (24). Therefore we hypothesize that 
there may be a link between HS-induced seasonal infertility and aberrant insulin 
signaling. 
 
Proper insulin-mediated PI3K signaling is not only critical for regulating 
primordial follicle activation (PFA) and recruitment (22, 30, 47, 49), but is also 
necessary for follicle maturation (15, 33), oocyte viability (49) and ovarian 
steroidogenesis (18, 68). Most downstream PI3K signaling events are governed through 
serine-threonine protein kinase B (AKT), a subfamily comprised of three mammalian 
isoforms (Akt1, Akt2 and Akt3; (23)). Upon PI3K activation, AKT is phosphorylated 
and translocated to the cell nucleus where it can regulate several targets including 
forkhead box O (FOXO 1-4) transcription factors which are critical for follicle activation 
and maturation (17) as well as apoptosis (21, 26, 54, 66). In rodent models, Akt-/- mice 
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have impaired fertility due to reduced primordial follicle viability (15), while, Foxo3-/- 
mice experience secondary infertility as a result of global PFA and their subsequent 
depletion (17). Interestingly, in oocyte specific FOXO3 overxpressing mice, unlike 
Foxo3-/- mice, PFA is prevented (34). Therefore, a proper balance in the insulin mediated 
PI3K/AKT/FOXO3 signaling pathway is crucial for female reproduction. 
 
Understanding the molecular mechanism(s) by which HS compromises 
reproductive performance is a prerequisite for developing strategies and therapeutics to 
mitigate HS-induced suboptimal fertility.  Since insulin influences ovarian PI3K 
signaling, we hypothesized that heat-induced hyperinsulinemia and aberrant insulin 
signaling may be a contributing factor to seasonal infertility during the warm summer 
months.  
 
Materials and Methods 
 
Animals and Tissue Collection 
Tissues analyzed in this manuscript were obtained as a subset from previous 
experiments.  Details regarding experimental design, animal handling, environmental 
conditions and results have been previously described (40, 53).  In brief, crossbred 
prepubertal gilts (35±4 kg) were housed in constant climate controlled rooms in 
individual pens with ad libitum feed intake. Gilts were exposed to thermal neutral (TN) 
conditions (20°C; 35-50% humidity; n = 3) or HS conditions (35°C; 20-35% humidity; n 
= 3) for 7 or 35 days. To eliminate the effects of dissimilar feed intake, an additional 
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group of gilts (n = 3) were pair-fed to the HS treatment but remained in thermal neutral 
conditions for 7d. All procedures were approved by the Iowa State University 
Institutional Animal Care and Use Committee.  Gilts were euthanized by captive bolt 
penetration, one ovary was snap frozen in liquid nitrogen and stored at -80oC and the 
other ovary was fixed in 4% paraformaldehyde.   
   
RNA isolation and real-time polymerase chain reaction (RT-PCR)  
Frozen ovaries were ground in liquid nitrogen using a mortor and pestle. The 
resulting powder was divided into two halves; one half was used for RNA isolation 
while the other half for protein purification. Total RNA was isolated using an RNeasy 
Mini kit and concentrated using an RNeasy MinElute kit according to the manufacturers’ 
protocols.  RNA was eluted using 14 L of RNase-free water and RNA concentration 
determined using an ND-1000 Spectrophotometer (λ = 260/280nm; NanoDrop 
technologies, Inc., Wilmington, DE). Prior to RT-PCR, total RNA was reverse 
transcribed into cDNA utilizing the Superscript III One-Step RT-PCR system. Two 
microliters of diluted cDNA (1:50) was amplified using gene-specific primers (see Table 
1) on an Eppendorf Mastercycler using a QuantitectTM SYBR Green PCR kit. The 
cycling program consisted of a 15 min hold at 95C and 45 cycles of: denaturing at 95C 
for 15 sec, annealing at 58C for 15 sec, and extension at 72C for 20 sec at which point 
data will be acquired. Following amplification, a melting curve analysis was conducted. 
Since there was no difference in ovarian glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) mRNA level across treatments, the relative mRNA expression of each target 
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gene measured in the current study was normalized using GAPDH as a housekeeping 
gene. The relative fold change was calculated using the 2-∆∆CT method and the results are 
presented as mean fold change ± standard error relative to the TN control group. 
 
 Protein Isolation and Western Blot Analysis  
Using tissue lysis buffer, samples were homogenized and the ovarian protein 
homogenates were placed on ice for 30 min, followed by two rounds of centrifugation at 
10,000 rpm for 15 min at 4oC. Supernatant was collected and protein concentration 
determined using a standard BCA protocol on a 96-well assay plate during which 
emission absorbance values were detected with a = 540nm excitation on a Synergy™ 
HT Multi-Detection Microplate Reader using KC4™ software (Bio-Tek® Instruments 
Inc., Winooski, VT). Samples were then stored at -80oC until further use. Using 10% 
SDS-PAGE, 50 µg of protein homogenates were separated and subsequently transferred 
to nitrocellulose membranes.  Briefly, membranes were blocked for 1-4 h with shaking 
at 4oC in 5% milk in Tris-buffered saline (TBS) with Tween-20 (TTBS). Membranes 
were incubated with primary antibody in 5% milk in TTBS for 1 h at 4oC. Equal protein 
loading was confirmed by Ponceau S staining of nitrocellulose membranes prior to 
antibody incubation. Membranes were washed with TTBS three times for 10 min. HRP-
conjugated secondary antibody was added for 1h at room temperature. Membranes were 
again washed in TTBS, followed by a single wash for 10 min in TBS. Western blots 
were detected using chemiluminescence (ECL plus reagent) and exposed to X-ray film. 
Densitometry of the appropriate sized bands was measured using Carestream molecular 
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imaging software version 5.0 (Carestream Health Inc., Rochester, NY) which eliminates 
background noise.  Proteins of interest were normalized to Ponceau S measurement.     
 
Immunofluorescence staining and microscopy analysis  
Immunofluorescence staining was performed as previously described (47). 
Briefly, following euthanasia, ovaries were fixed in 4% paraformaldehyde for 24 h, 
transferred to 70% ethanol, embedded in paraffin, serially sectioned, and every 6th 
section mounted. Three slides per ovary were deparaffinized and incubated with primary 
antibody specific to either IRα or pAKTSer473 (1:100) at 4C overnight. Secondary 
antibodies conjugated to fluorescein were applied for 1 h, followed by counterstaining 
with DAPI nuclear stain for 7 min. Immunofluorescence was visualized on a Leica 
DMI300B fluorescent microscope at  = 461 and 665 nm for DAPI (blue) and 
fluorescein conjugated (green), respectively.  
 
Statistical Analysis  
All data were statistically analyzed using GraphPad Prism software.  Comparison 
of two treatments was performed using t-test; comparison of more than two treatments 
was performed by ANOVA.  A P-value < 0.05 was considered significantly different. 
249 
 
Results 
The porcine ovary is highly enriched with insulin receptors 
Although the ovary possesses both insulin (IR) and insulin-like growth factor 1 
(IGF-1) receptors (9, 54, 56), localization of IR in porcine ovaries was confirmed by 
immunofluorescence staining to detect the alpha subunits of IR (green color in Figure 1). 
It is evident that the oocyte is highly enriched in the alpha subunit of the IR (IRα) 
protein (Figure 1).  The IRα was located in the oocyte cytoplasm and cytoplasmic 
membrane, and staining was also evident in the theca and granulosa cells.    
 
The mRNA of ovarian IR and IRS1 genes are upregulated during HS  
Using qRT-PCR primers the effect of HS on mRNA encoding the IR and IRS1 
were determined.   After 7d, HS markedly increased (P < 0.001) ovarian IR compared to 
TN controls (Figure 2A).  Although not to the same extent, IR mRNA abundance was 
also increased in the PF gilts compared to the TN controls (Figure 2A).  The HS-induced 
increased ovarian IR response was maintained (P < 0.01) after 35d (Figure 3B).  In 
contrast to IR mRNA, the IRS1 mRNA abundance on 7d was only increased in the HS 
ovaries as the PF and TN controls had similar levels of expression (Figure 2A).  
Although the magnitude of increase was less, the IRS1 mRNA level remained increased 
after 35d in the HS compared to TN controls (Figure 2B).    
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HS increases ovarian phosphorylated IRS1 in the ovary 
Concomitant with HS-induced ovarian IR and IRS1 mRNA levels, 7d ovarian 
phosphorylation of the Tyrosine 632 residue on the IRS1 protein was increased (P < 
0.05) in HS relative to the TN gilt ovaries (Figure 3A) while PF pIRS1 abundance was 
intermittent and not statistically different from either TN or HS groups.  The increase in 
ovarian pIRS1 was maintained for 35d of HS compared to the TN controls (Figure 3B).  
 
AKT1 and FOXO3 mRNA is increased during HS  
Following increased activation of insulin signaling pathway members during HS, 
whether the downstream insulin mediated PI3K members, AKT1 and FOXO3, are also 
impacted by HS was determined.  Ovarian AKT1 mRNA was increased (P < 0.05) after 
7d of HS (Figure 4A), compared to PF and TN controls and remained increased after 
35d of HS relative to TN controls (Figure 4B).  Interestingly, it is noteworthy that 
although there was no difference (P > 0.05) in FOXO3 mRNA between ovaries obtained 
from TN and HS gilts, reduced (P < 0.05) ovarian FOXO3 mRNA levels were observed 
after 7d of PF (Figure 4A). However, after 35d and in a similar pattern to AKT1, ovarian 
FOXO3 mRNA expression was increased (P < 0.05) in HS gilts relative to their TN 
counterparts (Figure 4B).  
 
HS increases ovarian AKT1 phosphorylation 
Similar to the localization pattern of IR, immunofluorescence staining revealed 
that pAKT1 protein is highly expressed in the porcine oocyte, in addition to being 
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localized to the theca and granulosa cells (Figure 5A, B). Western blotting to quantify 
the impact of HS on phosphorylated and activated AKT1 (pAKT1) protein demonstrated 
that ovaries from HS gilts, had increased (P < 0.05) pAKT1 protein levels compared to 
TN gilts after 35d of thermal treatment (Figure 5C). 
 
Expression of genes involved in ovarian steroid hormone production are affected by 
HS  
Since PI3K signaling was impacted by HS, and it is known that the insulin 
mediated-PI3K pathway can regulate ovarian steroidogenesis (1, 41, 55), we determined 
the impact of HS on mRNA expression of the genes involved in ovarian steroid 
production (Figure 6). Our data indicates that compared to TN and PF controls, mRNA 
levels of LDLR, LHR and CYP19a were elevated (P < 0.05) after 7d (Figure 6A) and that 
this HS-induced increase in mRNA abundance of these genes was maintained for 35d 
(Figure 6B).  Interestingly, STAR was not impacted by 7d of HS at the mRNA level 
(Figure 6A), but was increased after 35d of HS.  In addition, after 35d of HS (Figure 
6B), all other members of the steroidogenic pathway measured were increased.  
 
Ovarian STAR and CYP19 are elevated during HS  
Since the increase in STAR and CYP19a mRNA were unexpected, protein levels 
of these two critically important enzymes were quantified during HS. Relative to TN 
gilts, ovaries from HS gilts had increased (P < 0.05) STAR protein following 35d of 
thermal treatment (Figure 7). It is important to note that the seeming lack of STAR in 
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the TN gilts was not surprising, since they are pre-pubertal females. Compared to TN 
and PF females, ovarian CYP19a protein was elevated (P < 0.05) by HS after 7d (Figure 
8A) and this HS-induced increase was maintained for 35 d (Figure 8B). There was no 
difference (P > 0.05) in CYP19a protein levels between PF and TN gilt ovaries (Figure 
8A).  
 
Discussion 
 
Insulin plays a pivotal role in controlling carbohydrate, protein and lipid 
metabolism as well as influencing normal reproductive function (31, 43, 45). 
Physiological conditions characterized by hyperinsulinemia, including obesity and 
PCOS, are often associated with reduced fecundity.  Hyperinsulinemia has been reported 
in a number of environmentally-induced HS models, including pigs, therefore the HS 
gilt was utilized as a model of hyperinsulinemia to explore impacts of elevated insulin 
on ovarian function.  Since gilts in this experiment were in a prepubertal physiological 
state, this model presented an opportunity to determine ovarian impacts of 
environmentally-induced hyperthermia in the absence of gonadotrophin influence.    
 
Upon insulin binding, the IR undergoes conformation changes with subsequent 
auto-phosphorylation of IRβ subunits which in turn relay kinase cascades leading to 
phosphorylation of IRS proteins at various tyrosine/serine sites. Phosphorylated IRSs 
provide binding sites for the activation of various insulin mediated downstream effectors 
including PI3K. We report increased ovarian IR mRNA levels during acute (7d) and 
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chronic (35d) HS.  Interestingly, ovarian IR mRNA levels were also elevated in ovaries 
from PF gilts suggesting that restricted feeding and presumably decreased nutrient 
delivery to the ovary increases the initial capacity for insulin signaling. Concomitant 
with increased IR mRNA expression, ovaries from HS gilts demonstrated increased IRS1 
mRNA and pIRS1 protein levels during acute and chronic HS, confirming that the 
insulin-mediated signaling pathway was activated.  These results suggest that the ovary 
not only is responsive to insulin but that insulin signaling is upregulated during HS. This 
is also in agreement with previous work in rat models of diet-induced obesity, where in 
the face of elevated circulating insulin, the ovary maintained insulin sensitivity (65), and 
in our previous work using high fat diet-induced obesity in mice (Nteeba, et al., 2013). 
In rodent models, defects in IRS1 and IRS2 cause ovarian and hypothalamic dysfunction 
leading to impaired female fertility (16, 19, 43).  Since our model is independent of 
hypothalamic input, it is likely that the observed HS effects on IRS1 are ovarian specific.  
Despite the upregulation of the IR, the PF pigs had decreased IRS1:pIRS1 protein 
compared to the HS pigs and this suggests a reduced capacity of intracellular insulin 
signaling.  This differential effect between the HS and PF pIRS1 also demonstrates that 
HS directly (independent of reduced nutrient intake) alters insulin signaling.  The 
increased ovarian insulin action is similar to how non-lethal HS ameliorates systemic 
proxies of insulin insensitivity in diabetic rodents (Kokura et al., 2007, 2010) or rodents 
fed high fat diets (Gupte et al., 2009). Further, it is also similar to reports indicating 
thermal therapy (saunas and hot baths) improves insulin sensitivity in humans (McCarty 
et al., 2009). One potential mechanism by which heat offers protection from insulin 
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resistance is by upregulating HSP72; which inhibits the activation of stress kinases c-Jun 
N-terminal kinase (JNK) and inhibitor of kappa B kinase β (IKKβ; Kondo et al., et al., 
2011; Simar et al., 2012), enzymes involved in insulin resistance.   
   
To determine if the downstream pathways mediated by insulin’s binding to the 
IR are altered during HS, we investigated mRNA encoding genes involved in PI3K 
signaling. Both acute and chronic HS increased the expression of both AKT1 and 
FOXO3.  Interestingly, it is noteworthy that during reduced feed intake in the PF group, 
FOXO3 is reduced, thus the impact of inadequate nutrient intake during HS did not 
impact FOXO3 as would be energetically expected.  Previous studies have demonstrated 
that FOXO3 plays a pivotal role in maintaining the resting primordial follicular pool (17) 
in addition to influencing cell apoptosis (21, 26, 54, 66). Therefore, increased FOXO3 
during HS could be associated with impaired PFA similar to that observed in FOXO3OE 
mice (34). Such a scenario could negatively impact reproduction and result in a “barren” 
ovary since a lack of growing follicles progressing towards ovulation would result in a 
reduced number of dominant follicles required for E2 production. In addition, increased 
FOXO3 could indicate increased apoptosis, which is important in the ovary since 99% of 
oocytes are eliminated through pro-apoptotic pathways, potentially as a mechanism to 
ensure ovulation of oocytes that have the greatest reproductive potential. Thus, apoptosis 
prevention is not necessarily beneficial for the ovary and alterations to this process may 
result in ovulating an imperfect oocyte.   Similar to the localization pattern of the IR, 
pAKT1 (33, 34, 48, 49) is highly expressed in the porcine oocyte (in addition to being 
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localized to the theca and granulosa cells) and is increased by HS.  We hypothesize that 
increased AKT activation could be an ovarian attempt to sustain oocyte viability, and 
also could increase steroid production by the dominant follicles. Since the ovulation rate 
and quality of the ovulating follicles depend on the process of folliculogenesis in the 
earlier period (55), these data indicate that HS could directly (not associated with 
decreased feed intake) alter the ovarian mechanisms that regulate oocyte quality, 
viability and growth activation - all of which are potentially negative events for 
reproductive success. 
 
Similar to humans, porcine reproductive cycles are tightly regulated by a system 
of positive and negative feedback of reproductive hormones secreted and released from 
the hypothalamus (gonadotrophin-releasing hormone), the pituitary (follicle-stimulating 
hormone, luteinizing hormone, oxytocin and prolactin), the ovaries (progesterone, 17β-
estradiol, inhibins and relaxin) and the uterus (prostaglandin F2α) (55). While the major 
physiological functions of E2 in ovulation and regulation of follicular recruitment are 
well documented, it is also important to recognize that E2 is necessary for estrus display 
and maternal recognition of pregnancy in the pig, thus altered insulin signaling 
impacting E2 production could contribute to compromised fertility and increase the 
potential for early embryonic death (24, 29).  Unlike humans, pigs can ovulate more than 
15 oocytes during estrus, however, like humans, the ovulation rate and follicle quality 
depends on the preceding folliculogenesis period (55). Thus, any disruption in 
folliculogenesis could compromise ovulation and subsequent conception, while impaired 
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steroidogenesis could reduce conception rate and cause embryonic death. Additionally, 
unlike cyclic follicle recruitment which is controlled by gonadotropins, initial PFA is 
gonadotropin independent and it is thought to be tightly regulated by the PI3K signaling 
pathway (17, 22, 36, 42).  
 
Since both insulin (7, 69) and PI3K (18, 68) signaling pathways can influence 
ovarian steroidogenesis, we next examined the impact of HS on expression of genes that 
enable steroid production.  Our data revealed that mRNA levels of LDLR, LHR, STAR 
and CYP19a were elevated during both HS stages, though the increase in STAR was 
delayed. HS also increased STAR and CYP19a protein levels, relative to PF and TN 
conditions indicating the effects of HS are direct and not mediated by restricted feeding. 
Normally, STAR is upregulated in steroid producing cells in response to conditions that 
induce acute steroid biosynthesis. Under such circumstances, STAR increases 
cholesterol translocation from the outer to the inner mitochondrial membranes, the rate-
limiting step in steroid production (56). Therefore increased STAR expression during 
HS could be locally interpreted as an increased steroid production capacity, however, we 
suspect that HS compromises steroid biosynthesis and therefore STAR is being activated 
to compensate for the steroid production needs of ovarian cells. Additionally, increased 
LHR during HS could indicate that the ovary is attempting to upregulate the amount of 
LH receptors necessary to ensure ovulation.  Increased CYP19a could also locally imply 
that HS potentially alters the amount of circulating E2 since the pathway that produces 
E2 is increased, resulting in compromised fertility and estrus derangement. However, we 
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hypothesize that E2 levels are likely decreased and that the increase in the production 
pathway is a counteractive effort by the ovary to curtail dwindling levels of this critical 
reproductive hormone.  The impact of HS on reproductive hormone levels have been 
previously noted (6, 12, 13, 20, 28). In dairy cows, blood LH levels have been reported 
to either increase (50), decrease (35, 63) or stay unchanged (20, 25) during HS. 
Similarly, plasma P4 concentrations have been reported to increase (20, 59, 60), 
decrease (20, 67) or be unaltered (51, 62) with HS.  Furthermore, HS has been associated 
with reduced blood E2 concentrations (20, 62, 64) in dairy cows. Reasons for the 
inconsistencies within the literature are not clear but likely include differences in 1) 
species, 2) length and magnitude of the heat load, and 3) the incorporation of a pair-
feeding model. Regardless, these data suggest that HS alters gonadotropins and ovarian 
steroid production, in ways that are likely detrimental to reproduction.  
 
Taken together, our data indicates that the utilization of a hyperinsulinemic 
prepubertal porcine model has benefits for understanding ovarian physiological 
alterations in the absence of hypothalamic-pituitary input and that HS could be thought 
of as an endocrine disrupting environmental exposure that can negatively affect female 
reproduction.  Further, our data clearly demonstrate that the negative effects of HS on 
ovarian insulin signaling and steroid synthesis are the direct effects of environmental 
hyperthermia and not mediated by reduced nutrient intake.     
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Table 1: Primer Sequences 
 
Gene Forward Primer Sequence (5′ – 3′) Reverse Primer Sequence (5′ – 3′) 
GAPDH ACCCAGAAGACTGTGGATGG AAGCAGGGATGATGTTCTGG 
LDLR GAGTTGGCTTTTGCTCTGCT GGGTTTTGGTGAATGAATGG 
LHR CATGGCACCGATCTCTTTCT CGGAATGCCTTTGTGAAAAT 
STAR TTGGAAGAGACGGATGGAAG CCCACATTCCTGCTATTGCT 
CYP11a AGGCCAATGTTACCGAGATG ATTGCAGCATCTTGCTTGTG 
3β-HSD GACACACCTCCCCAAAGCTA TGTAGGAGACGGTGAACACG 
CYP19a GGAGCTTGGGGTTAATGGAT GGGAAGGATGCTCTTTGATG 
IRβ AGAGATTGCTGATGGGATGG AAAGGACCACATGTCGGAAG 
IRS1 GTGCGACAGAGCATCATTGT GCCTTGTTTTAAGCCTCTGC 
AKT1 ATCGTGTGGCAGGATGTGTA CTGGCCGAGTAGGAGAACTG 
FOXO3 TCAGCCAGTCTATGCAAACC CCATGTCACATTCCAAGCTC 
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Figure 1:  Effects of 7 days of HS (35oC) on IR protein levels in ovaries from pre-
pubertal gilts. Immunofluoresence staining was performed on ovarian sections from 
gilts after 7d of HS or TN conditions.  Thin arrow indicates small primary or primordial 
follicles; arrowhead indicates oocyte in secondary follicle, block arrow indicates oocyte 
in antral follicle.  Green staining indicates IR protein; Blue staining represents DNA. 
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Figure 2: Impact of HS on ovarian IR or IRS1 mRNA. qRT-PCR was performed on 
ovarian tissues from gilts after (A) 7d or (A) 35d of TN, PF or HS conditions.  Different 
letters indicate statistical difference between treatments; P < 0.05.  * indicates P < 0.05, 
different from TN. 
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Figure 3:  HS-induced effects on ovarian pIRSTyr632 protein.  Western blotting was 
performed on ovarian tissues from gilts after (A) 7d or (A) 35d of TN, PF or HS 
conditions.  Different letters indicate statistical difference between treatments; P < 0.05.  
* indicates P < 0.05, different from TN. 
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Figure 4:  Impact of HS on ovarian AKT1 or FOXO3 mRNA. qRT-PCR was 
performed on ovarian tissues from gilts after (A) 7d or (A) 35d of TN, PF or HS 
conditions.  Different letters indicate statistical difference between treatments; P < 0.05.  
* indicates P < 0.05, different from TN. 
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Figure 5: Effect of HS on ovarian pAKT1 protein localization and level. (A, B) 
Immunofluoresence staining was performed on ovarian sections from gilts after 7d of 
HS or TN conditions.  Thin arrow indicates small primary or primordial follicles; 
arrowhead indicates oocyte in secondary follicle.   Green staining indicates pAKT1 
protein; Blue staining represents DNA. (C)  Western blotting was performed on ovarian 
tissues from gilts after 35d of TN or HS conditions.  * indicates P < 0.05, different from 
TN. 
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Figure 6:  Impact of HS on ovarian steroidogenic gene mRNA. qRT-PCR was 
performed on ovarian tissues from gilts after (A) 7d or (A) 35d of TN, PF or HS 
conditions.  Different letters indicate statistical difference between treatments; P < 0.05.  
* indicates P < 0.05, different from TN. 
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Figure 7:  HS-induced effects of ovarian STAR protein. Western blotting was 
performed on ovarian tissues from gilts after 35d of TN or HS conditions.  * indicates P 
< 0.05, different from TN. 
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Figure 8:  Effect of HS on ovarian CYP19a protein. Western blotting was performed 
on ovarian tissues from gilts after (A) 7 or (B) 35d of TN, PF or HS conditions.  
Different letters indicate statistical difference between treatments; P < 0.05. * indicates 
P < 0.05, different from TN. 
 
274 
 
CHAPTER 8: GENERAL CONCLUSION 
 
The ovary performs two major roles; 1) production of oocytes required for 
perpetuation of species and 2) synthesis of steroid hormones required for cyclicity and 
secondary sexual development. Optimal reproduction is achieved when there is a 
balance between folliculogenesis and steroidogenesis in addition to proper ovotoxicant 
chemical metabolism to ensure protection of the ovarian follicular pool and developing 
embryo from potential damage. Perturbations in these processes are likely to alter 
ovarian function and consequently lead to impaired fecundity and other associated 
reproductive pathologies. This dissertation research focused on investigating impacts of 
metabolic perturbations on ovarian folliculogenesis, steroidogenesis and xenobiotic 
biotransformation. Specifically, mRNA and/or protein expression profiles of insulin, 
PI3K, steroidogenic, inflammatory and chemical metabolism members were quantified 
using qRT-PCR, Western blot or immunohistochemistry techniques using three models: 
1) high fat diet (HFD)-induced obesity, 2) a transgenic mouse model of progressive 
obesity and 3) a porcine model of hyperinsulinemia. 
 
Determination of suitable mouse model  
 
Although HFD-fed mice develop obesity, they require a long period of dietary 
treatment (~7 months). Additionally, although the mice develop diabetes associated with 
obesity as a result of overnutrition (80), there is no frank hyperglycaemia present in 
genetically normal animals and hence they are not the ideal model in which to mimic the 
obese state in humans. This prompted us to use the lethal yellow mouse which develops 
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progressive obesity starting at 8 weeks of age (41, 47). By 12 weeks, these mice also 
display progressive hyperinsulinemia (93), hyperleptinemia (7), along with insulin (41) 
and leptin (32) resistance. Since they lack a satiety signal due to hypothalamic agouti 
expression, they eat a normal diet until overweight - these characteristics make the lethal 
yellow mouse an excellent model for human obesity. 
 
Impact of changes in central metabolism on ovarian signaling pathways 
 
1) Insulin signaling 
Proper insulin signaling is essential for ovarian folliculogenesis, steroidogenesis 
and metabolism. Events that induce dysregulation of insulin signaling cascades in the 
reproductive axis result in a number of reproductive impairments. In the two models of 
obesity, increased body weight was associated with increased fasting blood glucose, 
accompanied by reduced glucose clearance. These observations were suggestive of 
reduced insulin activity and therefore we hypothesized that during obesity, ovarian 
insulin signaling is impaired. Our data revealed that during high fat diet (HFD)-induced 
obesity, there was a trend for decreased ovarian Insr, Irs1 mRNA and total INSR protein 
expression, locally meaning compromised insulin signaling. However, progressive 
obesity was associated with a temporal increase in Irs1, Irs2 and Irs3 mRNA as well as 
pIRS1Ser302 protein levels, perhaps indicating that the ovarian insulin signaling pathway 
is active in ovaries from obese mice. Previously reported effects of obesity on expression 
of insulin signaling members in a number of tissues are not conclusive. For instance 
consistent with our HFD results, reductions in expression of insulin receptor numbers 
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during obesity has been observed in human muscle (75) and adipose tissue (19). In 
contrast and similar to our progressive obesity data, increased phosphorylation of both 
IRS1 and IRS2 with obesity also have been observed in the rodent reproductive axis (11, 
89). Similarly, insulin induced-PI3K activation is maintained in the liver despite its 
downregulation in the muscle of diabetic rodent models, HFD-fed obese mice and obese 
monkeys (25). Interestingly, other studies have observed no effect of HFD-induced 
obesity on INSR (3, 26) or IRS1 (26, 38, 40). Taken together, these results indicate the 
complexity of obesity effects on insulin signaling members which may be species-, 
tissue- and/or time-specific. Despite the disharmony in available data, it is known that 
follicular fluid contains insulin and that insulin levels are elevated in both serum and 
follicular fluids of obese females compared to lean controls (71, 84). Therefore, our 
obesity data suggest that perturbation in insulin signaling is one of the underlying 
mechanisms for obesity-associated reproductive disorders. 
 
In a similar manner to progressive obesity, ovarian INSR, IRS1 mRNA and 
pIRS1 protein levels were increased during acute and chronic heat stress, suggesting that 
the ovary was responsive to HS-induced hyperinsulinemia. Interestingly, ovarian INSR 
mRNA levels were also elevated in ovaries from PF gilts confirming ovarian sensitivity 
to changing blood glucose levels due to underfeeding. Since these were pre-pubertal 
gilts, it is likely that the HS effects on IRS1 are independent of hypothalamic input and 
therefore can be considered ovarian specific. Rodent models, with defects in IRS1 and 
IRS2 experience ovarian and hypothalamic dysfunction concomitant with impaired 
277 
 
female fertility (13, 20, 63). In a number of in vitro studies, insulin administration 
increases the percentage of primordial follicles transitioning to the primary stage in 
cultured human ovarian cortex (46), rat ovaries (37, 52) and bovine cortical pieces (28). 
In canines (74) and fetal hamster cultured ovaries (97), elevated insulin concentrations 
promoted pre-antral follicular growth and viability, underscoring the importance of 
insulin signaling in regulating different stages of ovarian folliculogenesis. Overall, our 
data in conjunction with the above literature suggest that aberrant insulin signaling 
induced by changes in central metabolism is likely one of the mechanisms underlying 
reproductive disorders associated with both obesity and HS. Future studies to decipher 
the molecular pathways mediating hyperinsulinemia-induced alterations to ovarian 
physiology will advance our understanding and pave ways for therapeutic intervention. 
Additionally, although serum insulin levels are elevated during HS, we don’t know 
insulin levels in follicular fluid during HS.  
 
2) PI3K signaling  
PI3K signaling is a central pathway that integrates the reproductive and 
metabolic functions of the mammalian ovary (1). Alterations in expression of proteins 
involved in this pathway have been previously reported to undermine reproductive 
potential (1, 45, 67, 68). Both insulin and KITLG through interaction with their cognate 
receptors can activate the PI3K-AKT dependent pathway in a number of tissues 
including the ovary (39, 43, 69). For the first time, we demonstrated that obesity 
increases ovarian mRNA levels of Kitlg and its receptor concomitant with increased 
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Akt1 and decreased Foxo3a mRNA expression (56), and that in mice, this increase 
follows a temporal pattern with progressive obesity (Nteeba, et al. under review). It is 
interesting that unlike the inconsistence in changes induced by HFD-induced and 
progressive obesity models in insulin signaling members, alterations to ovarian Kitlg and 
cKit were consistent in both models of obesity used in our studies. KITLG-cKIT 
signaling is a pro-survival pathway that is essential for optimal ovarian folliculogenesis 
(43, 61, 94) and steroidogenesis (50, 60). Blocking of KIT receptor using an anti-KIT 
antibody, ACK2 in human ovarian follicles was demonstrated to induce ovarian 
follicular atresia (17). Moreover, like insulin, KITLG supplementation in culture media 
has been demonstrated to promote the transition of primordial to the primary follicle 
stage in bovine ovarian cortical pieces (29) and rodents (61, 94).  
 
Importantly, both insulin and KITLG signaling seems to impact similar ovarian 
pathways (PI3K-AKT) and lead to similar changes in ovarian folliculogenesis (increased 
follicle activation). It is therefore not surprising that previous studies using cultured 
neonatal rat ovaries (37, 52), found that insulin and KITLG have an additive effect for 
increased primordial follicle activation. Therefore, in addition to aberrant insulin 
signaling, hyperactivation of KITLG-cKIT signaling could be another pathway 
underlying obesity-induced reproductive impairments. Although our studies revealed 
that members in these two signaling pathways are altered during obesity, future studies 
that could separate the effects of insulin from those of KITLG during obesity will 
advance our understanding. 
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We have also demonstrated that during obesity pAKTSer473 and/or pAKTThr308 are 
increased in theca cells (56) and total ovarian homogenates (54), indicating increased 
ovarian PI3K-AKT activation in obese females. Although total ovarian FOXO3A protein 
was not significantly impacted during our studies (54), there was a trend for reduction in 
total FOXO3A protein expression (Nteeba, et al. under review) and a significant under 
expression of pFOXO3Ser253 (54) during obesity. Whether these changes are direct 
interactions between the IRS or involve other signaling mediators is difficult to surmise 
from the current data. However, hyperactivation of PI3K-AKT signaling pathway, could 
adversely impact ovarian function through accelerating the rate of primordial follicles 
activation and recruitment in to the growing pool with eventual death of most of those 
follicles, leading to accelerated premature ovarian failure (18, 36, 44, 45, 70). Therefore 
the upregulation of insulin-KITLG-cKIT-AKT1 signaling pathway by obesity as 
observed in our studies could be a potential mechanism underlying obesity-induced 
over-activation of primordial follicles into the growing follicular pool previously noted 
in rodent model (54, 86).  
 
In gilts, mRNA expression of AKT1, FOXO3 and pAKT1 protein levels were 
elevated during acute and chronic HS, indicating that PI3K-AKT1 dependent signaling 
pathway is activated by HS, likely due to increased circulating insulin. FOXO3 plays 
important roles in apoptosis (24, 31, 78, 92), cell cycle arrest (14, 83) and is believed to 
regulate the rate of initial primordial follicle activation (5, 8, 18). In rodent models, 
FOXO3-deficient mice display global primordial follicle activation while oocyte specific 
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FOXO3-overexpression primordial follicle activation is prevented (45). Although each 
of these FOXO3 alterations had contrasting effects on the primordial follicular pool, they 
all resulted in to impaired fertility, highlighting the importance of proper FOXO3 
expression in ovarian physiology. In the cycling sow, increased FOXO3 expression 
could mean impaired primordial follicle activation a scenario which could halt 
folliculogenesis leading to reduced number of dominant follicles required for E2 
production and subsequently compromise reproductive potential. Additionally, if 
increased FOXO3 is channeled towards increased apoptosis, this could be important in 
ensuring that imperfect oocytes are eliminated before ovulation and thus minimizing the 
risk of passing on damaged germline. Although, we did not determine FOXO3 protein 
levels in these samples due to challenges in finding appropriate antibodies against 
porcine FOXO3, we think that the observed HS-induced increased FOXO3 is directed 
towards impaired folliculogenesis and less apoptotic pathways. This is likely true since 
HS animals have compromised fecundity, and recently FOXO3 knockdown in pre-
pubertal pigs was associated with increased primordial oocyte activation (51). Future 
studies should also investigate the impact of HS on KITLG-cKIT signaling members, 
since this pathway is critical for porcine oocyte survival.   
 
3) Folliculogenesis 
Although no impact of obesity on ovarian weight was observed, ovaries from 
obese mice had fewer primordial and primary follicles with increased larger/tertiary 
follicle subtypes (54). This difference in follicle populations could indicate increased 
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activation of follicles from the primordial follicle pool, which could lead to accelerated 
premature ovarian insufficiency. This scenario is also supported by upregulated ovarian 
insulin-KITLG-KIT-PI3K signaling. Hyperactivation of these signaling molecules is 
associated with increased activation of primordial follicles to the growing follicles. 
Additionally, our results show that the steroidogenic pathway leading to E2 production is 
altered by progressive obesity and hyperthermia both of which are associated with 
hyperinsulinemia. In a number of studies, reduced E2 levels have been reported to 
stimulate primordial follicle activation from the resting to the growing pool (9, 10).  
Although we did not count follicles in HS gilts, these data support the observed low 
numbers of primordial follicles and higher numbers of growing follicles observed in 
ovaries from obese relative to lean mice. Taken together, these results are indicative that 
changes to central metabolism, may trigger changes in the intrinsic ovarian signals 
responsible for initiation of follicle activation and recruitment, adversely impacting 
female fecundity.  
 
4) Steroidogenic members 
Progressive obesity impacted ovarian cyclicity by decreasing the length of time 
spent in estrus with a concomitant increase in the length of the diestrus phase. 
Physiologically, ovarian E2 is predominantly associated with estrus and P4 with diestrus 
phases (48). Therefore, shorter length in the estrus stage would imply lower E2 levels 
while longer diestrus stages would imply more sustained P4 levels in obese females. E2 
is required for ovulation, whereas P4 is required for implantation along with 
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establishment and maintenance of pregnancy. In premenopausal women, a higher P4/E2 
ratio during follicular phase is associated with anovulation and/or premature 
luteinization (95), leading to compromised fertility. Interestingly, although genes 
involved in ovarian steroidogenesis were upregulated during early stages of obesity, at 
later stages of obesity establishment and consistent with the cyclicity data these genes 
were downregulated. Thus, this data implies that the pathways for production of both P4 
and E2 are compromised with progressive obesity, which could impact ovulation and 
subsequently compromise the reproductive capacity of obese females. Furthermore, 
these results underscore the importance of considering the time point at which data is 
collected when interpreting obesity associated ovarian impacts. Similar to early stages of 
obesity, ovarian steroidogenic members were elevated during HS in pre-pubertal gilts, 
which could alter the amount of circulating E2 and P4, resulting in estrus derangement 
and impaired fertility. Taken together these data suggest that changes to central 
metabolism lead to alterations in the estrous cycle and signaling cascades necessary for 
production of ovarian steroidogenic hormones, potentially negatively impacting oocyte 
competency, ovulation, conception rate and embryonic survival, thereby compromising 
female reproductive capacity. 
 
5) Inflammatory members 
Inflammatory pathways are involved in several ovarian processes to aid optimal 
fertility (12, 22, 53). For example they are involved in ovarian cellular proliferation and 
apoptosis (6) as well as steroidogenesis and ovulation (49, 85, 88). Despite their 
283 
 
beneficial effects, alterations in inflammatory pathways could negatively impact ovarian 
function. During HFD-induced obesity, obese female mice had increased adipocyte size, 
immune cell infiltration and the mRNA expression of immune cell and inflammatory 
markers in the peri-ovarian fat pad compared to the lean littermates (55). This was the 
first study to demonstrate that hypertrophic expansion of obese peri-ovarian adipose 
tissue is associated with crown-like structure formation and inflammation in obese 
female mice. Although humans and mice differ in the deposition of fat around the ovary, 
inflammatory cytokines produced in intra-abdominal adipose tissue in humans could 
potentially impact ovarian physiology due to the proximity of both tissues. Additionally, 
changes in peri-ovarian adipose tissue were associated with increased mRNA levels of 
pro-inflammatory cytokines, TNFα, RELA, Il6 and the oxidative stress marker, Nos2 in 
the ovaries of obese mice (55). Similarly, progressive obesity was also associated with 
increased TNFα-NF-ҡB dependent pathway indicating increased activation of 
inflammatory pathways in ovaries of obese mice. Dysregulation in ovarian Nos2 has 
been linked to impaired ovulation (33), ovarian cancer (34), endometriosis (81), and 
infertility (2, 58, 72). Aggravated inflammation in the ovary is associated with polycystic 
ovary syndrome (30, 65), endometriosis (15, 23) and premature ovarian failure (88). 
Therefore obesity-induced changes in inflammatory signals can adversely impact 
ovarian function and pose dire consequences for female fertility.  
 
 
 
284 
 
6) Xenobiotic metabolism members 
The ovary contains a finite number of primordial follicles, which once depleted, 
cannot be replaced; therefore ovarian xenobiotic metabolism of chemical compounds 
like DMBA which can deplete the primordial follicle pool is critical for protection of the 
female germ cell. Since insulin regulates hepatic expressed xenobiotic metabolism 
enzymes and obesity alters insulin sensitivity in a number of target tissues, 
understanding how obesity might influence the ovary’s capacity to metabolize chemicals 
is critical. Our data demonstrated that ovarian expressed mRNA and/or protein levels of 
GSTM1, GSTP1 and EPHX1 were upregulated but CYP2E1 was downregulated during 
both HFD-induced (56) and progressive obesity (Nteeba, et al. under review). 
Furthermore and for the first time, our results demonstrated that obesity accelerated 
DMBA-induced ovotoxicity (54). Therefore, our results not only show that ovaries from 
obese female mice have altered xenobiotic metabolism, these results are also suggestive 
that if similar changes are occurring in humans, those females would have increased 
susceptibility to environmental exposures including carcinogens and teratogens which 
could also potentially explain the increased rates of miscarriage (59, 66) and increased 
offspring birth defects in obese mothers (59) in addition to poor oocyte quality (64). 
Although, these enzymes are principally involved in the detoxification of xenobiotic 
compounds, their action can also lead to bioactivation of some environmental 
compounds, leading to increased toxicity. The ovary therefore requires the capacity to 
metabolize and detoxify these compounds in order to protect the female germ cell and 
ensure sound ovarian function.  
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7) MicroRNAs 
MicroRNAs are known posttranscriptional regulators of a number of biological 
processes including insulin signaling (27, 82, 87), PI3K signaling (57, 82, 91, 96), 
steroidogenesis (76, 77), adipocytes differentiation (90) and inflammation (35, 79, 90). 
During HFD-induced obesity, it was found that the ovaries from obese mice had 
decreased miR-21, miR-103, miR125b and miR143, however, miR-184 levels were 
increased (55, 56). Given the fact that these microRNAs regulate many targets, their 
dysregulation in the ovary during obesity could have wide implications. For instance in 
rodent models, downregulation of miR-21 (21) and upregulation of miR-184 (76, 77), 
negatively impacted ovarian steroidogenesis leading to reduced ovulatory rates. 
Additionally, loss or inhibition of miR-21 (16, 42) and increased miR-184 concomitant 
with reduced miR-205 (4, 96) expression negatively regulates PI3K-AKT signaling, 
potentially impacting PI3K-mediated death/survival functions and ovarian 
folliculogenesis. However, our data revealed that despite elevated miR-184 concomitant 
with decreased miR-205 and miR-21 levels, PI3K-AKT signaling was upregulated, 
suggesting that either the actions of these microRNAs were not sufficient to modulate 
PI3K-AKT actions or their changes are directed towards other ovarian processes 
including steroidogenesis and apoptosis (16).  
Our data also revealed that ovaries from obese mice displayed a 74% and 96% 
decrease in miR-125b and miR-143 levels, respectively, supporting increased Tnfα 
transcription activity. Downregulation of miR-125b (35) and miR-143 (90) is associated 
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with increased Tnfα mRNA expression which is supported by increased inflammatory 
signaling pathway members observed during HFD-induced (55) and progressive obesity 
(Nteeba et al. under review). Besides its role in inflammation, miR-143 is critical for in 
utero primordial follicle development, raising concerns about the impact of obesity on 
the neonatal ovary. Lastly, although the impact of obesity on miR-103 levels in extra-
ovarian tissues is inconsistent with increased (62, 73, 82) and decreased (90) expression 
being reported, it has been suggested that silencing miR-103 improves insulin sensitivity 
in adipocytes (82). Therefore observed low miR-103 level in ovaries from obese mice is 
in agreement with increased insulin signaling during progressive obesity. 
 
Future areas to address 
Although these studies have resulted in fascinating novel findings, it is important 
to note that these results have also generated interesting questions for future 
considerations. For instance our data demonstrated that obesity is associated with lower 
number of primordial and primary follicles but increased number of growing follicle 
subtypes, perhaps indicating increased follicle activation and recruitment. While these 
changes were accompanied by upregulation of insulin-KITLG-KIT-AKT dependent 
pathway, which notion could support the observed changes in follicle numbers, it was 
not possible from our data to clearly determine which molecule is the major regulator 
and whether other factors are involved in these changes. Therefore further studies will be 
needed to clearly define the mechanism(s) underlying obesity-induced changes in 
follicle subpopulations.  
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During HFD-induced obesity, changes in the peri-ovarian pad associated with 
changes in ovarian tissue were observed, however we could not answer from our studies 
how much of the changes we see are due to adipose tissue contributions. 
From our data it is apparent that during obesity, both KITLG-cKIT and insulin 
signaling members are upregulated however, the relationship between insulin and 
KITLG signaling remains unclear at the moment. 
Obesity and HS are both associated with a number of additional metabolic 
perturbations including hyperinsulinemia, hyperleptinemia and/or LPS which could all 
influence ovarian physiology.  From our studies it was not possible to decipher which of 
these alterations is chiefly responsible for the molecular changes we saw in ovaries from 
obese mice and HS pigs.  
We did not measure the steroid hormones at each time point. These 
measurements would have allowed us to see how ovarian steroids change over time from 
the onset through progression of obesity. 
 During HS study, we used pre-pubertal gilts, future studies need to explore if 
these changes are similar in cycling sows. Additionally, future studies need to explore 
how HS impacts steroid hormone concentrations in both the follicular fluid and serum 
and determine which concentrations correlate with ovarian changes observed during HS. 
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Overall summary 
 
The data presented herein, demonstrates that ovarian insulin-KITLG-KIT-AKT 
signaling pathway is active and upregulated during central metabolic alterations. 
Perturbations to ovarian insulin-KITLG-KIT-AKT signaling pathway are likely to 
impact 1) follicle activation, oocyte viability and recruitment, 2) steroid hormone 
biosynthesis, and 3) xenobiotic biotransformation, potentially accelerating susceptibility 
to chemical exposure. All of these scenarios can lead to impairment of ovarian function, 
and may at least partially explain why female fecundity is compromised during altered 
metabolic states. Future studies will be required to address the cellular origin and cause-
effect relationship between the observed changes in the ovary and the implications of 
these changes on ovarian function. This is critical because although the central focus for 
this dissertation has been on insulin, elevated circulating leptin and LPS present in both 
obesity and HS could potentially also affect ovarian physiology. Further understanding 
of the mechanisms that are involved in the onset and progression of the central 
metabolic-associated changes in the ovary will be of value in order to develop improved 
strategies to mitigate reproductive dysfunction experienced by both obese females and 
HS animals.  
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APPENDIX 
 
 
Figure 1. Impact of genotype on glucose clearance in mice. A glucose tolerance test 
(GTT) was performed at 6 weeks, by administration of bolus glucose (1 mg/kg), 
followed by measurement of blood glucose levels over time (30, 60, 90 and 120 min). 
There was no difference (P > 0.05) in fasting blood glucose levels and glucose clearance 
between the lean (CT) and obese (LY) mice.  n = 5 mice per treatment.    
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Figure 2. Obesity decreased glucose clearance rate in mice at 12 weeks of age. A 
glucose tolerance test (GTT) was performed at 12 weeks, by administration of bolus 
glucose (1 mg/kg), followed by measurement of blood glucose levels over time (30, 60, 
90 and 120 min). Obese (LY) mice had increased (P < 0.05) fasting blood glucose levels 
relative to their lean (control) littermates in addition to reduced (P < 0.0001) glucose 
clearance, indicating that obese mice were becoming insulin insensitive.  n = 5 mice per 
treatment.    
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Figure 3. Obesity decreased glucose clearance rate in mice at 18 weeks of age.  A 
glucose tolerance test (GTT) was performed at 18 weeks, by administration of bolus 
glucose (1 mg/kg), followed by measurement of blood glucose levels over time (30, 60, 
90 and 120 min). Obese (LY) mice had increased (P < 0.01) fasting blood glucose levels 
relative to their lean (control) littermates in addition to reduced (P < 0.0001) glucose 
clearance, indicating that insulin sensitivity is being compromised in obese.  n = 4 mice 
per treatment.    
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Figure 4. Obesity decreased glucose clearance rate in mice at 24 weeks of age.  A 
glucose tolerance test (GTT) was performed at 24 weeks, by administration of bolus 
glucose (1 mg/kg), followed by measurement of blood glucose levels over time (30, 60, 
90 and 120 min). Obese (LY) mice had increased (P < 0.05) fasting blood glucose levels 
relative to their lean (control) littermates in addition to reduced (P < 0.0001) glucose 
clearance, indicating that obese mice were becoming less insulin sensitive.  n = 5 mice 
per treatment.    
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Figure 5. Impact of obesity on ovarian energy utilization gene expression in mice. 
At 18 weeks, we determined the impact of obesity on glucose metabolism using PCR 
arrays. Obesity increased genes involved in gluconeogenesis (Fbp2, G6pc and Fbp1) 
while decreasing those in glycosis (Pklr and Gck). Interestingly, some members of the 
TCA cycle were increased (Sdha, Sdhb and Suclg2) while others being decreased (Acly 
and Mdh1b). Similar effects of obesity were observed on gene expression partner of the 
pentose phosphate pathway members where Rpe was increased but Rapia tended to 
decrease with obesity. Glycolysis, the TCA cycle and the pentose phosphate pathways, 
breakdown glucose into metabolites necessary for energy production, while 
Gluconeogenesis stores excess energy as glucose. These data suggest that the ovary is 
rensposive to changes in energy intake. 
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Figure 6. Impact of HS on porcine ovarian energy utilization gene expression. Using 
the 7 day time point group, we investigated the impact of HS on glucose metabolism 
using PCR arrays. Both PF and HS increased genes involved in gluconeogenesis.  The 
genes involved in glycolysis showed a general trend of reduction by PF but an increased 
trend in HS; demonstrating that thermal stress itself may impact energy requirements by 
the ovary. The genes in the TCA cycle were regulated in the same manner by PF and 
HS, with the exception of ACO1, however, the pentose phosphate pathway was reduced 
by HS.  Genes in the regulation of glucose metabolism group were increased by HS 
compared to TN and PF.  These data are not useful only in the context of HS, but also 
provide valuable information regarding the ovarian response to nutrient deprivation.      
 
